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Chapter 1
D endritic  cells in  specific  im m une resp o n ses
The im m une system protects u s  against diseases caused by invasion of 
pathogens such as bacteria and viruses. Many different cell types, both from 
the specific and non-specific arm  of the im m une system, cooperate to 
eliminate these invaders. The non-specific, innate, im m une system acts as a 
prim ary defense line against invading micro-organisms, bu t does not 
discrim inate between them. Macrophages are im portant cells of th is non­
specific arm  of the im m une system  and digest and degrade the foreign 
invaders. The specific, acquired, im m une system has two additional unique 
features. First, the specific im m une system can distinguish distinct 
antigens. This specificity is mediated by m em brane receptors th a t have an 
extremely large variability of s tructu res of antigen-binding sites. Second, the 
specific im m une response confers immunological memory, so tha t 
subsequent encounters with a  pathogen stim ulates an increasingly effective 
protective response. In addition, the specific im m une system  amplifies the 
m echanism s of natu ra l im m unity by directing and focusing the cells th a t are 
needed to the sites of foreign antigen entry.
The specific arm  of the im m une system consists of T and B lymphocytes. B 
lymphocytes form the hum oral arm  of the specific im m une system. They are 
activated by binding of antigens to specific receptors a t their cell surface and 
are involved in the production of soluble antibodies. These antibodies bind 
specifically to the foreign organism s to which they have been directed and 
th is finally resu lts in the elimination of the foreign organisms. The cellular 
part of the specific im m une system is mediated by T cells, which recognize 
foreign organism s in an indirect m anner. T cells recognize short peptide 
fragments, th a t are derived from proteins degraded inside the antigen 
presenting cell (APC). These antigens are presented at the cell surface in the 
context of major histocompatibility complex (MHC) molecules [1]. There are 
two types of MHC molecules, MHC class I and class II. Class I molecules are 
expressed by alm ost all cell types, w hereas class II is expressed mainly by B 
cells, m acrophages and dendritic cells (DC). The cytokine interferon gam m a 
can induce MHC class II expression on diverse cell types [1]. Mature T cells 
can be divided into two m ain populations, those expressing CD4 or CD8 
molecules a t their cell surface. Class I molecules mainly present peptides 
derived from cytosolic proteins to CD8+ cytotoxic T cells [2], w hereas class II 
molecules predom inantly present peptides from exogenous origin to CD4+ T 
cells [3]. Class I peptides are primarily generated in the cytosol by the large 
m ulticatalytic proteasome complex. Some of the peptide fragm ents are 
transported into the endoplasmic reticulum  (ER) by the TAP molecules 
(transporter associated with antigen processing). Once inside the ER, a 
ternary complex, consisting of peptide, MHC class I heavy chain and ß2- 
microglobulin is formed and subsequently transported to the cell surface for 
presentation to T cells [4]. Class II peptides are derived from exogenous 
proteins th a t are degraded in the endosom al/lysosom al pathway, and loaded 
onto class II molecules in endosom al com partm ents before transport to the 
cell surface for presentation to CD4+ T cells. The peptides presented by class
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II molecules are not only from exogenous origin, i.e. taken up by the cell, bu t 
can also be derived from self-proteins, including cell surface proteins like 
MHC and MHC-associated molecules and endosom al proteins [5].
CD8+ cytotoxic T cells are capable of lysing cells bearing foreign epitopes. 
CD4+ cells have a  two-fold function. They provide help in the form of 
cytokines to B cells and other T cells in order to become activated, mediated 
by T helper 2 and T helper 1 cells, respectively. Furtherm ore, cytotoxic CD4+ 
T cells attack  class II positive cells presenting foreign antigen, by either 
activation of non-specific cells like m acrophages and granulocytes or by 
direct cytotoxicity (Fig. 1). Both functions are mediated and regulated by 
differential cytokine production [6]. Both CD4+ and CD8+ T cells only 
recognize foreign epitopes in the context of their own class I and II 
molecules. During the differentiation of T cells in the thym us and bone 
marrow, T cells recognizing autologous MHC complexes are positively 
selected [7]. Subsequently, T cells recognizing self-epitopes are negatively 
selected, resulting in the elimination of m ost self-reactive T cells [8]. Peptides 
presented in the context of both MHC class I and II are recognized 
specifically by the T cell receptor (TCR), which resu lts in different activation 
signals. The strength of the activation signal depends mainly on the nature  
of the MHC-peptide complex, the presence of other m em brane molecules and 
the s ta tu s  of the T cell. The interaction between TCR and MHC-peptide 
complex ultim ately leads to activation and proliferation. This is mediated by 
upregulation of adhesion molecules, induction of T cell counter-receptors 
and initiation of cytokine synthesis, in addition to the signal provided via the 
TCR [9]. A naïve T cell th a t has never encountered antigen differs form 
activated T cells in its need for a  second signal in order to become activated. 
This signal is provided by co-stim ulatory molecules on the antigen- 
presenting cell, which bind to receptors on T cells. Upon specific ligand 
binding, the receptors deliver signals th a t act synergistically with TCR- 
induced signals to enhance T cell activation.
B and T lymphocytes are the m ediators of specific immunity, bu t their 
function is under the control of dendritic cells, the professional antigen 
presenting cells (APC) of the im m une system. DC are highly mobile cells and 
by the sequential migration of DC into and from tissues they serve as 
sentinels of the im m une system [10, 11]. As im m ature cells, DC are 
scattered throughout the body, and are specialized in antigen uptake. They 
efficiently take up particles and microbes by phagocytosis and sample 
extracellular fluid and solutes by macropinocytosis and cell surface 
scavenger receptors [12]. Antigen uptake and inflammatory cytokines are 
two of the signals th a t induce DC migration to the secondary lymphoid 
organs, where they can activate naive T lymphocytes and probably also B 
lymphocytes, to initiate prim ary im m une responses (Fig. 2). Moreover, DC 
may also provide the link between the innate and acquired im mune 
response, as they can also activate natu ra l killer (NK) cells [13]. This life 
cycle particularly holds for Langerhans cells and myeloid DC. It is now well 
appreciated th a t multiple distinct DC lineages exist, leading to the intriguing
13
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possibility th a t distinct DC subsets may follow distinct migration pathw ays 
and perform unique functions [14]. Additionally, the developmental state of 
the DC could determine its functional properties. The sam e DC precursor 
can give rise to different functional types of DC depending on the culture 
conditions. Accordingly, w hereas m ost studies focus on the power of DC 
from myeloid origin to activate T cells, recent studies point to an im portant 
role for DC in the induction of peripheral tolerance. The latter process seems 
to be mediated by resident DC of the lymphoid lineage [15]. In the mouse, a 
distinct lymphoid DC subset in the spleen has been characterized th a t is 
considered to play a  role in m aintaining self-tolerance [16]. These DC have 
also been found in the T-cell areas of secondary lymphoid organs, and are 
positive for CD8a and FasL [17]. However, th is DC population has recently 
been found to produce high levels of IL-12 and stim ulate vigorous T helper 
(Th) 1 responses [18, 19]. In hum an, tonsilar plasmacytoid DC might 
represent a  lymphoid DC subset with different functional properties [20].
Figure 1. Presentation of exogenous and endogenous antigens to different T cell subsets.
A. Extracellular antigen are phagocytosed by macrophages or B cells and presented as 
processed peptides in the context of MHC class II to CD4+ T cells. B cells use their B cell 
receptors for the specific uptake of antigen.
B. Endogenously synthesized antigens (for example viral antigens) are processed by the APC 
and presented in the context of MHC class I to CD8+ cytotoxic T cells (CTL). Thereby, the 
CTL get activated and are able to lyse target cells expressing the foreign antigen.




Thymic DC are probably involved in the negative selection process during T 
cell education in the thym us and are considered to be of lymphoid origin 
[15]. Thymic DC specifically express thym us-expressed chemokine (TECK) 
[21], which has chemotactic activity for isolated thymic precursors. However, 
neutralizing antibodies to TECK did not prevent thym us re-colonization by T 
cell precursors [22].
There is still limited understanding  of how in vitro cultured DC relate to the 
in vivo DC subsets. In vitro generated DC can either be obtained from 
monocytes or CD34+ progenitor cells, resulting in myeloid or Langerhans-like 
cells [23-25]. Recent in vivo studies support a  physiological role for the most 
commonly in vitro generated DC, the monocyte-derived DC. A sub-population 
of monocytes th a t had phagocytosed subcutaneously injected fluorescent 
m icrospheres migrated to the T cell area of draining lymph nodes, where 
they expressed DC-restricted m arkers [26]. Hum an peripheral blood 
contains a t least three different kinds of DC based on phenotypic m arkers, 
two myeloid subsets and one lymphoid subset [27]. Myeloid blood DC are 
positive for several myeloid m arkers and CD 11c, and can be discrim inated 
by the expression of CD1c. The plasmacytoid-like lymphoid DC are negative 
for CD11c, and strongly positive for the IL-3R (CD123) [28]. Recently, three 
new m arkers have been described, BDCA-2, BDCA-3 and BDCA-4, which 
identify these distinct blood DC subsets [29]. All together, th is indicates tha t 
DC should be regarded as a  multi-lineage system of leukocytes with variable 
functions.
DC in  th e  clin ic
As DC are crucial for the regulation of im m une responses, they are 
considered as interesting candidates for clinical applications such as the 
treatm ent of autoim m unity, graft versus host disease, and cancer. 
Monocyte-derived DC pulsed with tum or antigens, either as peptides or 
tum or lysates have been successfully applied in vivo for the induction of 
anti-tum or T cell reactivity in m elanom a [30, 31] or prostate cancer patients 
[32]. DC-tumor cell hybrids were used as an alternative vaccination strategy 
for the treatm ent of renal m etastatic melanoma. 7 out of 14 patients 
responded by either complete or partial rem issions [33]. As DC have now 
also been attributed  to play a  role in peripheral tolerance, their potential for 
the induction of transplantation  tolerance is actively pursued at the 
moment. Preconditioning of recipients with donor bone-marrow-derived DC 
progenitors, having a  low expression of co-stim ulatory molecules, resulted in 
prolonged cardiac allograft survival in both mice and ra ts  [34, 35]. 
Alternatively, DC can be transduced with “killer” molecules such as FasL. 
Administration of these cells to recipients in advance of transplantation  
resulted in a  m odest prolongation of allograft survival [36, 37]. Negative 
m odulation of the im m une response by tolerogenic DC will also be valuable 
for the treatm ent of autoim m une diseases and allergy. However, the balance
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between anti-tum or reactivity and autoim m unity can be very delicate, 
especially when tum or antigens are not-tum or specific, bu t are also 
expressed in peripheral non-lymphoid organs. Anti-tum or treatm ent can 
then be accompanied by severe autoim m une disease, as described for 
several mouse tum or models [38-40], and for breast and ovarian cancer 
patients in which tum or im m unity co-evolves with autoim m une neuronal 
degradation [41]. Clearly, the application of DC-based vaccines in clinical 
practice strengthens the requirem ent for a  profound knowledge regarding 
DC immunobiology.
Id en tifica tio n  of DC-specific genes
The unique phenotypic and functional properties of DC point towards the 
expression of a  unique combination of genes, including those th a t are DC- 
specific. At present, it is estim ated th a t the hum an genome contains 
approximately 30,000 genes, w hereas each cell expresses on average 6,000 
to 10,000 distinct genes. Several different strategies are exploited to identify 
genes expressed by DC, including random  sequencing of (subtracted) DC 
cDNA libraries, differential display PCR and RAP-PCR [42, 43], and serial 
analysis of gene expression (SAGE) [44]. The differential display PCR and 
RAP-PCR techniques compare mRNA subsets of DC and other cell types and 
have resulted in the isolation of differentially expressed genes in a  wide 
variety of cell systems. However, no DC-specific genes have been published 
th a t were isolated by these techniques. SAGE and random  sequence analysis 
of clones from cDNA libraries both provide a  representation of all expressed 
mRNAs, w ithout a  selection for differentially expressed genes. SAGE is a 
more recently developed sequence-based strategy th a t allows sim ultaneous 
analysis of a  large num ber of transcrip ts, with a  very restricted length of 9 ­
10 nucleotides per sequence tag [44]. SAGE tags can only be identified if 
m atching cDNA sequences exist in public databases, and therefore is not 
suited for the cloning of novel transcrip ts expressed by DC. However, SAGE 
analysis can provide im portant information on the abundance of a  large 
num ber of transcrip ts in a  particular cDNA population. Hashim ato et al have 
published an extensive SAGE analysis of monocytes, m acrophages and 
monocyte-derived DC, in which they show th a t there are m any differentially 
expressed genes, either known and unknow n, with either decreased, 
increased or no expression in DC compared to monocytes and m acrophages 
[45]. In addition, comparison of im m ature and activated monocyte-derived 
DCs identified 225 differentially expressed transcrip ts, mainly genes 
encoding chemokines [46]. A novel PCR-based subtractive hybridization 
method [47] was successful in the identification of several genes expressed 
by DC. This method sub tracts DC RNA with RNA from another cell type and 
specifically amplifies the remaining, potentially differentially expressed 
cDNAs by PCR. Examples are a  novel di-ubiquitin [48], serpin PI-11 [49], 
decysin [50], DC-LAMP [51] and M1204 [52], all molecules th a t are 
preferentially expressed by DC.
16
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Figure 2 . The life cycle of a dendritic cell.
Immature dendritic cells (DCs) are very efficient in antigen uptake and processing. Antigens 
are taken up by scavenger receptors or by macropinocytosis (a). Next to the common 
pathways for MHC class I and II restricted antigen presentation, DCs are unique in that 
exogenous antigen also gets access to the class I pathway (b). This process is referred to as 
crosspriming and is thought to result from the release of endosomal contents into the 
cytosol. Inflammatory agents induce the migration into the T-cell areas of secondary 
lymphoid organs. This migratory process (c) is controlled by different subsets of chemokine 
receptors and aided by the secretion of metalloproteases, which degrade the extracellular 
matrix. One explanation for the efficiency of DCs as antigen presenting cells (APCs), is the 
proposed intracellular pre-assembly of a T-cell activation unit (d), consisting of peptide 
loaded MHC class II and co-stimulatory molecules such as B7. Only upon maturation of the 
DC, is this pre-assembled unit exposed to the cell surface, where it probably represents part 
of the immunological synapse. The immunological synapse represents the 3-D distribution 
of receptors and intracellular proteins that cluster at the contacts between APCs and T cells 
during antigen-specific interactions. Mature DCs also secrete several chemokines and 
cytokines, whose activity is modulated by proteases and protease inhibitors (e). 
Abbreviations: ER, endoplasmatic reticulum; MHC, major histocompatibility complex; MIIC, 
MHC class II compartment; TAP, transporter-associated with antigen processing.
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Random sequencing of DC cDNA libraries proved rem arkably successful, 
showing th a t around 30% of all sequenced clones are unknow n [50, 53]. 
This would imply th a t DC express a  m aximum of 2,000 to 3,000 still 
unidentified gene products, part of which may be DC-specific. This approach 
has lead to the identification of the DC-specific molecules DC-CK1 and DC- 
STAMP [54, 55].
A different approach, aiming at the selection of DC surface m arkers, is the 
generation of antibodies directed against DC-specific epitopes, followed by 
the characterization of the antigen recognized. This approach has resulted in 
the isolation of several proteins with restricted recognition in m ouse DC 
(DEC-205 [56], 4F7 [57] and 33D1 [58], as well as in hum an DC (DC-SIGN 
[59], CMRF-44 [60] and CMRF-56 [61]. The antibodies against CMRF-44 and 
CMRF-56 can be used for either the isolation or identification of DC [62], but 
the recognized antigens have not been identified yet. A major draw back of 
th is technique forms the preferential antibody responses against 
im m unodom inant epitopes from proteins highly expressed on DC, such as 
MHC class I and class II molecules. Second, cloning of the antigens can be a 
difficult and tim e-consum ing task, which usually comprises the screening of 
expression libraries.
As distinct DC (sub) lineages and m aturation stages are known to exist but 
not fully characterized, it is often difficult to determine absolute DC- 
specificity. Therefore, DC-associated genes/an tigens is a  more appropriate 
term. Applying the aforementioned approaches, several interesting novel DC 
associated antigens have been identified th a t have provided new insight in 
DC immunobiology (Table 1). Based on their (putative) function, they will be 
described in the next paragraphs, which deal with the different aspects of 
DC biology.
A ntigen hand ling  by DC
The unique antigen uptake and antigen processing in the 
endocytic/lysosom al com partm ent of the DC, reflected by the presence of the 
LC's Birbeck granules [63], is associated with two im portant functional 
aspects. First, DC acquired the unique capacity to direct exogenous antigens 
towards the MHC class I presentation pathway. This process, referred to as 
cross-presentation, is crucial for the initiation of CTL responses to viral 
infections confined to non-haem atopoietic tissues and tum ors [64-66]. 
Interestingly, a  recent report described a  unique transport way in DC tha t 
links the lum en of endocytic com partm ents to the cytosol. Thereby, 
internalized antigens can gain access to the cytosolic antigen-processing 
m achinery and to the conventional MHC class I antigen-presentation 
pathway [67]. Secondly, antigen loading onto MHC class II molecules and 
transport of these antigenic M HC/peptide complexes to the cell surface are 
clearly segregated in time. Efficient transport of M HC/peptide to the cell 
surface is only observed in m ature DC and coincides with the presence of 
large am ounts of co-stim ulatory molecules [68, 69]. Such a  m echanism
18
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might serve to prevent prem ature presentation of the antigenic load, which 
could result in tolerance ra ther than  immunity, and to confine the immuno- 
stim ulatory capacity of DC to the secondary lymphoid organs. Intriguingly, 
the co-stim ulatory molecule CD86 is also present in the vesicles containing 
the properly loaded MHC-peptide complexes, suggesting the intracellular 
pre-assem bly of a  “T cell activation un it“ [70]. Intracellular assem bly of the 
com ponents th a t make up the immunological synapse [71, 72] may be part 
of DC’s secret to effectively activate naive T cells.
Newly identified DC-associated molecules may help to explain the unique 
process of antigen handling in DC. An im portant feature of DC is the 
efficient uptake of antigens by macropinocytosis and receptor mediated 
endocytosis and their processing and presentation in the context of MHC 
molecules [12] (Fig. 2). DC express m any C-type lectins th a t mediate the 
uptake of glycosylated antigens [10, 11].
The DC-associated DEC-205 protein is a  type I C-type lectin containing 
multiple Ca2+-dependent carbohydrate binding dom ains and has an overall 
homology to the m annose receptor of 29% [56]. DEC-205 is abundantly  
expressed on mouse Langerhans cells and interdigitating DC and its hum an 
homologue has recently been isolated from the Hodgkin's disease-derived 
L428 cell line [73]. Antigens bound to the DEC-205 receptor are efficiently 
internalized and targeted to the antigen-processing com partm ent. 
Intriguingly, DEC-205 contains a  unique cytoplasmic tail of 31 amino acids 
distinct from the m annose receptor th a t directs captured antigens to the 
specialized antigen-processing com partm ent containing MHC class II 
molecules and the DC-specific lysosome-associated m em brane glycoprotein 
(DC-LAMP). Thereby, DEC-205 increases the efficiency of antigen 
presentation to CD4+ T cells [74].
Langerin, a  novel type II Ca2+-dependent lectin, displays m annose-binding 
capacity, and is specifically expressed by hum an Langerhans cells. At 37°C, 
Langerin is rapidly internalized, a t comparable ra tes as the m annose 
receptor. Though intracellular Langerin co-localizes with Birbeck granules, it 
is not associated with MHC class II molecules or DC-LAMP, suggesting tha t 
the function of Langerin is not related to the delivery of antigens to the MHC 
class II pathway. In line with th is observation, in one patient, from which the 
Langerhans cells show a  complete lack of Birbeck granules, the LC do not 
differ in their function in a  num ber of assays tested [75]. Nevertheless, 
Langerin might still be involved in the routing of extracellular antigens into 
the MHC class I pathway [76]. Interestingly, transfection of Langerin into 
fibroblasts induces the formation of m em brane struc tu res with typical 
features of Birbeck granules, suggesting th a t antigen uptake by Langerin 
resu lts in the formation of Birbeck granules in LC [77].
Recently, other novel type II C-type lectins, which contain a  single C-type 
carbohydrate binding domain (CRD) [78], have been identified, including DC 
im m unoreceptor (DCIR) [79], DC-associated lectin-2 (dectin-2) [80] and C- 
type lectin receptor 1 (CLEC-1) [81]. DCIR contains a  putative 
im m unoreceptor tyrosine-based inhibitory motif (ITIM) and is expressed on 
interstitial/derm al-type DC. The capacity to bind glycosylated ligands and its
19
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down-regulation upon m aturation signals as LPS and CD40 ligation, support 
a  role for DCIR in antigen handling. However, upon receptor crosslinking, 
DCIR was only slowly internalized in DC [79]. Dectin-2 is a  type II C-type 
lectin expressed by LC with highest homology to m urine DCIR (33.5%). 
However, the relatively short intracellular domain of dectin-2 does not 
contain an ITIM motif. No information is available with respect to the natu ra l 
ligand recognized by dectin-2 [80]. CLEC-1 is expressed by monocyte-derived 
DC and is m ost homologous to proteins of the NK cell receptor family. Since 
it lacks a  motif for carbohydrate binding, CLEC-1 might function as a 
scavenger receptor for alternative ligands like lipoproteins [81].
Antigen Type of protein DC specificity1 Putative function in DC2 Refs
Dectin-2 type II C-type lectin +++ antigen uptake 80
CLEC-1 type II C-type lectin +++ antigen uptake 81
TLR3 Toll-like receptor +++ antigen uptake 82
Langerin type II C-type lectin +++ formation of Birbeck granules 77
p55/fascin actin bundling protein +++ migration 84-85
TECK chemokine +++ migration (thymus) 21
DC-CK1 chemokine +++ attraction of naïve T cells 54




DC-LAMP lysosomal glycoprotein +++ antigen presentation 51
Dectin-1 type II C-type lectin +++ T cell interaction 110
DC203 transcription factor +++ unknown
M1204 oligoadenylate synthase +++ unknown 52
BDCA-2,3,4 surface markers +++ unknown 29
DEC-205 type I C-type lectin ++ antigen uptake 56
DORA member Ig superfamily ++ antigen uptake 115
TARC chemokine ++ attraction of lymphocytes 103
decysin disintegrin proteinase ++ antigen presentation 50
DC-STAMP multimembrane spanner ++ unknown 55
CMRF-56 (Mab) unknown ++ unknown 61
FDF03 member Ig superfamily ++ unknown 116
di-ubiquitin ubiquitin + antigen processing 48
MDC chemokine + attraction of lymphocytes 104
PI-11 serpin + antigen presentation 49
CD83 member Ig superfamily + antigen presentation 113
ILT3 member Ig superfamily + antigen presentation 114
TRANCE-R type I membrane protein + T cell interaction 162
CMRF-44 (Mab) unknown + unknown 62
Table 1. Summary of DC-associated molecules, based on DC-specificity.
1Specificity is arbitrarily defined as +++ when specifically expressed by DC, ++ when mainly 
expressed by DC, + when also expressed by other leukocyte populations. The specificity is 
only indicated for haematopoietic cells, since for several antigens expression has only been 
investigated in a limited number of cell types.
2Functions have been indicated as basic DC processes, unless clear evidence exists for a 
specific function.
Ig, immunoglobulin; further abbreviations, see text.
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Members of the toll-like receptor (TLR) family are part of the innate im mune 
system  and are probably involved in the recognition of pathogens. DC 
express the full TLR repertoire, which now comprises 6 members. 
Interestingly, the expression of TLR3 is specific for DC [82]. The cytoplasmic 
domain of TLR3 was shown to activate N F -kB , suggesting th a t th is receptor 
could regulate the expression of NF-KB-controlled genes, such as IL-1, IL-6 
and IL-8 [83].
The M1204 protein was cloned from mouse spleen DC and has an active 
oligoadenylate synthase domain. Since the oligoadenylate/RNaseL system 
m ediates early protection against virus infection, it was postulated tha t 
M1204 prevents virus-induced cell death in DC [52].
Di-ubiquitin is a  novel mem ber of the ubiquitin protein family expressed by 
DC, and is unique in th a t it contains two ubiquitin moieties. Di-ubiquitin 
could function in directing (internalized) antigens towards the proteasome, 
where proteolysis resu lts in the generation of peptides for class I 
presentation [48].
DC-LAMP is a  mem ber of the lysosomal associated glycoproteins, similar to 
CD68. It is specifically expressed in interdigitating dendritic cells and 
strongly upregulated upon DC m aturation by CD40 triggering. The presence 
of DC-LAMP in the lysosomal MHC class II+ com partm ents suggests an 
im portant function for DC-LAMP in the processing of exogenous antigens or 
in the remodeling of these com partm ents, by facilitating transport of the 
putative intracellular ‘T cell activation u n it’ to the cell surface [51]. 
Interestingly, m aturation signals, like those provided by the CD40-CD40L 
(ligand) pathway, induce DC-LAMP as well as the cell surface exposure of the 
antigenic load. Further studies are needed to dem onstrate a  causal 
relationship between both events.
M igration and  A ppearance
The functional separation in time of antigen uptake, processing and 
presentation correlates with the migration of DC from peripheral tissues to 
the T cell areas of secondary lymphoid organs. Although directed migration 
of DC is still poorly understood, proteins involved in organization of the 
cytoskeleton and breakdown of the extracellular m atrix might be of crucial 
im portance. M etalloproteases are proteolytic enzymes th a t degrade 
extracellular m atrix com ponents and thereby aid the migration of DC 
through tissues. Indeed, random  sequencing of cDNA libraries prepared from 
DC resulted in a  relatively high am ount of m essengers for m etalloproteases 
[45, 53]. The p55 or fascin protein is highly expressed on circulating hum an 
blood DC and lymph node interdigitating DC. Although fascin has a  widely 
distributed expression pattern  in other cell types in the body, including 
epithelial and neuronal cells [84, 85], among leukocytes its expression is 
restricted to DC. Since fascin is an actin bundling protein, it is likely to be 
involved in the organization of a  specialized cytoskeleton. This suggests a 
specialized function for fascin in DC motility and possibly also in antigen
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uptake [84] and the formation of dendritic processes [86, 87].
Several recent studies show th a t migration of DC correlates with a 
coordinated up- and down-regulation of a  set of chemokine receptors [88, 
89]. Chemokine receptors are seven transm em brane spanning molecules 
th a t signal via G proteins. They form a  large family of receptors th a t are 
involved in diverse im m une processes, including the migration of 
lymphocytes, adhesion, degranulation and lipid mediator synthesis [90]. 
Im m ature DC mainly express chemokine receptors responding to 
chem okines produced at inflammatory sites, like CCR6, CCR1 and CCR5 
[88, 91]. Intriguingly, CCR6 has recently been shown not only to bind the 
chemokine MIP-3a, bu t also serve as target for ß-defensins. Defensins are 
small antimicrobial peptides, which are released upon inflammatory signals 
and act by disrupting the cytoplasmic m em brane of micro-organisms. 
Apparently, ß-defensins recruit im m ature DC, and also memory T cells, to 
the site of microbial invasion [92]. Following stim ulation, CCR1, CCR5 and 
CCR6 are rapidly down-regulated and DC acquire high levels of CCR7, which 
is the receptor for ELC and SLC, chemokines produced in lymphoid organs 
[93]. Studies in CCR7-deficient mice have shown th a t expression of CCR7 is 
essential to bring together DC and T cells for the initiation of an adaptive 
im m une response [94]. Although some of the aforementioned chemokine 
receptors, like CCR6, have been first isolated from DC [95, 96], it m ust be 
emphasized th a t their expression is not restricted to DC.
Recruitm ent of DC into tissues is regulated at the level of the endothelial 
cells. Leukocytes first need to tether to the endothelium , a  process th a t is 
mediated by selectins [97]. DC th a t circulate in peripheral blood express a 
glycosylated form of P-selectin glycoprotein ligand (PSGL)-1 th a t binds to P­
and E-selectins, upregulated on endothelial cells by inflammatory stimuli 
[98]. Additionally, entry of DC from lymph or blood into tissues might be 
mediated by the DC-specific ICAM-3 grabbing non-integrin (DC-SIGN), a 
novel type II C-type lectin expressed by DC. DC-SIGN supports tethering and 
rolling on the intercellular adhesion molecule 2 (ICAM-2) under shear flow. 
ICAM-2 is abundantly  expressed on endothelial vascular (HEV) cells as well 
as lymphatic vessels in vivo. Additionally, DC-SIGN regulates chemokine- 
induced transm igration of DC across both resting and activated endothelium  
in vitro [99].
DC /  T cell in te ra c tio n
The potency of DC to activate naive T cells has been well established. As 
early as in 1974, it was known th a t DC attrac t and cluster with naive or 
resting T cells in an antigen independent m anner to find the rare T cells (at 
frequencies of 1 /100,000 or less) th a t express a  TCR recognizing the MHC- 
peptide complexes at the DC’s cell surface [100]. Molecular analysis of DC 
has now led to the identification of a  num ber of intriguing molecules tha t 
shed light on the attraction and early physical interactions between DC and 
T cells (Figure 3).
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Figure 3 . Model for the initiation of a primary immune response.
Within the secondary lymphoid organs, naïve T cells are attracted to DC by the chemokine 
DC-CK1 (1). The initial physical interaction is mediated by DC-SIGN and ICAM-3 (2) and 
subsequent complex signaling events allow interactions between co-stimulatory molecules 
like LFA-1/ICAM-1 (3) and the smaller sized molecules B7/CD28 and CD2/LFA-3 (4) to 
occur. In addition, it allows scanning of the DC cell surface by the T cell receptor for the 
compatible MHC/peptide complex (4). Although many complex signaling pathways are 
activated, only productive TCR engagement allows adhesion strengthening and formation of 
a functional immunological synapse, ultimately leading to full activation of T cells (right part 
of the figure). In the absence of a productive TCR engagement, the T cell will dissociate from 
the DC (left part). Next to activation of the T cells, also DC become activated in response to a 
functional interaction with a T cell.
DC secrete an array of chemotactic cytokines, called chemokines. The main 
functions of chemokines include the directional migration of leukocytes and 
the regulation of the expression of adhesion molecules. Chemokines can be 
classified on the basis of a  conserved cystein motif near their N-terminal 
end, into C, CC, CXC, or CXXXC subgroups, or upon their function, into 
inflammatory and hom eostatic chemokines [101]. Inflammatory chemokines 
such as interleukin 8  (IL-8), eotaxin and R antes (regulated on activation 
norm al T cell expressed and secreted) are expressed during inflammation
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and regulate the recruitm ent of leukocytes to inflammatory sites. 
Chemokines involved in hom eostasis are constitutively expressed within 
lymphoid organs and have a  key function in the hom eostasis of lymphocyte 
circulation. DC produce various chemokines of both groups (Table 2), and 
thereby regulate the trafficking of other leukocyte subsets [89]. DC-CK1 is a 
CC chemokine, th a t is abundantly  produced by DC in secondary lymphoid 
organs and chem oattracts naive CD4+ and CD8+ T lymphocytes and also B 
lymphocytes [54, 102]. Two other CC chemokines th a t are abundantly  
produced by myeloid DC are thym us and activation-regulated chemokine 
(TARC) [103] and macrophage-derived chemokine (MDC) [104], both of which 
bind CCR4. MDC also binds the CCR8 chemokine receptor [105]. Next to the 
role of these chem okines in attracting CCR4 positive Th (helper) 2 cells and 
NK cells [106, 107], a  recent study reported th a t a  subset of memory T cells 
also expresses CCR4 [108]. In addition to CCR4, these memory T cells 
express CCR7 and CD62L, allowing them  to re-enter secondary lymphoid 
organs [108]. This finding implicates th a t w hereas DC-CK1 secretion by DC 
might a ttrac t the cells from the naive T cell pool, MDC and TARC may be 
involved in attracting the CCR4 and CCR7 expressing memory T cells to the 
DC for a  renewed encounter.
W hereas chemokines secreted by DC are responsible for the guidance of T 
and B cells to the DC, subsequent physical contact and clustering between T 
cells and DC are likely mediated by cell surface receptors. DC-SIGN is a 
novel DC-specific ligand for intercellular adhesion molecule 3 (ICAM-3), 
expressed on naive T lymphocytes. Interestingly, DC-SIGN is not an integrin, 
bu t a  Ca2+-dependent, type II C-type lectin. DC-SIGN m ediates a  transien t 
clustering between DC and T cells, allowing DC to screen ten thousands of T 
cells to find the T cell th a t expresses a  compatible TCR [59]. Interestingly, 
expression of DC-SIGN and the LC’s Langerin, both of which belong to the 
type II C-type lectin family, appears m utually exclusive. The question 
w hether Langerin is the LC version of DC-SIGN is particularly interesting, 
because DC-SIGN is able to capture HIV-1 in the periphery and facilitate its 
transport to the secondary lymphoid organs, enhancing infection of T cells 
using a  unique trans-m echanism  [109].
Recent studies have reported another type II Ca-dependent lectin specifically 
expressed by DC, dectin-1 [110]. The cytoplasmic domain of dectin-1 
contains a  putative im m unoreceptor tyrosine-based activation motif (ITAM). 
Furtherm ore, a  His-fusion protein of the extracellular domain of dectin-1 
promoted the proliferation of T cells, bu t failed to show any binding to 
several carbohydrate probes [110]. This suggests th a t C-type lectins 
expressed by DC seem to perform dual functions: type I C-type lectins 
primarily serve as scavenger receptors in the process of antigen uptake, 
w hereas type II C-type lectins can also act as co-stim ulatory molecules in 
DC-T cell interactions.
Several other novel molecules likely to be im portant in the later stages of 
im m une activation have been isolated from CD40-activated DC, which are 
known to express high levels of IL-12, th u s  favoring Th1 responses [111, 
112]. They include a  novel serpin, PI-11, expressed in hum an tonsil
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dendritic cells bu t also in keratinocytes and a  lung fibroblastic cell line. 
Serpins have been reported to inhibit serine proteases, suggesting a  role for 
PI-11 in the protection of cytokines/chem okines from proteolysis [49]. 
Similarly, decysin is a  m em ber of the family of disintegrin proteinases and is 
highly expressed by several m ature DC subsets, and at a  lower level by 
monocytes and norm al B cells. As disintegrin proteinases have been shown 
to process and activate the TNF-a precursor protein [50], a  similar function 
could be envisaged for decysin, ultim ately leading to the micro-environment 
m ost suitable for T cell activation.
The CD83 antigen is present on the cell surface of a  distinct peripheral blood 
DC population, LC and some IDC and is widely used as a  m aturation m arker 
for in vitro generated DC. The CD83 transm em brane protein contains an 
extracellular V-type immunoglobulin (Ig)-like domain and its structu ra l 
similarity to other m em bers of the Ig superfamily suggests th a t it may be 
involved in antigen presentation or cellular interactions [113]. However, no 
ligand for CD83 has been identified yet. O ther novel proteins belonging to 
the immunoglobulin superfamily th a t are expressed by DC include 
immunoglobulin-like transcrip t 3 (ILT3) [114], a  protein Down-regulated by 
Activation (DORA) [115] and the novel inhibitory receptor FDF03 [116]. 
Interestingly, like DCIR, FDF03 and ILT3 contain two or three putative ITIMs 
in their cytoplasmic regions, respectively, which could be involved in 
negative regulation of DC activation and m aturation. Further inside in the 
role of these molecules in DC function awaits the identification of their 
ligands.
Inflammatory chemokines Receptor Main target cells
Fractalkine (CX3CL1) CX3CR1 Mo, NK, T
IL-8 (CXCL8) CXCR1, CXCR2 Neu
IP-10 (CXCL10) CXCR3 Th1
Lymphotactin (XCL1) XCR1 T, NK
MCP-1 (CCL2) CCR2 Mo, act T, act NK
Mig (CXCL9) CXCR3 Th1
M IP-1a (CCL3) CCR1, CCR5 Mo, T, NK, iDC
MIP-1ß (CCL4) CCR5 Mo, Th1, iDC
Rantes (CCL5) CCR1, CCR3, CCR5 Mo, T, NK, iDC, Eo, Ba
Homeostatic chemokines
BLC (CXCL13) CXCR5 B, act T
DC-CK1 (CCL18) Unknown naïve T, naïve B
ELC (CCL19) CCR7 T, B, mDC
MDC (CCL22) CCR4 Th2, NK, iDC
M IP-3a (CCL20) CCR6 T, iDC (CD34)
SLC (CCL21) CCR7 T, B, mDC
TARC (CCL17) CCR4 Th2, NK, iDC
TECK (CCL25) CCR9 T
Table 2. Inflammatory and homeostatic chemokines expressed by DC, their receptors, and 
the target cells on which they are active. The new nomenclature for the chemokines has 
been indicated between brackets. Act, activated; B, B cells; Ba, basophils; Eo, eosinophils; 
iDC, immature dendritic cells; mDC, mature dendritic cells; Mo, monocytes; Neu, 
neutrophils; NK, natural killer cells; T, T cells; Th1, T helper 1 cells; Th2, T helper 2 cells.
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DC and  th e  co n tro l o f im m u n ity
T cell responses
DC do not only ju s t efficiently present antigens to T cells, bu t also m odulate 
the im m une response by preferentially inducing Th1 or Th2 responses. Th1 
cells produce high levels of IFN-y and promote cellular m echanism s of 
im m unity through the activation of NK cells and cytotoxic T lymphocytes 
(CTL). Th2 cells, producing high levels of IL-4 and IL-5, support hum oral 
im m unity by providing B cell help. Several factors affect Th development, 
including the character and dose of antigen, contact-m ediated signals such 
as the strength of the T cell receptor-m ediated signal, and soluble products 
of APC and T cells [117, 118]. IL-12 is the principal cytokine th a t drives Th1 
polarization [119, 120], w hereas IL-4 is the m ain cytokine driving Th2 
responses [121].
Accumulating d a ta  exist th a t support a  role for the APC in the control of the 
development of naïve T cells into Th1 or Th2 subsets. Several studies 
described th a t myeloid DC give rise to Th1 inducing DC (DC1), w hereas 
cultured plasmacytoid DC generate Th2 responses (DC2), correlating with 
the presence or absence of IL-12 production, respectively [14, 122]. However, 
other studies have shown th a t myeloid DC can induce both Th1 and Th2 T 
cells, depending on the production of IL-12 [123] or the ratio of DC and T 
cells present during T cell polarization [124]. Monocyte-derived DC can 
produce high levels of IL-12 upon stim ulation with LPS, bacteria and 
viruses, or ligation of the CD40 molecule by activated T cells [111, 112, 117]. 
Vitamin D3 [125], agents th a t increase cyclic AMP such as prostaglandin-E2 
or cholera toxin [126, 127], or suppressing cytokines such as TGF-ß and IL- 
10 [128, 129] can all inhibit IL-12 production by DC. Comparably, the 
plasmacytoid blood DC were capable to induce Th1 responses in vitro upon 
stim ulation with CD40L or after addition of influenza virus [130] or herpes 
simplex virus [131]. This potent Th1 polarization is driven by the synergistic 
effect of IL-12 and type I interferon, and correlates with the presence of 
interferon producing plasmacytoid DC in tonsil [130]. However, in all cases it 
is possible th a t activated (memory) T cells further activate DC through 
CD40L/CD40 interaction, triggering the production of IL-12 by DC and 
shifting the im m une response toward Th1 [108, 112]. Activation by CD40L 
licenses the DC to induce T helper-dependent CTL responses [132-134]. 
Together, these da ta  strongly suggest th a t not the DC subset itself, bu t the 
activation s ta tu s  of the DC plays an im portant role in the polarization of 
im m une responses, dependent on the way and environm ent in which the DC 
is activated. The capability of a  single APC to induce either a  Th1 or a  Th2 
response could assign the flexibility to the DC th a t is needed to respond 
adequately to all kinds of pathogens.
Interestingly, recent studies indicate th a t under strong polarizing conditions, 
analogous to T cells, also B cells can develop th a t secrete similar polarized 
arrays of cytokines. Thereby, effector B and T cells might reciprocally 
regulate the differentiation of their naïve counterparts and possibly allow for
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amplification of an existing im m une response [135]. In addition, a  negative 
feedback regulation on the level of the APC seem s to exist, which probably 
serves to control the balance between Th1 and Th2 responses in order to 
prevent Th1-mediated autoim m une inflammatory responses or Th2- 
mediated allergic responses. In the absence of stim ulation by CD40L, the 
Th2 cytokines IL-4 and IL-10 can kill the Th2 inducing plasmacytoid DC by 
apoptosis, w hereas IL-4 prom otes m aturation of myeloid DC. Interferon-y 
can protect plasmacytoid DC from apoptosis by IL-4 and IL-10 and promote 
its differentiation, possibly representing an indirect m echanism  to inhibit 
Th1 development a t later stages of Th1 responses [14].
M ature DC express high levels of co-stim ulatory molecules such as B7.1, 
B7.2, LIGHT and 0X40 ligand. Studies in mice have shown th a t B7.1 and 
B7.2 can differentially modulate Th1/Th2 differentiation [136]. LIGHT is a 
novel mem ber of the TNF superfamily selectively expressed on im m ature DC, 
th a t induces a  Th1 response both in vitro and in vivo [137, 138]. In contrast, 
0X40L was suggested to induce the production of the Th2 cytokine IL-4 in 
vitro [139, 140], bu t th is Th2 bias was not supported by several in vivo 
studies [141, 142].
It should be taken into account th a t in vivo the effect of the APC and its 
secreted factors on Th differentiation is likely influenced by m any other 
factors, including the microenvironment, the migratory pathw ays followed by 
distinct DC subsets, the lifespan of the DC and selective expression of 
chemokines. For example, the presence of im m unosuppressive cytokines 
such as IL-10 and TGF-ß have a  profound effect on DC. These DC might 
provide the non-polarizing conditions th a t result in the expansion of 
uncom m itted T cells. These T cells express the lymph-node-homing receptors 
CCR7 and L-selectin and have recently been identified in vivo as a  distinct 
subset of “central memory T cells” [108]. Even under the strongest polarizing 
conditions, only a  fraction of responding T cells acquires effector function 
and tissue homing capacity, and also non-polarized T cells are generated. 
These uncom m itted T cells are more responsive to TCR stim ulation than  
naïve T cells and can efficiently differentiate into effector T cells upon a 
secondary antigenic stim ulation. A reciprocal population of memory T cells 
exists th a t lack CCR7, express receptors for homing to inflamed tissues and 
are capable of immediate effector function, the so-called effector memory T 
cells. Both memory subsets are present for years after priming, and may 
serve as a  source of effector cells in secondary responses as well as may 
perform regulatory functions [108, 118].
B cell responses
Besides the unique capability of DC to activate naïve T cells, several in vitro 
studies have now indicated th a t DC can directly activate B cells. However, 
th is a  still a  developing area and likely m any other cells and cytokines play a 
role in the activation of B cells in vivo. Cultured DC induce proliferation and 
IgM secretion in CD40-activated naïve B cells [143, 144]. CD34-derived DC 
could induce the production of IgA by CD40-activated naïve B cells, bu t only
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in the presence of IL-10 and TGF-ß [145]. During a  T cell-dependent hum oral 
response, B lymphocytes first proliferate in T cell areas and develop locally 
into plasm ablasts, before entry into the germinal center. Interestingly, 
interdigitating DC isolated from the T cell area of tonsil were recently shown 
to induce isotype switching and IgM production in CD40-activated naïve B 
cells [146]. B cells can be attracted to these DC by DC-CK1, which was 
recently shown to a ttrac t naïve B cells [102]. Additionally, germinal center 
DC induce a  strong expansion of germinal center B cells, and induce a 
CD40-dependent isotype switching toward IgG1 [147]. These studies using 
isolated in vivo DC subsets confirm a  direct effect of DC on B cell activation 
and m aturation. This is further supported by an im pairm ent of isotype 
switching upon antigen challenge in mice with an insertional m utation 
disrupting the gene encoding for relB, lacking functional DC [148]. 
BAFF/Blys-L (B cell activating factor belonging to the TNF family) is a  novel 
molecule expressed by DC and T cells and binds to a  B cell-restricted 
receptor. Since BAFF induces both proliferation and immunoglobulin 
secretion by different B cell subsets, it might represent an im portant co­
stim ulator through which DC regulate B cell function. BAFF is a 
transm em brane molecule th a t is processed and secreted by a  yet unknow n 
protease [149-151]. Possibly, decysin, a  novel disintegrin-m etalloproteinase 
isolated from GCDC [50], plays a  role in the cleavage of BAFF.
DC-specific gene regu la tion
The tight regulation of the expression of various key molecules in DC during 
its life cycle suggests the existence of DC-associated promotor regions and 
transcription factors. The im portance of several transcription factors for DC 
morphology and function have been studied in mice, in whom the gene 
encoding the transcription factor has either been disrupted or m utated. 
Ikaros is a  mem ber of the Kruppel family of zinc finger DNA-binding proteins 
and differentially controls the development of fetal and adult lymphocytes 
[152, 153]. Interestingly, knockout mice for Ikaros lack thymic DC, while 
myeloid DC and LC in the skin are unaffected. Adoptive transfer of m utan t 
bone marrow into norm al mice showed th a t the defect in lymphoid cell 
production was a  direct result from the Ikaros m utation and not due to 
environm ental factors [154].
The transcription factor relB is a  mem ber of the NF-KB/rel family. RelB is 
highly expressed in DC, and strongly upregulated during in vitro generation 
and m aturation of DC [155], suggesting an im portant role in DC function. 
Knockout mice for RelB have poor cellular immunity, multi-organ 
inflammation and reduced thymic and splenic DC populations [156]. Since 
the architecture of the thym us is largely disturbed, RelB dependent events in 
other cell types can influence DC development, which is supported by the 
finding th a t the in vitro culture of bone marrow cells from RelB deficient mice 
give rise to comparable num bers of phenotypically and functionally norm al 
DC. However, the deficiency of a  distinct splenic DC population (CD8a-
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DEC205-) was shown to be a  direct, intrinsic effect of the RelB m utation 
[157].
Mice deficient in TGF-ß revealed a  clear phenotype in th a t they completely 
lack epidermal Langerhans cells [158]. It is now known th a t LC require this 
growth factor for their development, both in vitro and in vivo, stressing the 
im portance of environm ental factors as signals for the regulation of DC 
development and m aturation [159].
Transcription factors regulating the expression of DC-specific genes could 
possibly bind to specific, novel regulatory sequence elem ents in the promotor 
regions of DC-specific genes. At present, no hum an DC-specific promotor 
sequences have been characterized. In the mouse, the promotor of CD 11c 
has been used for DC-specific gene targeting [160]. However, the hum an 
CD11c has a  more widespread expression pattern , as it is also expressed at 
high levels in macrophages. Identification of DC-specific promotor regions 
would be extremely useful in targeting gene expression specifically to DC. 
This strategy could for example be used for the specific delivery of antigens 
to DC in order to provoke or dam pen im m une responses. Furtherm ore, the 
identification of novel transcription factors active in DC will increase our 
understanding  of the specific regulation of gene expression in DC. Specific 
expression in particular DC subsets will shed light on the different 
haematopoietic lineages from which DC subsets evolve and their relationship 
with other cell types such as osteoclasts and m acrophages [161, 162]. 
Importantly, it should be taken into account th a t gene expression is guided 
by environm ental factors, which can bind to receptors and influence the 
patterns of gene expression, including those of transcription factors.
Scope of th is  th e s is
The scope of th is thesis is the characterization of dendritic cells a t the 
molecular level. Although m any DC-associated molecules have been cloned 
and characterized, several questions regarding how DC perform their 
specialized functions are still unclear (Box 1). A molecular approach was 
followed in order to clone novel molecules th a t are preferentially expressed 
by DC. Because chem okines play a  crucial role in the attraction of 
lymphocytes toward the DC, a  detailed analysis was performed to study the 
chemokine profiles of different DC subsets.
Random sequencing of cDNA libraries prepared from monocyte-derived DC 
resulted in the identification of two novel DC-associated molecules. C hap ter
2 describes the identification of DC-CK1 (DC-specific CC-chemokine 1), a  
novel chemokine specifically expressed by DC. DC-CK1 preferentially 
a ttrac ts  naïve T lymphocytes, establishing contact between DC and T cells 
for antigen presentation. DC-STAMP (DC-specific transm em brane protein) 
was also isolated from a  DC cDNA library and is described in C hap ter 3. 
DC-STAMP is expressed by monocyte-derived DC as well as myeloid 
peripheral blood DC th a t have been activated in vitro. The DC-STAMP protein 
sequence contains 7 putative transm em brane regions, but, surprisingly,
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shows no homology to other transm em brane proteins, suggesting th a t DC- 
STAMP represents a  novel protein family. C hap ter 4 deals with the genomic 
structu re  and chromosomal localization of the DC-STAMP gene. This study 
shows th a t the DC-STAMP gene has a  unique intron-exon structure, and 
localizes to hum an chromosome 8q22. Analysis of the DC-STAMP promotor 
region indicated binding sites for several transcription factors th a t were 
previously shown to be involved in the regulation of immunological 
im portant proteins and myeloid dendritic cell differentiation.
The second approach th a t was followed to isolate DC-associated molecules 
was differential display PCR. This resulted in the cloning of DC203 (C hapter 
5), a  putative transcription factor highly restricted to DC. DC203 is 
expressed by all DC subsets tested so far, which suggests an im portant role 
for DC203 in the regulation of DC differentiation.
DC produce a  broad array of chemokines th a t are im portant to bring DC and 
the rare antigen-specific T and B lymphocytes into close contact. Using real­
time quantitative PCR we performed a  detailed analysis of a  panel of twelve 
chem okines expressed by several DC subsets, both in vitro and in vivo 
(C hapter 6). The chemokine profiles expressed by activated lymphoid-like as 
well as myeloid blood DC mimics th a t of monocyte-derived DC. Additionally, 
purified Langerhans cells expressed a  similar chemokine pattern. These data  
indicate th a t different DC subsets in vitro and in vivo can express the same 
chem okines to a ttrac t leukocytes. This suggests th a t regulation needs to 
exist a t other levels, including the expression of chemokine receptors and 
the in vivo activity and stability of chemokines. In C hap ter 7 we dem onstrate 
with real-time quantitative PCR th a t monocyte-derived DC and ex vivo 
isolated germinal center DC produce the chemokine BLC, which a ttrac ts 
both B cells and activated T cells. This was confirmed by staining of tonsilar 
sections with a  BLC-specific antibody. These findings implicate a  role for 
BLC in establishing the contact between DC and B and T cells.
Finally, C hap ter 8 d iscusses the implications of these novel findings for DC 
function and describes the m ain perspectives for future studies.
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Box 1. Questions regarding DC immunobiology
• How many different DC subsets exist and how do 
they functionally relate to each other?
• How do in vitro cultured DC relate to DC in situ?
• Can one DC subset exert distinct functional roles, 
like immune activation and tolerance induction in
vivo?
• How do environmental factors affect maturation and 
phenotype of the DC and thereby the outcome of the 
immune response (immunity/tolerance, Th1/Th2)?
• Do DC express specific tolerance inducing 
receptors?
• Do different DC subsets exhibit distinct migration 
pathways?
• Which set of DC specific molecules explain the 
unique capacity of DC to induce immune responses?
• How is DC-specific gene expression regulated at the 
transcriptional level?
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Chapter 2
A dendritic cell-derived C-C chemokine that 
preferentially attracts naive T cells
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Sum m ary
Dendritic cells form a  system of highly efficient antigen-presenting cells. 
After capturing antigen in the periphery, they migrate to lymphoid organs 
where they present the antigen to T cells. Their seemingly unique ability to 
interact with and sensitize naive T cells gives dendritic cells a  central role in 
the initiation of im m une responses and allows them  to be used in 
therapeutic strategies against cancer, viral infection and other diseases. How 
they interact preferentially with naive ra ther than  activated T lymphocytes is 
still poorly understood. Chemokines direct the transport of white blood cells 
in im m une surveillance. Here we report the identification and 
characterization of a  C-C chemokine (DC-CK1) th a t is specifically expressed 
by hum an dendritic cells a t high levels. Tissue distribution analysis 
dem onstrates th a t dendritic cells present in germinal centers and T-cell 
areas of secondary lymphoid organs express th is chemokine. We show tha t 
DC-CK1, in contrast to RANTES, MIP-1a and interleukin-8, preferentially 
a ttrac ts  naive T cells (CD45RA+). The specific expression of DC-CK1 by 
dendritic cells a t the site of initiation of an im m une response, combined with 
its chemotactic activity for naive T cells, suggests th a t DC-CK1 has an 




Dendritic cells are key regulators in im m une responses, capable of priming 
naive T cells. Their potent antigen-presenting capacity can be explained in 
part by their unique life cycle and their high expression of major 
histocompatibility complex (MHC) class I and II molecules as well as co­
stim ulatory molecules [1, 2]. Detailed molecular analysis of dendritic cell 
function has been ham pered, however, by the low num bers of dendritic cells 
present in blood m ononuclear cells. The m echanism  by which dendritic cells 
interact with or activate resting naive T cells to initiate an im m une response 
is not fully understood. One possibility is th a t secreted cytokines or 
chem okines preferentially a ttrac t or activate naive ra ther than  activated T 
cells [3, 4]. We generated sufficient num bers of dendritic cells in vitro [5, 6] to 
prepare a  panel of dendritic-cell cDNA libraries, which allowed u s to analyse 
dendritic cells a t the molecular level.
M aterials and M ethods
Cell culture
Dendritic cells were generated by culturing elutriated monocytes [7] (>90% 
CD14+) in Iscove's medium with 5% FCS, 800 U /m l GM-CSF (Schering- 
Plough, The Netherlands) and 500 U /m l IL-4 (Schering-Plough) as described 
[8]. Dendritic were collected directly or after activation with LPS (2 |ig/ml), 
TNF-a (15 ng/m l) plus 75 LAF u /m l IL-1 (Hoffman LaRoche, Nutley, NJ) or 
40% monocyte supernatan t for 4 h or 16 h. A mixture of the 4-h and 16-h 
portions was used for Northern analysis and cDNA library construction. The 
phenotype and effects of subsequent stim ulation were confirmed by FACS 
analysis [5, 6, 8]. For Northern analysis, total PBMC and the non-adherent 
fraction of PBMC were activated with 1 |ig /m l PHA and 20 U /m l IL-2 (Cetus, 
Emmeryville) (PBMC-act; Non-Adh act) for 3 days. The adherent PBMC 
fraction was activated with 2 |ig /m l LPS for 2 days. E lutriated monocytes 
(>85% CD 14+) were activated with 2 |ig /m l LPS. 75 U /m l IFN-y (Boehringer 
Ingelheim, Alkmaar, The Netherlands) or 5% FCS for 4 days and elutriated T 
cells (>95% CD3+) with GM-CSF (800 U/ml) and IL-4 (500 U/ml) with or 
w ithout 1 |ig /m l PHA and 20 U /m l IL-2 for 3 days. T-cells subsets used for 
chemotaxis were obtained by negative selection with the appropriate 
cocktails of monoclonal antibodies against CD 14 (Leu-M3), CD 19 (Leu-12), 
CD20 (Leu-16), CD56 (Leu-19), CD45RA (Leu-18), CD45RO (Leu-45RO) (all 
Becton Dickinson, M ountain View, USA), CD67 (IOM-67, Im munotech, 
Westbrook), glycophorin (10F7MN, ATCC Rockville), CD4 (OKM-1) and CD8 
(BL12) from ficoll banded m ononuclear cells using sheep anti-m ouse M-450 
D ynabeads (Dynal, Oslo, Norway). Purity was >94% as determ ined by FACS 
analysis.
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cDNA library construction and Northern blot analysis
Total RNA was isolated from the dendritic cell cultures described above 
using the guanidine th iocyanate/cesium  chloride procedure. After isolation 
of poly(A)+ RNA (Oligotex, Qiagen), cDNA was synthesized and cloned into 
pSport1 using the superscrip t plasmid system (Gibco BRL). Nucleotide 
sequence analysis of 360 random ly picked clones was performed using the 
ABI system. For Northern analysis, RNA isolated using the RNAzol B method 
(Biotecx Lab., Houston, TX) was used. As a  DC-CK1-specific probe, we used 
a  random  primed labeled 380-bp BSTX-I/Not1 fragment comprising the 3' 
non-coding region. Spotblots containing MIP-1a cDNA were included in each 
hybridization to ensure specificity. To control for the am ount and quality of 
the RNA sam ples, blots were also hybridized with a  28S ribosomal probe [9],
Recombinant chemokines and chemotaxis
The N term inus of DC-CK1 was defined by N-terminal sequencing of purified 
recom binant DC-CK1 produced in COS-7 cells using the pFLAG system 
(International Biotechnologies, New Haven, CT). To produce recom binant 
DC-CK1 used in the chemotaxis experiments, Escherichia coli strain  X156F 
was transform ed with the pOMP plasmid containing the m ature DC-CK1 
coding region. After lysis, the periplasmic fraction was purified on Q- 
sepharose and S-sepharose colum ns (Pharmacia) using a  linear NaCl 
gradient (0-0.1 M). The DC-CK1-enriched fractions were loaded on a  reverse­
phase column and eluted using a  linear gradient of 2-80%  acetonitrile. DC­
CK 1 protein concentration was estim ated by densitom etric scanning of a 
coomassie blue-stained gel containing lysozyme as a  standard. RANTES, 
MIP-1 and IL-8 were obtained from R&D Systems. T-cell migration was 
m easured using 48-well chemotaxis cham bers (Neuroprobe) as described 
[10]. In brief, chem okines in RPMI-1640 were added to the lower cham ber 
and were separated from 105cells in RPMI-1640 with 10% FCS by either an 8 
|im or a  5 |im PVP-free polycarbonate m em brane (Poretics, Livermore). After 
incubation for 1 h, the m em brane was removed and the upper side washed 
with PBS, scraped to remove residual cells and w ashed again. After 
m ethanol fixation and staining, the num ber of fully migrated cells was 
counted microscopically in 5 high-power fields (400) per well. Pertussis toxin 
(100 ng/m l) (Calbiochem) was used for 2 h. Each experiment was performed 
in duplicate, and experim ents with DC-CK1, RANTES, MIP-1 a  and IL-8 were 
performed in parallel in the sam e assay to make a  direct comparison of their 
activities possible ,
In situ hybridization,
Cryosections (8 |im) of tonsils and lymph nodes were fixed in 4% 
paraformaldehyde and pretreated with 2 |ig /m l pepsin in 0.2 M HCl for 10 
min and 0.1 M triethanol am in e /0.2 5 acetic acid anhydride for 10 min. 
Sections were hybridized overnight with either a  sense or an antisense DIG- 
labelled DC-CK1 RNA probe consisting of the 3' non-coding region generated 
by in vitro transcription (Boehringer Mannheim). Before incubation with 
anti-DIG-alkaline phosphatase monoclonal antibody the sections were
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treated with 40 U /m l RNAse I (Promega) to ensure specificity. After 
incubation for 2-3 h with nitroblue tetrazolium /5-brom o-4-chloro-3-indolyl 
phosphate (Boehringer Mannheim) the sections were stained with methylene 
green and embedded in Kaiser's. Im m unostaining was performed as 
described [11].
R esu lts
While searching at the genetic level for molecules expressed by dendritic 
cells, we identified a  cDNA clone encoding a  C-C chemokine th a t is 
abundantly  expressed. The deduced sequence predicts a  protein of 89 amino 
acids, of which the am ino-term inal 20 amino acids contain all the 
characteristics of a  signal peptide (Fig. 1a). The m ature protein comprises 69 
amino acids and is 63%, 38% and 33% identical to the chemokines MIP-1a, 
RANTES and MCP-2, respectively (Fig. 1b). The idea th a t th is chemokine is 
expressed abundantly  by dendritic cells is supported by the finding th a t of 
350 dendritic cell cDNAs analyzed, six encode th is C-C chemokine. We 
term ed it DC-CK1.
An RNA species of 1.1 kb was readily detected by Northern blot analysis in 
both total and poly(A)+ RNA isolated from dendritic cells (Fig. 2a). No DC-CK1 
expression could be detected in T cell-, B cell- or three different monocyte 
cell lines. Moreover, freshly isolated resting or phytohaem agglutin 
(PHA)/interleukin (IL)-2 activated peripheral blood m ononuclear cells 
(PBMCs), the resting or PHA/IL-2 activated non-adherent PBMC fraction (T, 
B and NK cells), and the adherent PBMC fraction (monocytes) activated with 
lipopolysaccharide (LPS) all failed to express th is chemokine. Two endothelial 
cell lines, representatives of a  non-leukocyte cell type known to be capable of 
expressing a  variety of chemokines [3, 4], did not express the chemokine 
either (data not shown). Because dendritic cells abundantly  expressing DC- 
CK1 were derived from purified monocytes cultured in the presence of GM- 
CSF and IL-4 [5, 6, 8], we tested the ability of different stim uli to induce its 
expression in monocytes. Fetal calf serum  (FCS), interferon (IFN)-y and LPS 
were all unable to induce DC-CK1 mRNA (Fig. 2b). To dem onstrate further 
the specific induction of th is chemokine by GM-CSF plus IL-4 in monocytes, 
we cultured purified T cells in the presence of GM-CSF plus IL-4, with or 
w ithout PHA/IL-2. No DC-CKl mRNA could be detected in T cells under 
either of these conditions (Fig. 2b). Splenocytes activated with IL-4 and anti- 
CD40 monoclonal antibodies also do not express DC-CK1 (data not shown). 
Taken together, these da ta  dem onstrate th a t DC-CK1 is primarily expressed 
in dendritic cells bu t not in any of the other leukocytes tested.
To investigate the time required for the expression of DC-CK1 and the 
dependence on GM-CSF and IL-4, a  tim e-course experiment was performed 
using either GM-CSF, IL-4 or a  combination of both. No DC-CK1 mRNA 
could be detected in freshly isolated monocytes, or monocytes cultured for 
24 h in any cytokine combination (Fig. 2c). However, after 3.5 days of 
culture, DC-CK1 mRNA is abundantly  present in cells cultured with either
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1 CAGGAGTTGTGAGTTTCCAAGCCCCAGCTCACTCTGACCACTTCTCTGCC
51' TGCCCAGCATCATGAAGGGCCTTGCAGCTGCCCTCCTTGTCCTCGTCTGC 
M K G L A A A L L V L V C  
1 0 1  ACCATGGCCCTCTGCTCCTGTGCACAAGTTGGTACCAACAAAGAGCTCTG 
T . M A L C S C A Q V G T N K E L C  
1 5 1  CTGCCTCGTCTATACCTCCTGGCAGATTCCACAAAAGTTCATAGTTGACT 
C L V Y T S W Q I  P Q K F I V D Y  
2 0 1  ATTCTGAAACCAGCCCCCAGTGCCCCAAGCCAGGTGTCATCCTCCTAACC 
S E T S P Q C P K P G V I L L T  
2 5 1  AAGAGAGGCCGGCAGATCTGTGCTGACCCCAATAAGAAGTGGGTCCAGAA 
K R G R Q I C A D P N K K W V Q K  
3 0 1  ATACATCAGCGACCTGAAGCTGAATGCCTGAGGGGCCTGGAAGCTGCGAG 
Y I S D L K L N A  
3 5 1  GGCCCAGTGAACTTGGTGGGCCCAGGAGGGAACAGGAGCCTGAGCCAGGG 
4 0 1  CAATGGCCCTGCCACCCTGGAGGCCACCTCTTCTAAGAGTCCCATCTGCT 
4 5 1  ATGCCCAGCCACATTAACTAACTTTAATCTTAGTTTATGCATCATATTTC 
5 0 1  ATTTTGAAATTGATTTCTATTGTTGAGCTGCATTATGAAATTAGTATTTT 
5 5 1  CTCTGACATCTCATGACATTGTCTTTATCATCCTTTCCCCTTTCCCTTCA 
6 0 1  ACTCTTCGTACATTCAATGCATGGATCAATCAGTGTGATTAGCTTTCTCA 
6 5 1  GCAGACATTGTGCCATATGTATCAAATGACAAATCTTTATTGAATGGTTT 
7 0 1  TGCTCAGCACCACCTTTTAATATATTGGCAGTACTTATTATATAAAAGGT 
7 5 1  AAACCAGCATTCTCACTGA
b.
DC-CKl AOVGTNK*ELCCLVYTSWQIPQKFIVDY*SETSPQCPKP
MIP-la -PLRADTPTA— FS--- R----N--A--*F---S--S--
MCP-2 QPDSVSIPIT— FNVINRK— ÏQRLES-TRI-NI----E
ÄAOTES SPYSSDT*TP— FA-IARPL-RAH-KE-*FY— GK-SN-
DC-CK1 GVILLTKRG RQICADPNKKWVQKYIS DLKLNA
MIP-la S— F--------V----SEE-----V---E-S-
MCP-2 A--FK---- KEV---- KER- -RDSMKH-DQIFQNLKP
RAOTES A-VFV--- N— V--N-E--- RE--NS-EMS
Figure 1. (a). Nucleotide and amino-acid sequence of DC-CK1. Characteristic cysteines and 
the experimentally determined signal peptide are in italics. The non-consensus poly(A) site is 
underlined. (b). Amino-acid comparison of mature DC-CK1 with the C-C chemokines MIP-1, 
MCP-2 and RANTES. The characteristic cysteines are shown in bold. Identical amino acids 
(dashes) and gaps (asterisks) introduced for optimal alignment are indicated.
GM-CSF plus IL-4 or IL-4 alone, bu t not with GM-CSF alone. After 6 days, 
DC-CK1 mRNA is still present in abundance in GM-CSF plus IL-4 and IL-4 
cultured cells, w hereas only a  small am ount can be discerned with GM-CSF 
alone. This latter finding might be explained by the survival of contam inating 
dendritic cells residing in the monocyte fraction. Collectively, these data  
indicate th a t high-level expression of DC-CK1 is dependent on the presence 
of IL-4. The finding th a t prolonged incubation in the presence of IL-4 (3.5 
days) is required for the induction of DC-CK1 mRNA is consistent with IL-4 
being a  key cytokine in directing the differentiation of monocytes towards the
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dendritic cell lineage, w hereas GM-CSF is merely thought to act as a  survival 
factor [5, 6]
Figure 2. DC-CK1 mRNA is specifically expressed by dendritic cells. (a). Northern blot 
analysis of DC-CK1 expression (filled arrow) in T (Jurkat), B (EBV-B) and monocyte (THP-1, 
U937, MonoMac-6) cell lines, freshly isolated resting or activated (act) PBMC subsets and 
GM-SCF plus IL-4-generated dendritic cells before (DC and D-A+ for polyA+ RNA) and after 
activation with TNF-a plus IL-1 (DC-act and DC-act-A+ for polyA+ RNA) as indicated above 
each lane. (b). Northern analysis of DC-CK1 expression in monocyte-derived dendritic cells 
and freshly isolated monocytes (mono) stimulated as indicated and T cells cultured in GM- 
CSF plus IL-4 with or without activation with PHA/IL-2. (c). Time course of DC-CK1 mRNA 
expression in freshly isolated monocytes cultured in the presence of IL-4, GM-CSF or the 
combination for the time (days) indicated in brackets. Northern blots were hybridized to a 
DC-CK1-specific and a control 28S ribosomal (open arrow) probe. Analogous results were 
obtained when cDNA libraries prepared from most of the same cell types were examined on 
Southern blots after digestion to release their inserts (not shown).
To determine the num ber of dendritic cells in our preparations th a t express 
DC-CK1 mRNA, we did in situ hybridization (ISH) on cytospins of dendritic 
cell cultures. The resu lts dem onstrated th a t m ost cells (65-90%) expressed 
DC-CK1 mRNA, excluding the possibility of a  contam inating cell population 
being responsible for its production (data not shown). To investigate the 
expression of DC-CK1 in situ, ISH was performed on secondary lymphoid 
tissues, which are known to contain dendritic cells. DC-CK1-expressing cells 
were readily observed in T-cell areas (identified by CD34 staining of high 
endothelial venules [12]) and germinal centers of a  tonsil (Fig. 3), consistent 
with the distribution and morphology of dendritic cells [1, 13]. A similar 
expression pattern  of DC-CK1 mRNA was observed in lymph nodes. Staining 
of serial sections for DC-CK1 by ISH and with monoclonal antibodies 
directed against CD68 and DRC-1/CD21 dem onstrated th a t the DC-CK1-
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producing cells in the germinal centers were distinct from tingible body 
m acrophages and follicular dendritic cells, respectively (data not shown). As 
determ ined with anti-CD3, -CD19 and -CD14 monoclonal antibodies, the 
DC-CK1-positive cells are also distinct from T cells, B cells and monocytes 
(data not shown). The DC-CK1-expressing dendritic cells in germinal centres 
are likely to represent the recently identified T-cell stim ulatory germinal- 
center dendritic cells [13].
Figure 3. Detection of DC-CK1 in germinal centres and T-cell areas of a tonsil by in situ 
hybridization. Tonsil sections were stained with a sense (a) or antisense (b-d) DIG-labelled 
DC-CK1 RNA probe. Magnifications are 40 (a, b) and 200 for c (germinal centre) and d (T-cell 
area). The filled arrow indicates staining in the germinal centres (GC) and the open arrow in 
a T-cell area. No staining was observed in the mantle zone (MZ). An incubation time of 2-3 
hours with NBT/BCIP was sufficient to detect DC-CK1 mRNA, which is consistent with the 
abundance of DC-CK1 in the cDNA libraries.
Because dendritic cells are so im portant for the activation of unprim ed T 
cells, we investigated the ability of DC-CK1 to function as a  chem oattractant 
for different T-cell subsets. Freshly isolated T cells respond optimally to 10 
ng /m l DC-CK1 (Fig. 4c), which is similar to the am ount required for the 
potent T-cell chem oattractant RANTES. CD4+ and CD8+ T cells respond 
equally to DC-CK1. In contrast, separation of T lymphocytes into resting 
(CD45RA+) or activated (CD45RO+) subpopulations dem onstrated th a t the 
m ain T-cell population attracted by DC-CK1 consists of naive resting T cells.
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Checkerboard analysis dem onstrated th a t the effect of DC-CK1 on resting T 
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c.
Migrated cells
Figure 4 . DC-CK1 is a potent chemoattractant for the CD45RA+ T-cell subset. (a). Migration 
of purified T cells and the CD4+, CD8+, CD45RA+ and CD45RO+ T-cell subsets in response to 
DC-CK1 and RANTES is indicated as the number of migrated cells versus the amount of 
chemokine. Experiments using filters of 5-|j,m and 8-|j,m pore-size yielded similar results. 
Results shown are representative from experiments using 5-m pore-size filters. Cells on the 
filter are counted from 5 fields under high power. Each point represents mean (s.e.m.) 
number of migrating cells minus the number of cells in the medium control from 3 
experiments performed in duplicate. (b, c). Migration of CD45RA+ and CD45RO+ T cells in 
response to DC-CK1, RANTES, MIP-1a and IL-8, and their sensitivity to 100 ng/ml pertussis 
toxin. The concentration of chemokine yielding the optimal response (10 ng/ml for all 
chemokines) is shown. Results are representative from experiments using 8-m pore-size 
filters. Each point represents mean (s.e.m.) number of migrating cells minus the number of 
cells in the medium control from 3 experiments performed in duplicate.
The T-cell chem oattractants RANTES, MIP-1a and IL-8 do not show this 
specificity for naive CD45RA+ T cells [14-16] (Fig. 4b). DC-CK1 may therefore 
be used by dendritic cells to preferentially a ttrac t naive T cells which, after 
recognition of peptide/M HC complexes presented by dendritic cells resu lts in 
the induction of a  prim ary im m une response.
Chemokines induce chemotaxis when they interact with specific receptors 
th a t signal through heterotrim eric G proteins. As a  consequence, chemotaxis 
is sensitive to pertussis toxin, a  potent inhibitor of Gai proteins [17]. 
Pretreatm ent of cells with pertussis toxin completely abrogated the 
chemotactic response of CD45RA+ T cells to DC-CK1 (Fig. 4c). These data  
provide further evidence th a t DC-CK1 acts primarily on the CD45RA+ T-cell 





The specific expression of a  chemokine, DC-CK1, preferentially attracting 
naive T cells may be one of the m echanism s used by dendritic cells to 
interact preferentially with unprim ed T cells, and is likely to be an im portant 
first step in the initiation of an im m une response. Monoclonal antibodies 
directed against DC-CK1 will be useful in analyzing the lineage relationship 
between subsets of dendritic cells, as well as in defining stages of their 
activation and m aturation [18]. Further, such antibodies will be an 
im portant tool for detecting dendritic cells in different pathological 
conditions, including cancer and HIV infection. Notably, HIV-1 infection has 
recently been shown to be suppressed by chemokines and to be dependent 
on chemokine receptors as a  cell entry cofactor [19, 20]. Further 
characterization of DC-CK1 and its receptor will make clear its function as 
an im m unoregulator and its im portance in the biology of dendritic cells, 
including their role and th a t of DC-CK1 in the pathogenesis of HIV.
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Sum m ary
Dendritic cells (DC) are unique in their ability to present antigen to naive T 
cells, and play therefore a  central role in the initiation of im m une responses. 
Characterization of DC-specific genes may help to unravel the m echanism  
underlying their potent antigen presenting capacity. Here we describe the 
identification of a  novel transcrip t, isolated by random  sequencing of a  cDNA 
library prepared from monocyte-derived DC, which we termed DC-STAMP. 
DC-STAMP is specifically expressed by DC, and not in a  panel of other 
leukocytes or non-haem atopoietic cells. Interestingly, DC-STAMP was also 
detected in activated bu t not resting blood DC. The DC-STAMP transcrip t 
encodes a  470 amino acid protein, containing 7 putative transm em brane 
domains. Expression of a  DC-STAMP-GFP fusion protein in 293 cells 
indicates th a t DC-STAMP is expressed at the cell surface, and has an 
intracellular C-term inus. Surprisingly, no sequence homology was found 
with any other protein or m ultim em brane spanning receptor. Therefore, we 
propose th a t DC-STAMP is a  novel DC-specific m ultim em brane spanning 




Multiple studies have indicated th a t DC are superior in priming naive T cells 
when compared to other APC such as B cells and macrophages. As 
im m ature cells, DC are scattered throughout the body, and are specialized in 
antigen uptake. Antigen uptake and inflammatory cytokines are two of the 
signals th a t induce DC migration to the secondary lymphoid organs, where 
they can activate naive T lymphocytes and probably also B lymphocytes, to 
initiate prim ary im m une responses [1]. Recent experim ents suggest tha t 
distinct DC subsets can be recognized th a t have strikingly different 
influences on the type of im m une response generated in vivo [2, 3].
Although the role of DC in a  wide variety of immunological processes has 
been dem onstrated, the molecular m echanism s th a t regulate DC 
differentiation, migration and m aturation are still poorly understood. 
Isolation and characterization of novel molecules expressed by DC will lead 
to a  better understanding  of these processes. We exploited cDNA libraries 
derived from monocyte-derived DC and identified a  novel 470 amino acid 
protein specifically expressed by DC, which we designated DC-STAMP.
M aterials and M ethods
Leukocyte preparations
PBMC were obtained by leukapheresis of healthy donors, and adherence for
2 hours resulted in a  non-adherent PBL fraction. Monocytes were elutriated 
from PBMC by counterflow centrifugation, and stim ulated with 2 |ig /m l LPS 
for 16 hours. DC were generated in vitro from adherent monocytes as 
described earlier [4]. Purified tonsil B lymphocytes were isolated as described 
[5]. Blood DC were isolated from PBMC using the MACS Blood DC isolation 
kit (CLB, Amsterdam, The Netherlands). M ature CD11c+ blood DC were 
obtained by culture in RPMI-1640 (Life Technologies, Inc.) enriched with 
10% FCS and 50% (v/v) MCM for 3 days [6]. CD4+/CD11c- blood DC were 
obtained by an additional im m unom agnetic depletion of CD11c+ cells with 
Dynal beads (Dynal, Oslo, Norway), and m atured in RPMI-1640 medium 
enriched with 10% FCS and 100 U /m l IL-3 (Sandoz, Basel, Switzerland) for
3 days, followed by 1 |ig /m l CD40L for an additional 24 hours [7].
cDNA library screening, 5 ’ RACE PCR and DNA constructs 
Complementary DNA libraries were prepared as described [8, 9] and 
screened using the random ly labeled 444 bp RcaI/SalI fragment of DC- 
STAMP as a  probe. The m ost 5 ’ end of the DC-STAMP cDNA was isolated by 
5 ’ RACE PCR, using the DC-STAMP specific prim ers RACE-1 (5’- 
ATGAAGAGGCCAGTGCCAAGCAG) and RACE-2 (5’-TCTGTGGTTGT 
TGCCATCTG-3’). To generate the DC-STAMP-EGFP construct the DC-STAMP 
ORF was amplified using the Expand Long Template PCR System 
(Boehringer Mannheim) and cloned N-terminal of EGFP as an EcoRI/BglII 
PCR fragment, deleting the STOP codon, into EcoRI/BamHI digested pN3-
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EGFP (Clontech, Palo Alto, CA). The CCR-1 molecule was amplified by RT- 
PCR from monocytes and cloned as a  GFP fusion protein using a  similar 
approach.
RT-PCR
Total RNA was transcribed into cDNA using an oligodT prim er and 
Superscript II reverse transcrip tase (RT, Gibco BRL). Primers for DC-STAMP 
are indicated in Figure 1, yielding a  specific product of 334 bp (24 cycles). As 
a  control for RNA quality, ß-actin was amplified (18 cycles, 328 nt). Southern 
blot analysis of the PCR products was performed using specific 32P- 
endlabeled internal oligonucleotides. For sem i-quantitative PCR analysis, 2.5 
to 5 |ig of DNAse treated total RNA was transcribed into cDNA using random  
hexam ers and Mo-MLV reverse transcrip tase (Gibco BRL). PCR reactions 
were performed in triplicates according to the TaqmanTM assay [10, 11], and 
run  on the ABI/PRISM 7700 Sequence Detector System (PE Applied 
Biosystems). The am ount of DC-STAMP expression was normalized to the 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
and compared to expression of another housekeeping gene, 
phorphobilinogen deam inase (PBGD) within the sam e donor. Probes were 
synthesized by PE Biosystems, and prim ers surround  an intron sequence. 
Sequences of all prim ers and probes are available upon request. 
Calculations were performed as described by Perkin-Elmer [12].
Expression o f GFP-fusion proteins into 293  cells
H um an embryonic kidney (HEK) 293 cells (2x106) were transfected with 3 |ig 
DNA mixed with 18 |il LipofectAMINE (Gibco BRL), as described [13]. 
Expression was checked by FACScan analysis in the FITC channel (Becton 
Dickinson & Co., Oxnard, CA). Stably transfected bulk populations were 
obtained after selection on G418 (1 m g/m l; Life Technologies Ltd, Paisley, 
Scotland) and FACS sorting on the Coulter Epics Elite (Coulter, Hialeah, FL). 
For im m unohistochem istry, cells were stained with rabbit polyclonal anti- 
GFP serum  (E. Cuppen, University of Nijmegen, The Netherlands), either 
before or after cytospin preparations. Cytospins were fixed with aceton for 10 
m inutes, incubated with a  horse anti-m ouse biotinylated antibody and 
positive cells visualized by im munoperoxidase staining (Vectastain Elite ABC 
kit, Vector Laboratories, Burlingame, USA). For Confocal Laser Scanning 
Microscopy (CLSM), cells were attached to poly-l-lysine coated glass slides, 
after which GFP-fusion protein distribution was determ ined at 488 nm  with 
a  krypton/argon Laser (Biorad 1000, Hercules, CA).
R esu lts
Identification o f a novel cDNA expressed  by DC
To characterize DC at the molecular level, cDNA libraries were prepared from 
hum an monocyte-derived DC [8]. From over 250 clones, one cDNA was 
analyzed in further detail as it contained a  unique sequence not present in
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the G enebank databases and initial screening indicated a  DC-specific 
expression. A second cDNA library screening, followed by 5 ’ RACE PCR 
(rapid amplification of cDNA ends) resulted in the isolation of the full-length 
transcrip t of 1954 bp. The cDNA contains a  single long ORF of 1410 
nucleotides starting with the first ATG codon at nucleotide 52, which is in 
the appropriate sequence context for translation initiation [14], and is 
followed by a  490-nucleotide 3 ’ UTR. The poly A-tail is preceded by the 
polyadenylation signal sequence ATTAAA (Fig. 1). Genebank/EM BL database 
searches revealed m atches with several unpublished EST fragm ents from 
hum an tum ors. Since DC-STAMP contains several TM regions, we termed 
th is novel protein DC-STAMP (DC-Specific Transm em brane Protein).
The ORF of DC-STAMP predicts a  protein of 470 amino acids, with a  
predicted molecular weight of around 53 kDa and an isoelectric point of 
9.41. The amino term inus of the protein s ta rts  with a  short stretch of 
hydrophobic amino acids, which predicts an uncleavable signal sequence 
(pSORT, O saka University, Japan). Hydrophobicity analysis of the sequence 
revealed 7 putative transm em brane (TM) regions (not shown), suggesting 
th a t the DC-STAMP molecule is spanning the m em brane multiple times. 
Prosite analysis of the protein revealed 3 potential N-linked glycosylation 
sites and a  consensus sequence for phosphorylation by protein kinase C. 
The 72 amino acid cytoplasmic tail of DC-STAMP contains several serine 
residues, two of which might serve as a  target for phosphorylation. 
Interestingly, the C-term inus of the DC-STAMP protein is extremely rich in 
positively charged residues, comprising 25% of the tail and conferring an 
overall positive charge (+14). Pairwise protein sequence alignm ents 
performed between DC-STAMP and m em bers of several 7 TM subclasses 
(ClustalW) showed identities below 20%, suggesting th a t the DC-STAMP 
protein represents a  novel protein family.
DC-STAMP is preferentially expressed  by dendritic cells
Northern blot analysis revealed a  2.3 kb message for DC-STAMP in DC (not 
shown). To further analyze the expression pattern  of th is novel m essenger 
RNA, RT-PCR was performed on RNA from a  panel of freshly isolated resting 
or activated leukocyte populations and several cell lines of haematopoietic as 
well as non-haem atopoietic origin. As shown in Figure 2, a  distinct band of 
the expected size was detected in im m ature as well as in m ature DC. In 
contrast, freshly isolated monocytes did not express the DC-STAMP RNA, 
even after overnight stim ulation with LPS. A low expression was detected in 
freshly isolated total PBMC and B cells, probably as a  consequence of 
contam inating DC, and in the pre-monocytic cell line U937.
Using real-time sem i-quantitative PCR analysis [10, 11], the expression of 
DC-STAMP at different tim e-points during in vitro culture and m aturation of 
monocyte-derived DC has been investigated (Fig. 3a-c). DC-STAMP is 
constitutively expressed from day 3 to day 8 (Fig. 3a-b). No expression of DC- 
STAMP could be detected in monocytes (Fig. 3a), in accordance with the RT- 
PCR data. Activation of DC with CD40L, normally present on activated T 
cells, induced a  downregulation of DC-STAMP expression of approximately
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10 fold (Fig. 3c). The expression of DC-STAMP is in the sam e range as 
expression of the housekeeping gene phorphobilinogen deam inase (PBGD), 
although there is some variation between donors.
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1 4 5 3 GAC AAG TC A T G A G A G A CCC CG A C T A C T CCT C A G C CA CA T CG CA CC A A C A A T T CT CT T C A G G T CT A G G A T G G C A G T C 1 5 2 8
1 5 2 9 G T C A C T A T T C A T G C C G G A T A A T A G A G A A C TA TG TG A C G C A G TC CTCTCA G G A G TCTG A G TTTA CA G A G C CA A CTTG CA C 1 6 0 7
1 6 0 8 CTG G TTATG CC TCCTTTCA TCTCA A A G C C A A A G A G C T G C C A G G T A A A T G G TT A T G T G G T C T A T G TT C C A A A C A A A C C A C 1 6 8 6
1 6 8 7 A TG A TCTTG CC TG T G T C A C A A T G T A A C A A G A C T C T A G C T G G G T C C C C T G G TG A T G A G T T T C A G C A T A G A A T A A T G T T C A 1 7 6 5
1 7 6 6 A G G A A A AG A A A ACGA A A A CA GTTTA A ATCTCTACCA CA G CCTCA CA AG CAA A TG CTA AG G G GA A CA TA CA TG TA A A AA G 1 8 4 4
1 8 4 5 C C A G C A A A C T A T C T T C A A A C T C T T C C G T C C T T A A T G T C T T C C A T G G C T A T T G C C C C C A C A A T G G T C T C T T T T C T C C C T G 1 9 2 3
1 9 2 4 C T C C C T T A T T A A A G A A C TC T T TC T G A A A C C C 1 9 5 4
Figure 1. Sequence analysis of DC-STAMP (Genbank accession nr. AF305068). The 7 
putative transmembrane domains are in bold and underlined, the 3 N-linked glycosylation 
sites in italic, and the potential phosphorylation sites for PKC or cAMP-dependent protein 
kinases are in bold and underlined, respectively. The non-consensus polyadenylation signal 
is boxed. Primers used for the RT-PCR are indicated by arrows.
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Figure 2. RT-PCR analysis of DC-STAMP expression. Upper panel: DC-STAMP; lower panel: 
ß-actin. DC were cultured for 7 days (DC), activated with LPS (DC-LPS) or the combination 
of TNF-a and an activating antibody to CD40 (DC-act.). Non-adherent PBL and PBMC were 
stimulated with PHA and rIL-2. Elutriated monocytes were stimulated with LPS (16 hours). 
B cells were isolated from tonsils. BLM is a human melanoma cell line, U2OS an osteoblastic 
cell line, U937, Mono-Mac and THP-1 are monocytic cell lines, EBV is a mixture of 3 EBV 































Figure 3. Expression of DC-STAMP by in vitro cultured DC and freshly isolated blood DC. 
(a). Expression of DC-STAMP in monocytes and monocyte-derived DC (day=3) compared to 
PBGD. (b). immature (day=6) and mature monocyte-derived DC (+ TNF-a or LPS). (c). 
immature DC and DC + CD40L (day=8). (d). freshly isolated blood DC, d=0 and day=3 
(+MCM). Each graph represents data from 1 representative donor out of 3 or more.
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Quantitation o f DC-STAMP expression in fresh ly  isolated blood DC 
Using sem i-quantitative PCR analysis we have determ ined the in vivo 
expression of DC-STAMP in freshly isolated blood DC. Blood DC mainly 
consist of two defined subsets, based on the expression of CD 11c. CD 11c- 
DC are thought to belong to the lymphoid lineage, w hereas CD11c+ DC 
belong to the myeloid lineage [15]. Freshly isolated blood DC did not express 
DC-STAMP. However, upon culture of the blood DC for 3 days with MCM, 
which induces the m aturation of myeloid blood DC [6], DC-STAMP mRNA 
could readily be detected (Fig. 3d). The CD11c- DC population was m atured 
by the addition of IL-3 for 3 days, followed by overnight stim ulation with 
CD40L [7]. These cells had no or low expression of DC-STAMP (data not 
shown). Activated CD11c+ blood DC expressed lower levels of DC-STAMP 
compared to in vitro cultured DC. This phenom enon is also observed for the 
production of several chemokines produced by DC [16].
DC-STAMP-EGFP is expressed  at the cell surface in 293  cells and has an 
intracellular C-terminus
A DC-STAMP-EGFP (Enhanced Green Fluorescent Protein) fusion protein 
was generated by cloning the EGFP sequence C-terminal of the DC-STAMP 
ORF. 293 cells were transfected with th is construct and analyzed by 
Confocal Laser Scanning Microscopy (CLSM) to determine the cellular 
localization of DC-STAMP. Since m ultim em brane-spanning proteins are very 
hydrophobic and complex proteins, the CCR-1 molecule, a  7 TM chemokine 
receptor expressed at the cell m em brane, was taken along as a  control. 
CCR1-EGFP transfectan ts showed bright m em brane fluorescence, often 
accompanied by an additional highly fluorescent spot in the cytoplasm, 
possibly representing the Golgi (Fig. 4b). Analysis of transien t as well as 
stable transfectan ts of the DC-STAMP-EGFP construct showed a  similar 
fluorescence staining pattern , indicating th a t DC-STAMP can also be 
expressed at the cell surface (Fig. 4a). T ransfectants expressing the EGFP 
protein alone showed bright cytoplasmic fluorescence, not localized to a 
particular cell structu re  (not shown).
Since the EGFP protein is attached to the C-term inus of DC-STAMP, we 
could determine the cellular localization of the C-tail of DC-STAMP. 
Therefore, transien t transfectan ts of DC-STAMP-EGFP in 293 cells were 
stained with polyclonal anti-GFP serum  either before or after 
permeabilization. Im m unohistochem istry of cytospins showed th a t EGFP 
could only be detected after permeabilization (Fig. 4d), indicating th a t DC- 
STAMP has an intracellular C-term inus. The am ount of positive cells was 
consistent with the percentage of GFP positive cells in the transien t 
transfected bulk population as observed by FACS analysis (Fig. 4e). The few 
cells th a t stained positive after pre-incubation with the anti-GFP serum  (Fig. 
4c) were due to leakage of the antibody into dead cells.
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Figure 4. The DC-STAMP-EGFP fusion protein localizes to the cell surface in 293 cells and 
has an intracellular C-terminus. (a). 293/DC-STAMP-GFP transient transfectants were 
adhered to poly-l-lysine coated slides and fluorescence was visualized with confocal laser 
scanning microscopy (CLSM). A representative cell is shown. (b). CLSM of transient 
293/CCR-1-EGFP transfectant. DC-STAMP-EGFP transfectants were stained with polyclonal 
anti-GFP serum either before (c) or after cytospin preparation (d). (e). FACS analysis of 
293/DC-STAMP-EGFP transfectants used for cytospin preparations (closed histogram). The 
open histogram corresponds to 293 mock transfected cells. The percentage of positive cells 
is indicated.
D iscu ssion
DC-LAMP [17], Langerin [18], DC-CK1 [9] and DC-SIGN [19] are recently 
cloned molecules with a  DC-specific expression. These proteins are either 
involved in antigen processing or the establishm ent of DC-T cell interaction, 
processes instrum ental for DC function. DC-STAMP is yet another DC-
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specific molecule th a t could help to explain DC’s unique immunobiology. 
Analysis of the protein suggests th a t DC-STAMP is a  novel receptor, sharing 
no identity to other m ultim em brane spanning proteins. Expression studies 
of DC-STAMP-EGFP fusion proteins in 293 cells localize DC-STAMP to the 
cell surface, with an intracellular C-term inus. The use of several TM 
prediction program s for the hydrophobicity analysis of DC-STAMP resulted 
in different models, regarding the position and num ber of transm em brane 
domains. We prefer a  model in which the DC-STAMP protein contains 7 
transm em brane domains, which is supported by the position of potential 
glycosylation and phosphorylation recognition sites, an intracellular C- 
term inus, and the presence of charged amino acids, which generally flank 
transm em brane regions. However, since TM2, TM3 and TM4 are ra ther weak 
TM regions, we cannot exclude alternative models comprising 6, 5 or 4 TM 
regions.
It should be considered th a t DC are present in vivo in different m aturation 
stages and can be derived from different haematopoietic lineages [20]. When 
studying myeloid DC, DC-STAMP is expressed both in im m ature and m ature 
in vitro generated DC, as well as in m ature CD11c+ blood DC (Fig. 4). 
Preliminary findings show th a t DC-STAMP is also expressed at similar levels 
in DC cultured in vitro from CD34+ progenitor cells. However, Langerhans 
cells isolated from skin were found negative for expression of DC-STAMP 
(data not shown). Lymphoid CD11c- blood DC express no or low levels of DC- 
STAMP, even after activation. These da ta  suggest th a t the expression of DC- 
STAMP is restricted to several myeloid DC subsets.
Characteristic of the DC-STAMP C-term inus is its very basic content. There 
is some indication th a t juxtam em brane clusters of positively charged 
residues in cytoplasmic receptor tails can associate with proteins of the ERM 
(ezrin, radaxin, moesin) family [21]. Since these ERM proteins have been 
implicated as m em brane cytoskeletal linkers, th is might suggest association 
of DC-STAMP with the cytoskeleton. Ligation of DC-STAMP might affect 
adhesive or migratory capacities, essential for proper DC function. As of this 
time, we can only speculate about a  possible function of DC-STAMP in vivo. 
However, as ligation of CD40 appears to downregulate DC-STAMP 
expression on DC, th is suggests th a t DC-STAMP is not involved in late DC-T 
cell contact. Further studies are required to elucidate the function of the DC- 
specific m ultim em brane spanning receptor DC-STAMP in DC 
immunobiology.
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Sum m ary
This study establishes the genomic organization of the hum an dendritic cell- 
associated DC-STAMP gene. The gene spans 15 kb, consists of four exons 
and three introns and localizes to hum an chromosome 8q22, a  region tha t 
has been linked to several myeloid leukemias. Its unique intron-exon 
structu re  suggests th a t DC-STAMP represents a  novel protein family. 
Analysis of the DC-STAMP promotor region indicated binding sites for 
several transcription factors th a t are involved in the regulation of 
immunological im portant proteins and myeloid dendritic cell differentiation. 
In addition, we identified two variant mRNAs resulting from differential 
splicing of exon 2. The DC-STAMP gene is well conserved in several species, 




Dendritic cells (DC) play an im portant role in the induction of antigen- 
specific im m une responses. Im m ature DC capture antigens in peripheral 
tissues and subsequently migrate to the T-cell areas of secondary lymphoid 
organs to present these antigens to naïve T and B cells [1-3]. The DC-specific 
transm em brane protein (DC-STAMP) is a  novel transm em brane molecule 
preferentially expressed by DC th a t was identified by random  sequencing of 
DC cDNA libraries (accession num ber AF305068) [4, 5]. DC-STAMP is 
expressed by both im m ature and m ature DC, and its expression is down- 
regulated by ligation of the CD40 molecule. The protein contains seven 
putative transm em brane regions, and has an intracellular C-terminus. 
Surprisingly, no sequence homology was found with any other protein or 
m ultim em brane-spanning receptor, indicating th a t DC-STAMP represents a 
new group of transm em brane proteins [5].
In th is study we cloned the DC-STAMP gene and characterized its genomic 
structu re  and chromosomal localization. Screening of a  hum an genomic 
phage library with a  DC-STAMP cDNA probe yielded several positive phage 
clones, all containing the 3' part of the DC-STAMP gene. A p-1-derived 
artificial chromosome (PAC) clone containing the 5’ part of the DC-STAMP 
gene, including the prom otor region, was isolated from the RCPI 6 PAC 
library (Genome Technology Center, Leiden, The Netherlands). Meanwhile, 
database searches with the DC-STAMP cDNA sequence revealed an 
unfinished contig of chromosome 8 from the Humane Genome Project 
(accession num ber AC055117) th a t harbored part of the DC-STAMP gene, 
including exon 1 and approximately 2 kb of the prom otor region. This 
allowed u s to compile the complete genomic structu re  of the DC-STAMP gene 
(Fig. 1a). The DC-STAMP gene contains four exons and three introns. All 
intron-exon bounderies are in agreem ent with the splice site consensus (5' 
GT/AG 3') rule [6] and are depicted in Fig. 1b. The large intron 1 of the DC- 
STAMP gene is located in the 5' un transla ted  region of the cDNA and 
separates the small non-coding exon 1 from the exons encoding the DC- 
STAMP protein. Intron 3 was completely sequenced, w hereas from introns 1 
and 2 only the 5' and 3' parts were sequenced and their lengths estim ated by 
analysis of the sizes of the PCR products on agarose gels. The coding region 
of the DC-STAMP gene s ta rts  a t base 13 of exon 2, spans exon 3 and 
includes the first 75 bp of exon 4. Exon 2 encodes the DC-STAMP protein 
from the N-term inus to 30 amino acids dow nstream  of the sixth putative 
transm em brane (TM) region. Exon 3 includes the seventh TM region and the 
first 34 amino acids of the intracellular C-term inus, while exon 4 encodes 
the final 24 amino acids of the C-tail. Exons usually represent protein 
dom ains th a t are functional un its  and intron-exon bounderies are therefore 
well conserved in evolution. The intron-exon structu re  of the DC-STAMP 
gene is ra ther unique, and has not been described so far for any other 
m ultim em brane-spanning protein. An intron in the 5' un transla ted  region of 
genes has been described for several other transm em brane proteins, 
including the prostaglandin EP4 receptor gene [7], the gene for the ra t m4 
m uscarinic receptor [8], and the hum an CC chemokine receptor 5 (CCR5) 
gene [9]. Interestingly, intron 1 of the CCR5 gene is GC-rich and was
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dem onstrated to have strong constitutive promotor activity. Likewise, the 
sequence of intron 1 of the DC-STAMP gene might contain additional binding 
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b Exon Size (bp) 5’ splice donor Intron size 
(kb)
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1 29 GAAACCT gtaag 8 ttcag GACGCAGG
2 1041 C GGA GAG gtegg 5.5 tttag AAA CAA G
3 309 T ACA AAG gtaag 0.9 ttcag ATT CAT T
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Figure 1. Genomic organization, exon-in tro n  bounderies an d  alternative splicing of the  
h u m an  DC-STAMP gene. (a). Physical m ap  of the  h u m an  DC-STAMP gene. The exons are 
rep resen ted  by boxes, an d  th e  black sections indicate the  protein-encoding sequences. The 
gray blocks in  th e  pro tein  rep resen t th e  pu tative  tran sm em b ran e  regions in  th e  DC-STAMP 
protein. (b). Exon-in tro n  organization. In tron  sequences are  in  lowercase letters an d  exon 
sequences are  in  uppercase letters. Exon sequences are  g rouped  by codons w hen they  are 
p a rt  of th e  open reading  fram e. (c). A lternatively spliced mRNA products. Exons are 
ind icated  a s  numbered boxes. The novel am ino acid sequence derived of in tro n  2 for the  






Interestingly, we identied two alternative DC-STAMP cDNAs expressed by DC 
(Fig. 1c). A sm aller cDNA was identified by RT-PCR, and subsequent cloning 
and sequence analysis indicated the loss of exon 3. Since both introns in the 
coding region are type 1 (introns occur between codons), the reading frame is 
unchanged, and th is alternatively spliced mRNA would therefore encode a 
protein lacking TM7 and part of the C-term inus, including the putative 
phosphorylation sites. The second variant cDNA was identified by screening 
a  DC cDNA library and contains an additional 771 bp of intron 2 by using an 
alternative non-consensus 5' splice site (Fig. 1c). Since the sequence of 
intron 2 contains an in-frame stop codon at position 23, th is would result in 
a  truncated  protein, which lacks part of the last interm em brane loop, TM7, 
and the complete cytoplasmic tail. As the initially described cDNA appears to 
be the m ost abundan t by Northern analysis in both im m ature and m ature 
DC, the biological significance of these alternatively spliced mRNAs rem ains 
unclear.
The chromosomal localization of the hum an DC-STAMP gene was 
determ ined by fluorescence in situ hybridization (FISH). For th is purpose, 
intron 2 was amplified by PCR from the phage clone, purified, biotin-labelled 
for nicktranslation and hybridized to hum an m etaphase chrom osomes as 
described by Lichter and co-workers [10]. This resulted in highly specific 
signals of the probe on chromosome 8q22 (not shown). Localization to this 
region is supported by the fact th a t the genomic clone AC055117 originates 
from chromosome 8. Interestingly, region 8q22 has been linked to several 
cases of chronic myeloid leukem ias [11, 12]. One might speculate about the 
possible involvement of DC-STAMP in the development of these leukemias, 
since DC-STAMP not only m aps to th is locus, bu t also encodes a  protein 
specifically expressed by DC of myeloid origin.
1 23 4 5
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Figure 2. Zoo blot analysis of genomic DNA from 
hamster (1), pig (2), mouse (3), chicken (4) and 
human (5). Genomic DNA was digested with 
EcoRI, separated on an agarose gel and 
hybridized with a probe containing part of exon 
2 of the DC-STAMP gene. The arrows indicate 
the specific signals obtained by hybridization.
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A Zoo blot analysis was performed to determine w hether the DC-STAMP gene 
is conserved in evolution. D atabase searches did not reveal any sequences 
homologous to the DC-STAMP gene in other species. Genomic DNA from 
hum an, pig, ham ster, chicken, and m ouse was digested with EcoRI, size- 
separated on an agarose gel, and hybridized at 50°C with a  DC-STAMP 
specific probe containing part of exon 2. This revealed a  specific band for 
hum an, ham ster, pig and mouse, w hereas no signal was obtained for the 
chicken DNA (Fig. 2). These resu lts indicated th a t the DC-STAMP gene is a 
single copy gene th a t is well conserved in mammals.
As DC are crucial for the regulation of im m une responses, they are 
considered as interesting candidates in clinical applications such as the 
treatm ent of autoim m unity, graft versus host disease and cancer. Since the 
highly conserved DC-STAMP gene is preferentially expressed by DC, the 
prom otor region would be an interesting tool for in vivo targeting of (tumor) 
antigens to the DC. Therefore, we analyzed the 5' flanking genomic DNA of 
the hum an DC-STAMP gene (Fig. 3), which revealed a  TATA-box like 
prom otor region, located 35 nucleotides 5 ’ of a  predicted transcription start 
site (A in the sequence, TSS Hum an Core Promotor Finder [13]). 5' Rapid 
amplification of cDNA ends (RACE) of DC-STAMP identified a  dom inant 
cDNA product starting with the G 6 bp 3 ’ from the predicted A. Additionally, 
the length of these cDNAs corresponds to a  m essenger RNA of 2.3 kb 
detected on Northern blot. Taken together, these da ta  suggest th a t the 
indicated transcription sta rt positions are a t or very near the actual 5' end of 
the DC-STAMP cDNA. Analysis of the 5' putative promotor region of the DC- 
STAMP gene revealed several potential consensus motifs for transcription 
factors, including both ubiquitous and lymphoid-specific factors. AP-1, 
C/EBP, N F -kB , and octam er factors have quite broad expression patterns. 
The families of N F -kB  and octam er transcription factors play a  role in the 
expression of genes of principal im portance in the im m une system, such as 
major histocompatibility complex (MHC) class I and II molecules, cytokines 
and their receptors, and immunoglobulin genes [14, 15]. Both N F -kB  and 
octam er factors have recently been shown to be differentially expressed 
during the differentiation and m aturation of DC [16]. Interestingly, the DC- 
STAMP promotor region contains several putative binding sites for N F -kB  
and octam er factors, supporting a  role for DC-STAMP in the im m une system. 
Furtherm ore, the DC-STAMP prom otor region contains several potential 
binding sites for interferon regulatory factor 1. Since th is factor is involved in 
the activation of interferon-inducible MHC class I genes [17], th is suggests 
th a t the DC-STAMP gene might be inducible by type I interferons. Finally, 
the DC-STAMP promotor region contains a  PU.1 binding site and a  signal 
transducer and activator of transcription (ST AT) 6 binding site. ST AT 6 is 
activated via the IL-4 signaling pathway [18], w hereas PU.1 is essential for 
the development of myeloid dendritic cells [19, 20]. Additional experiments 




In sum m ary, our work establishes the genomic organization of the hum an 
dendritic cell-associated DC-STAMP gene. The gene spans 15 kb, consists of 
four exons and three introns and localizes to hum an chromosome 8q22, a 
region th a t has been linked to several myeloid leukemias. Its unique intron- 
exon structu re  suggests th a t DC-STAMP represents a  novel protein family. 
Analysis of the DC-STAMP promotor region indicated binding sites for 
several transcription factors th a t are involved in the regulation of 
immunological im portant proteins and myeloid dendritic cell differentiation. 
In addition, we identified of two variant mRNAs resulting from differential 
splicing of exon 2. The DC-STAMP gene is well conserved in several species, 





I R F - 1
-1782 taatcaggaagatatgagatatcctgtgaaggcttcccgaagaatggagaggaagggaag
P U . 1
-1722 accatttcagttggaagaaggatacattatgggaataagtcattttactggagatatgaa




O c t - 1
-14 82 taaattcttggaatgactaattctagtagcttataaatttgtataggtattgtcaaatca 
A P - 1
-142 2 gcctttttctttcactcccaagttgggaattgctggggactctcaaaaccatgtcactga 
I R F - 1  N F - k B 1
-13 6 2 ctccatttttggttgtgggagctgggagcccctccatttcctcttcccagttctttcttc 
-13 02 tgcagctgcccccaggtttgttctccatgatccagcaacttctgtctccatcccccgttc 
-1242 tcagaaggctccatctcctccttccccaagaaggttgcaactgccctcagctttcctccc 
-1182 tccctcctcagggagtaccaacatctctctcttatctttattcttctttgtgaggctgat 
-112 2 atgctaaatttcatctagttttccccaaactcaaaccactacctctctactgctgccttc 
-106 2 tccctctccatttccatccctagcactactacaaaggaaccccatccagtccagccggtt 




- 82 2 accatggctgcttctggatgactcaatcagacacccacattgcagtcccatccttcctgt
A P - 1
- 76 2 tcaaatgaaaacatctcatttcaacagctctcttcatcttcaggactaagtcagcccctt




A P - 1 - S p 1 / N F - k B
- 52 2 acaagctggtccttttgacttggaagctaaatttctaagatggaaagtcactgtatgaga
N F - k B
- 462 tgggaggcatgaaaccaattattcgacctgtctggggtcatgagtgcagaggcggctcct
- 402 acgaaccatctgcctcttcaagtgtggatgagaggtgggtatggcggatgttcgtcattt
- 34 2 cccaatggctcgagtggatgtggggagtatgggagtgagggcaaaagagaaaagagggag
I R F - 1
- 2 82 agaggccgtccaagctttcacaactcactctcttgtgtttgaaaatatctgatttcatta
C / E B P
- 22 2 attttctataattaatttctagaacatctattctgaggaaaatgctagaaagaaatatgc
O c t - 6
- 16 2 tttcatttgtatcagcattactctttgttgatattaaatggcttagtcactttatggggg
O c t - 1  A P - 1
- 102 aaataaagaggttgattcatggtgatgtgaccctctcgccacttctggttccctttttcc
- 4 2 tgctatatatcaagacctacagcccttgggaagtgcAtttctGcattcgaagaagaatct
T A T A  b o x
+ 19 gagagaaacct....intron1..... gacgcagggagcATGGGTATCTGGACCTCAGGC
M G  I W T S G
Figure 3. Nucleotide sequence of th e  proxim al 1.9 kb of th e  prom otor sequence of the  
h u m an  DC-STAMP gene. The two po ten tia l tran sc rip tio n  s ta r t  s ites  are  depicted  in  bold. 
Potential tran sc rip tio n  factor-binding s ite s  are  underlined. The sequence enum eration  show s 
the  guanosine  of th e  tran scrip tiona l s ta r t  site  a s  position  +1. The s ta r t  of th e  open reading 
fram e is ind icated  by a one-letter am ino acid sequence.
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Sum m ary
Using differential display PCR a  novel gene was isolated from hum an 
monocyte-derived dendritic cells, which was term ed DC203. Evaluation of 
the expression of DC203 in a  panel of leukocytic and non-leukocytic 
populations showed th a t DC203 is highly specific for dendritic cells. Detailed 
analysis of in vivo DC subsets dem onstrated th a t myeloid and lymphoid-like 
blood dendritic cells as well as Langerhans cells express DC203. The mRNA 
encodes a  putative protein of 744 amino acids containing a  nuclear targeting 
sequence and a  putative DNA binding domain, suggesting th a t DC203 is a  
nuclear transcription factor. Southern blot analysis indicated th a t DC203 is 
a  single copy gene th a t is well conserved. The gene consists of five exons and 
four introns, which distribute the DNA binding domain over three exons. 
Functional studies will shed light on the role of DC203 in DC immunobiology 
and DC differentiation.
Note: Nucleotide and amino acid sequences as well as prim er sequences are 




Dendritic cells (DC) are bone marrow-derived antigen presenting cells (APC) 
of the immune system. DC are unique in their capacity to activate naïve T 
cells and prime the immune response [1]. DC are present in non-lymphoid 
tissues such as skin as immature cells that endocytose antigens and 
apoptotic cells through a variety of receptors. Stimuli such as pathogens and 
tissue damage induce the maturation and migration of DC towards the T 
cells areas of the secondary lymphoid organs. Upon maturation, the major 
histocompatibility antigens (MHC) class I and class II are loaded with 
peptides and move to the cell surface. Additionally, co-stimulatory molecules 
are upregulated, leading to efficient stimulation of naive T cells [1, 2]. DC 
have recently also been shown to down-regulate immune responses by 
inducing tolerance or anergy [3, 4]. Therefore, DC are now actively employed 
in the clinic as vaccination strategy for the treatm ent of a variety of diseases 
such as cancer, graft-versus-host disease and auto-immunity.
However, many questions regarding the molecular mechanisms regulating 
DC differentiation, migration and maturation remain still unanswered. 
Several DC subsets have now been described that seem to originate from 
different haematopoietic lineages, i.e. myeloid or lymphoid. Distinct DC 
subsets might follow distinct migration pathways and perform unique 
functions, such as modulating the type of immune response. Myeloid DC 
subsets have mainly been described to efficiently induce immune responses 
[5]. In the mouse, a DC subset has been characterized that is considered of 
lymphoid origin and is thought to be important in deletional tolerance [6]. In 
hum an, tonsilar plasmacytoid DC might represent a lymphoid DC subset 
with different functional properties [7].
Molecular characterization of the genes that are expressed by DC will provide 
more insight into their specific behavior and function. Therefore, we have 
applied differential display PCR in order to isolate genes that are specifically 
expressed by monocyte-derived DC [8]. Differential display PCR allows 
simultaneous comparison of RNA subsets expressed by different cell 
populations and has lead to the identification of many differentially 
expressed genes [9]. In this report, we describe one cDNA clone, DC203, that 
was highly specific for DC. Sequence analysis of the complete DC203 cDNA 
suggests that it encodes a novel transcription factor containing a putative 
DNA binding domain. Interestingly, DC203 is expressed by several DC 
subsets, both in vitro and in vivo, suggesting that DC203 might have an 
important function in the differentiation pathway of DC.
M aterials and m eth od s
Leukocyte preparations
PBMC were obtained by leukapheresis of healthy donors, and adherence for
2 hours resulted in a non-adherent PBL fraction. Monocytes were elutriated 
from PBMC by counterflow centrifugation, and stimulated with 2 |ig/ml LPS
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for 16 hours. DC were generated in vitro from adherent monocytes as 
described earlier [10]. Purified tonsil B lymphocytes were isolated as 
described [11]. Blood DC were isolated from PBMC using the MACS Blood 
DC isolation kit (CLB, Amsterdam, The Netherlands). Mature CD11c+ blood 
DC were obtained by culture in RPMI-1640 (Life Technologies, Inc.) enriched 
with 10% FCS and 50% (v/v) MCM for 3 days [12]. CD4+/CD11c- blood DC 
were obtained by an additional immunomagnetic depletion of CD11c+ cells 
with Dynal beads (Dynal, Oslo, Norway), and matured in RPMI-1640 medium 
enriched with 10% FCS and 100 U/ml IL-3 (Sandoz, Basel, Switzerland) for
3 days, followed by 1 |ig/ml CD40L for an additional 24 hours [13]. 
Langerhans cells (LC) were isolated as cells that had migrated out of 
epidermal sheets derived from healthy donors undergoing plastic surgery of 
the breast or abdomen (42 hours), in the presence or absence of 500 U/ml 
GM-CSF (Scheringer-Plough) [14]. LC were enriched using anti-HLA-DR 
monoclonal antibodies and magnetic cell sorting (MACS, CLB) and were 
>98% pure as analyzed by FACS.
Differential display PCR (DD-PCR)
DD-PCR was performed essentially as described [9]. The 3' primers used 
were the anchored oligo-dT primers T1 2 MC, T1 2 MA, T1 2 MT and T 1 2 MG, where 
M represents A, C, G or T. The 5' primers were randomly-designed 
oligonucleotides of 10 bases. PCR was performed in the presence of 35S-dATP 
to allow visualization of the products following separation by denaturing 
polyacrylamide gel electrophoresis. PCR products that were reproducibly 
cell-specific were eluted from the gel, re-amplified by PCR and cloned into 
pGEM-T (Promega). Cellular specificity of the clones was determined by RT- 
PCR followed by Southern hybridization.
cDNA library screenings
Complementary DNA libraries were prepared as described [8, 15] and 
screened using the randomly labeled 155 bp DC203 fragment from the 
differential display PCR as a probe. The most 5’ end of the DC203 cDNA was 
isolated by preparing a cDNA library with a DC203 specific primer, using the 
Superscript Plasmid System for cDNA synthesis (Gibco BRL, Life 
Technologies) and subsequent screening of the library by Southern blot 
hybridization with a DC203 specific probe.
Southern and Northern blot analysis
For Northern blot analysis, total RNA was isolated with Trizol Reagent (Life 
Technologies, Inc.), resolved on a formaldehyde gel and transferred to a 
nylon membrane by capillary blotting. Hybridization was performed 
overnight at 65°C in Church solution (0.5 M NaHPO4 , pH 7.2; 7 % SDS; 0,5 
M EDTA). Multiple tissue Northern blot # 7780-1 (Clontech, Palo Alto, CA) 
was probed and washed under stringent conditions according to the 
m anufacturer’s recommendations. The Zoo blot and cDNA library filters were 
hybridized in PEG buffer (10% PEG-8000, 7% SDS) at 50°C and 65°C, 
respectively. All membranes were hybridized with a DC203 specific probe
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containing the most 3’ of the ORF and part of the 3’ UTR, obtained by PCR, 
and randomly labeled with 32P-dCTP (T7 QuickPrime Kit, Pharmacia).
RT-PCR
Total RNA was transcribed into cDNA using an oligo-dT primer and 
Superscript II reverse transcriptase (RT, Gibco BRL). Primers for DC203 were 
located in the original DD-PCR product, yielding a specific product of 144 bp 
(24 cycles). As a control for RNA quality, ß-actin was amplified (18 cycles, 
328 bp). Southern blot analysis of the PCR products was performed using 
specific 32P-endlabeled internal oligonucleotides. For semi-quantitative PCR 
analysis, 2.5 to 5 |ig of DNAse treated total RNA was transcribed into cDNA 
using random hexamers and Mo-MLV reverse transcriptase (Gibco BRL). 
PCR reactions were performed in triplicates according to the TaqmanTM 
assay [16], and run on the ABI/PRISM 7700 Sequence Detector System (PE 
Applied Biosystems). The DC203-specific probe was labeled at the 5' end 
with a FAM fluorescent group and at the 3' end with a TAMRA quencher 
group. The used primers yield a specific product of 104 bp and surround 
intron 4, resulting in a product of more than 3 kb on genomic DNA. The 
am ount of DC203 expression was normalized to the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and compared to 
expression of another housekeeping gene, phorphobilinogen deaminase 
(PBGD) within the same donor. Calculations were performed as described by 
Perkin-Elmer [17].
Expression of GFP-fusion proteins into 293 cells
To generate the DC203-EGFP construct the DC203 ORF was amplified using 
the Expand Long Template PCR System (Boehringer Mannheim) and cloned 
N-terminal of EGFP as a SalI/BamHI PCR fragment, deleting the STOP 
codon, into pN3-EGFP (Clontech, Palo Alto, CA). Human embryonic kidney 
(HEK) 293 cells (2x106) were transfected with 3 |ig DNA mixed with 18 |il 
LipofectAMINE (Gibco BRL), as described [18]. Expression was checked by 
FACScan analysis in the FITC channel (Becton Dickinson & Co., Oxnard, 
CA).
R esu lts
Differential display PCR identifies a novel DC-specific cDNA 
To identify novel transcripts that are specifically expressed by DC we 
performed differential display PCR (DD-PCR), a technique used to detect 
genes that are differentially expressed between two or more cell populations. 
We used anchored oligo-dT primers for the reverse transcription of the 
cDNAs and combined these primers with random hexamers for the PCR 
reaction. Immature and mature monocyte-derived DC were compared with a 
mixture of 3 monocytic, B- and T cell lines. DC from 2 donors were prepared 
in an attem pt to avoid the identification of donor-specific molecules. Twenty- 
four different primer combinations were tested, and 20 bands which were
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DC-specific in two independent experiments were rescued from gel and 
amplified. Since most bands contain multiple PCR products of identical 
length, half of the product was cloned and the other half used as a 
radioactive labeled probe in the hybridization of the resulting clones. This 
method eliminates contaminating sequences and identifies the dominant 
PCR product [19]. For two bands no dominant product could be identified, 
whereas several clones that had resulted from bands that were in the same 
region on the gel contained identical sequences. Database analysis of the 
nucleotide sequences of the remaining 15 dominant clones revealed that 7 
were identical to a known cDNA, two corresponded to contaminating 
mitochondrial DNA, three encoded repetitive sequences, and three clones 
were either novel or identical to expressed sequence tags (Table 1). 
Subsequent screening of these novel cDNAs for DC-specificity using 
Southern blots of a panel of available cDNA libraries identified clone DC203 
as a novel DC-specific cDNA with no homology to any of the known genes or 
ESTs (not shown). The original DD-PCR gel for the DC203 cDNA fragment is 
shown in Figure1. To further confirm DC-specific expression of DC203 a RT- 
PCR with primers in this 155 bp fragment was performed on a panel of 
leukocyte populations and non-leukocytic cell lines (Fig. 2). Strikingly, 
DC203 appeared to be highly specific for DC.
Clone Length (bp) Homology
8 480 Alternative spliced IFN-aß receptor subunit
19* 165 CXCL16
*32 350 small GTPase
61* 280 Several ESTs
81 >575 Mitochondrial DNA
91 210 Mitochondrial DNA
111 450 Alpha-2-macroglobulin
125* 361 Several ESTs
134 >500 Repetitive DNA
145 >500 Ferritin heavy chain
156 175 Alu repeat
172 159 L1 repeat
203 155 unknown
217* 243 HnRNP A2 / ABCA1
234 160 HLAB27/Bw58
Table 1. Clones expressed by monocyte-derived DC resulting from differential 
display PCR.




Figure 1. Part of a polyacrylamide gel loaded with sam ples from one primer combination in 
the differential display PCR. M = monocytic cell lines; T = T cell lines; B = B cell lines; 
D 1/D 2 = immature DC from donor 1 or 2; D S1/D S2 = mature DC from donor 1 or 2. An 
arrow indicates the DC-specific product DC203.
DC203
ß-actin
Figure 2. RT-PCR analysis of the expression of DC203. The sam ples were loaded on an 
agarose gel, blotted to a nylon membrane and hybridized with a specific radioactive internal 
oligonucleotide. Upper panel: DC023; lower panel: ß-actin. DC were cultured for 7 days (DC), 
activated with LPS (DC-LPS) or the combination of TNF-a and an activating antibody to 
CD40 (DC-act.). Non-adherent PBL and PBMC were stimulated with PHA and rIL-2. 
Elutriated monocytes were stimulated with LPS (16 hours) or GM-CSF (5 days). B cells were 
isolated from tonsils. BLM is a hum an melanoma cell line, U2OS an osteoblastic cell line, 
U937, Mono-Mac and THP-1 are monocytic cell lines, EBV is a mixture of 3 EBV 
transformed B cell lines, and Jurkat, CEM and Peer are T cell lines.
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The DC203 mDNA is 8 kb and is highly expressed by monocyte-derived DC 
Since the DC203 differential display product was a novel transcript 
specifically expressed by DC, we screened a cDNA library derived from 
monocyte-derived DC in order to obtain the full-length messenger RNA, 
using the original DD-PCR product as a probe. This resulted in the isolation 
of a 1.2 kb transcript, that did not contain any open reading frame (ORF). 
Subsequently, a DC cDNA library was prepared with a DC203 specific 
primer. Multiple screening rounds of this library finally resulted in the 
isolation of a cDNA clone of approximately 3700 nucleotides. Northern blot 
analysis with several different probes derived from the full length DC203 
cDNA clone (see below) identified a dominant DC-specific transcript of 
approximately 8 kb (Fig. 3). Hybridization of a Northern blot containing 
polyA+ RNA from 12 hum an tissues (Clontech blot MTN # 7780-1) showed 
highest expression of DC203 in heart and placenta, whereas lower 
expression could be detected in kidney, liver, brain, skeletal muscle, colon, 
thymus, spleen and small intestine (Fig. 4). Interestingly, heart and placenta 
are tissues with a relatively high amount of DC.
8.0 kb
Figure 3. Northern blot analysis of DC203. Total RNA was isolated from freshly isolated 
leukocyte populations and cell lines (U937 and Jurkat). All RNA samples were fractionated 
through a formaldehyde gel, blotted and hybridized with a specific 32P-labeled DC203 probe. 
DC were cultured for 7 days (DC) and activated with LPS (DC+LPS). Adherent and non­





■+• t ril if
Figure 4 . Multiple Tissue Northern of DC203. Blot # 7780-1 (Clontech), containing polyA+ 
RNA from twelve hum an tissu es w as hybridized with a DC203 specific probe under stringent 
conditions according to the manufacturer’s  recommendations. The 8 kb DC203 mRNA is  
indicated with an arrow.
Using real-time semi-quantitative PCR analysis [16, 20], the expression of 
DC203 in monocyte-derived DC was determined in more detail. DC203 is 
constitutively expressed from day 6 to day 8, and is not significantly up- or 
down-regulated upon maturation stimuli as CD40L. This is in contrast to 
the expression of DC-STAMP, another DC-specific gene that is down- 
regulated upon CD40 ligation [21]. Simultaneous addition of CD40L and 
IFN-y to monocyte-derived DC induces the production of IL-12 [22]. However, 
this did not influence the expression of DC203 or DC-STAMP. The 
expression of DC203 was always similar or higher than the expression of the 
housekeeping gene phorphobilinogen deaminase (PBGD) or DC-STAMP, 
dependent on the donor (Fig. 5a).
DC203 is expressed in several in vivo DC subsets
To investigate expression of DC203 in in vivo DC subsets, we have isolated 
DC from peripheral blood. Blood DC mainly consist of two defined subsets, 
based on the expression of CD11c. CD11c- DC are thought to belong to the 
lymphoid lineage, whereas CD11c+ DC belong to the myeloid lineage [23]. 
Freshly isolated blood DC expressed intermediate levels of DC203, whereas 
no DC-STAMP expression could be detected. Upon culture of the blood DC 
for 3 days with MCM, which induces the maturation of myeloid blood DC 
[12], DC203 mRNA was up-regulated (Fig. 5b). The CD11c- DC population 
was matured by the addition of IL-3 for 3 days, followed by overnight
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stimulation with CD40L [13]. These cells expressed comparable levels of 
DC203 as myeloid blood DC (Fig. 5b), in contrast to DC-STAMP, which is 
negative in CD 11c- blood DC. Activated CD11c+ and CD 11c- blood DC 
expressed comparable levels of DC203 as in vitro cultured DC. Langerhans 
cells isolated from epidermal skin layers were also positive for expression of 
DC203, with or without the addition of GM-CSF (Fig. 5c). In contrary, these 
Langerhans cell populations do not express DC-CK1 or DC-STAMP [21, 22]. 
These data indicate that DC203 is rather unique in that it is expressed by all 








DC203 PBGD DC- 
STAM P
Figure 5. Quantitative expression of DC203 by in vitro cultured DC, freshly isolated blood 
DC, and Langerhans cells. (a). Expression of DC203 in immature (day=6) and mature 
monocyte-derived DC (+ CD40L or CD40L and IFN-y compared to PBGD and DC-STAMP. (b). 
Freshly isolated blood DC (d=0), blood DC + MCM (day=3), and CD11c- blood DC + IL- 
3/CD40L. (c). Langerhans cells that have migrated out of epidermal sheets in the absence or 




The DC203 cDNA encodes an 85 kDa protein containing a putative DNA 
binding domain
Sequence analysis of the 3.7 kb DC203 cDNA revealed the presence of a 
single large ORF starting with the first ATG codon, which is in the 
appropriate sequence context for translation initiation [24]. Interestingly, the 
protein sequence contains a nuclear targeting sequence (NTS) and a putative 
DNA binding motif, strongly suggesting that this protein is a nuclear 
transcription factor (Fig. 7). Outside of the putative DNA binding motif, no 
homology was present to any known protein. The ORF of the DC203 cDNA 
encodes a protein of 744 amino acids with a predicted molecular weight of 
around 85 kDa and an isoelectric point of 8,62. Since no specific antibodies 
are available yet that recognize the DC203 protein, a construct was 
generated in which the ORF of DC203 was cloned N-terminal of the 
enhanced green fluorescent protein (EGFP). 293 cells were transfected with 
this construct and analyzed by Western blot for expression of the fusion 
protein. The polyclonal anti-GFP antibody specifically detected a product of 
around 105 kDa, not present in non-transfected cells, corresponding to a 







Figure 6 . Western analysis of DC203-EGFP fusion
----  35 protein. 293 cells were transfected with DC203-EGFP
(lane 1) or EGFP (lane 2) and lysates were analyzed with
___  30 an anti-GFP polyclonal antibody. Arrows indicate the
detected products.
The DC203 gene is a highly conserved single copy gene consisting of five  
exons
To determine whether the DC203 gene contains intron sequences Long 
Range PCRs were performed on genomic DNA with several primer 
combinations ranging the complete ORF. In addition, two genomic clones 
were identified in the database consisting of unordered contigs. These 
contigs contained almost the complete gene of DC203, except for part of the 
sequence of intron 3. Together, these data allowed us to compile the 
complete genomic structure of the DC203 gene (Fig. 7). The first of four
78
DC-203, a novel DC specific protein
introns is located 13 nucleotides in front of the start codon and has a length 
of at least 21 kb. Three more intron sequences are present in the ORF of 
DC203, of 3.5 kb, 10 kb and 3 kb, respectively. All exon-intron bounderies 
were in agreement with the splice site consensus (5' GT/AG 3') rule [25]. As 
a consequence, the DC203 protein is encoded by five exons. The putative 
DNA binding domain is encoded by part of exon 3, exon 4 and part of exon 5, 
as depicted in Fig. 7.
Detailed analysis of genomic sequences revealed that the DC203 cDNA 
probably has a 3’ untranslated region (UTR) of at least 3.5 kb. However, it is 
still unclear which of several consensus polyadenylation sites is actually 
used. Similar to the 3’ UTR, the exact length of the 5’ UTR remains to be 
determined. PCR analysis with several primers sets in the 5’ part of the 
DC203 gene suggested that the transcription start of DC203 could be 
located upstream  of the sequence from the cDNA clone. Inspection of this 
sequence revealed a CAAT-box like promotor region, located 750 nucleotides 
in front of the start of the cDNA (TSS Human Core Promotor Finder, [26]).













Figure 7. Genomic organization of the hum an DC203 gene. A physical map of the hum an  
DC203 gene is shown in which the exons are represented by boxes, and the black parts 
indicate the protein-encoding sequences. The position of the nuclear targeting sequence 
(NTS) and the DNA binding domains in the protein are indicated. The exact lengths of exons 
1  and 5  and intron 1  are unclear.
To determine whether the gene of DC203 is conserved in evolution, genomic 
DNA from human, chicken, mouse, ham ster and pig was digested with 
EcoRI, separated on an agarose gel and hybridized with a DC203 specific 
cDNA probe surrounding the 3’ end of the ORF. One or two specific bands 
could be detected in all species tested, including hum an (Fig. 8). 
Hybridization of hum an genomic DNA digested with several different 
restriction enzymes also gave rise to one specific band (not shown). This 






Figure 8. Zoo blot analysis of genomic DNA from hamster, pig, 
m ouse, chicken and human. Genomic DNA was digested with 
EcoRI, separated on an agarose gel and hybridized with a 
DC203 specific probe containing the m ost 3 ’ of the ORF and 
part of the 3 ’ UTR. The arrows indicate the specific signals 
obtained by hybridization.
D iscu ssion
DC are a heterogeneous population of immune cells that have a unique life 
cycle, differentiation pathway and function. Part of this is explained by the 
expression of DC-associated molecules such as DC-CK1, DC-LAMP, DC- 
SIGN, and Langerin [27]. Here we describe another molecule, DC203, which 
is expressed exclusively by various DC subsets.
Differential display PCR is a widely used technique to isolate differentially 
expressed genes, but no DC-specific genes that were identified by this 
technique have been described so far. This study clearly shows that DD-PCR 
can be used to isolate DC-specific or DC-associated genes. Although some 
contaminating sequences were obtained and some clones encoded 
ubiquitous gene products, next to DC203 several other genes were isolated 
with a DC-associated expression, including CXCL16, alpha-2-macroglobulin 
and HLA-B27. DC express high levels of MHC class I and class II molecules, 
explaining the isolation of the HLA-B27 molecule. Additionally, both DC 
donors m ust have been positive for this HLA molecule, whereas the cell lines 
were negative for class I in general or had a different haplotype. Alpha-2- 
macroglobulin (ß-2M) is a serum protein that is inhibits a wide variety of 
proteinases [28, 29]. It also can regulate cytokine and growth factor activity 
such as TGF-ß, TNF-a and VEGF [30, 31]. Therefore, ß-2M might influence 
the cytokine environment of a DC. Interestingly, ß-2M has also been shown 
to bind antigens and increase their presentation to T cells by uptake via the 
high-affinity ß-2M receptor [32], which is also present on DC. Finally, recent 
database searches identified clone 19 as a novel transm em brane CXC 
chemokine, CXCL16. CXCL16 is expressed in vivo by T cell area DC in 
lymphoid organs and by cells in the splenic red pulp, and attracts several T
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cell subsets [33].
Expression of DC203 is detected in many hum an tissues, with the highest 
expression levels in heart and placenta. Since these organs are all known to 
contain DC, the observed expression could well be explained by the presence 
of DC but still needs further study. Zoo blot analysis indicated that the 
DC203 gene is very well conserved in nature, which is supported by 
sequence analysis of a partial mouse DC203 cDNA. This mouse DC203 
sequence has an overall homology of approximately 85%, and is also highly 
specific for mouse DC. DC203 is expressed by several DC subsets, including 
the lymphoid-like CD 11c- blood DC. Furthermore, DC203 mRNA is already 
present in freshly isolated DC subsets, and its expression increases upon 
activation. Monocyte-derived DC constitutively express DC203. These data 
suggest a role for DC203 early in and during differentiation towards a DC. 
Since DC203 probably acts as a transcription factor, it is tempting to 
speculate that DC203 regulates the expression of genes important for DC 
differentiation. More information is needed about the time-point of onset of 
DC203 expression.
As DC203 expression is restricted to DC, DC203 could be used as a marker 
for the am ount of DC present in blood, and possibly also in tissues. Since 
the expression of DC203 is very specific for DC, the promotor region could be 
a very useful tool to specifically target antigens to the DC in vivo, in order to 
elicit or repress immune responses. Promotor studies in DC will have to 
proof its DC specificity and to lead to the elucidation of its own 
transcriptional regulation.
Analysis of the DC203 gene structure revealed that the DNA binding domain 
of DC203 is encoded by 3 exons. Since exons usually represent protein 
domains that are functional units, the intron-exon boundaries in the DC203 
gene might well serve to regulate the function of the gene. However, no clear 
alternatively spliced transcripts could be detected by Northern blot analysis. 
Interestingly, the DC203 protein sequence contains several proline-rich 
stretches, which could represent transactivation domains. These domains 
serve to interact with other transcriptional modulators [34]. Hereby, the 
function of DC203 could be influenced by other transcription factors, or, on 
the contrary, DC203 could bind to other transcription factors. More studies 
are needed to determine whether the DNA binding domains are indeed 
involved in DNA or protein binding and to define the functionality of the 
putative transactivation domains.
Other transcription factors that are active in DC include RelB and Ikaros. 
Ikaros is a member of the Krüppel family of DNA-binding proteins and 
differentially controls the development of fetal and adult lymphocytes, 
including thymic DC. However, it does not seem to regulate the 
differentiation of myeloid DC subsets [35]. RelB is a  member of the NF- 
KB/rel family that is highly expressed in DC. Absence of relB results in a 
disturbance of the architecture of the thymus and spleen, resulting in 
reduced thymic and splenic DC populations [36]. A direct, intrinsic effect of 
relB was shown for a distinct myeloid, but not lymphoid-related splenic DC 
population. RelB is strongly upregulated during in vitro generation and
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maturation of DC [37]. Assuming that DC203 is a transcription factor, it 
would be the first transcription factor that is exclusively expressed by DC in 
the immune system. Additionally, DC203 is expressed by both myeloid and 
lymphoid DC subsets. DC203 could either function as an enhancer or a 
repressor or both on the transcription of other genes. More insight into the 
relevance of DC203 for DC differentiation and function has to come from in 
vitro studies blocking the expression of DC203, such as anti-sense 
technology or the expression of DC203 deletion m utants, and the generation 
of DC203 knockout mice.
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Sum m ary
Upon maturation, dendritic cells (DC) have to adjust their chemokine 
expression in order to sequentially attract different leukocyte subsets. We 
used real-time quantitative PCR analysis to study in detail the expression of 
twelve chemokines, involved in the recruitment of leukocytes into and inside 
secondary lymphoid organs, by DC in distinct differentiation stages, both in 
vitro and in vivo. Monocyte-derived immature DC expressed high levels of 
DC-CK1, ELC, MDC, MIP-1a and TARC. Upon m aturation DC up-regulated 
the expression of DC-CK1 (60-fold), ELC (7-fold) and TARC (10-fold). 
Activation of DC by CD40L further up-regulated the expression of ELC (25­
fold). We found that freshly isolated blood DC expressed only low levels of IL- 
8, lymphotactin and MIP-1a. Interestingly, the chemokine profile expressed 
by activated CD 11c- lymphoid-like as well as CD11c+ myeloid blood DC 
mimics that of monocyte-derived DC. Additionally, purified Langerhans cells 
that have migrated out of the epidermis expressed a similar chemokine 
pattern. These data indicate that different DC subsets in vitro and in vivo can 




Dendritic cells (DC) are professional antigen-presenting cells well capable to 
attract and interact with naïve (CD45RA+) T cells to initiate a primary 
immune response [1-3]. Several different DC populations have been 
identified, each of which is differentiated via a unique pathway. Two DC 
subsets of myeloid origin have been described: Langerhans cells (LC) present 
in the epidermis, which take up antigen and subsequently migrate to local 
lymph nodes to differentiate into DC, and myeloid lineage-derived DC located 
in the dermis, blood and B-cell follicles, which lack LC markers. There is 
also evidence for the existence of a distinct lymphoid DC subset, which is 
represented by the CD11c- plasmacytoid DC [4].
Following antigen uptake in the periphery immature DC change their 
chemokine receptor profile and migrate into secondary lymphoid organs, 
where they mature and m ust interact in an antigen-specific m anner with B 
cells and T cells in order to initiate an immune response [4, 5]. Chemokines 
are involved in the recruitment of B cells, T cells and DC into the secondary 
lymphoid organs and the attraction of these cells to each other. This process 
requires accurate regulation, which can be defined at three different levels. 
(a) Regulation of chemokine production [6]. (b) Regulation of chemokine 
receptor expression and desensitization [5, 7-9]. (c) Chemokines acting as 
antagonists [10].
To unravel in detail the fine-tuning of chemokine-regulation in 
microenvironments, we studied the regulation of chemokine production. 
Since DC play a key role in the induction of an antigen-specific immune 
response, we analyzed the chemokine expression by DC. For this purpose, 
we used real-time quantitative PCR, a new technique to precisely quantify 
mRNA levels. This approach utilizes a sequence-specific probe containing at 
its 5' end a reporter dye which is quenched by a second fluorescent dye. 
During specific extension of the PCR, Taq polymerase cleaves the probe and 
the quencher-dye is released. The subsequent increase of fluorescence of the 
reporter dye is proportional to the amount of amplified copies and can be 
monitored on-line [11-13]. We have determined the chemokine expression of 
in vitro cultured immature and mature monocyte-derived DC. Furthermore, 
we studied whether monocyte-derived DC primed, at the cytokine level, to 
induce a T-helper 1 response exhibit a chemokine profile different from that 
of DC primed to induce a T-helper 2 response. Chemokine expression of 
monocyte-derived DC was compared with that of in vivo DC subsets, namely 
peripheral blood DC and LC. Strikingly, although we observed quantitative 
differences between chemokine expression levels, all tested DC subsets 
expressed a similar chemokine expression profiles. This indicates that they 
are able to attract the same set of cells of the immune system.
M aterials and M ethods
Antibodies
To characterize the different DC subsets, flow cytometry was performed
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using either FITC-conjugated or PE-conjugated mAbs. FITC-conjugated 
mAbs: anti-HLA class I (W6/32) and anti-HLA DR/DP (Q5/13). PE- 
conjugated mAbs: anti-CD3, anti-CD 11c, anti-CD80 (all Becton Dickinson, 
Mountain View, CA); anti-CD 14 and anti-CD83 (both Beckman Coulter, 
Mijdrecht, The Netherlands); anti-CD 16 and anti-CD 19 (both Dako, 
Glustrop, Denmark); and anti-CD86 (Pharmingen, San Diago, CA).
Generation of monocyte-derived DC
Peripheral blood mononuclear cells (PBMC) of healthy individuals were 
separated by Percoll density centrifugation and were allowed to adhere for 1 
hour at 37°C in RPMI-1640 (Life Technologies, Inc., Grand Island, NY) 
enriched with 2% hum an serum (HS) in 75 cm2 tissue culture flasks (Costar, 
Badhoevedorp, The Netherlands). Adherent monocytes were cultured in 
RPMI-1640 enriched with 10% FCS and antibiotic-antimycotic (all Life 
Technologies, Inc.) in the presence of IL-4 (500 U/ml, Schering-Plough, 
Amstelveen, The Netherlands) and granulocyte macrophage colony 
stimulating factor (GM-CSF, 800 U/ml, Schering-Plough) for 6 days. Fresh 
cytokine-containing culture medium was added at day 3. At day 6, the 
immature DC were harvested. To generate mature DC, immature DC were 
resuspended in fresh cytokine-containing culture medium and stimulated by 
addition of either 10 ng/m l TNF-a, (Bender Wien, Vienna, Austria), 2 ^g/ml 
lipopolysaccharide (LPS, Sigma, Chemical Co., St. Louis, MO), 1 mg/ml 
CD40L trimer or 1 m g/ml CD40L in combination with 1000 U/ml IFN-y 
(Boehringer Ingelheim, Ingelheim am Rhein, Germany) in 6 well culture 
plates. Mature monocyte-derived DC were used at day 8. DC cultured in 
autologous serum were prepared according to the same procedure, using X- 
VIVO 15 medium (BioWhittaker, Walkersville, MD) enriched with 1% 
autologous serum. Maturation was established by addition of the 
combination of 10 ng/m l TNF-a, (Bender Wien), 10 ^g/m l prostaglandin E2  
(PGE2 , Sigma), and 50% (v/v) monocyte-conditioned medium (MCM, from 
IgG-activated monocytes) [14].
Isolation and stimulation of fresh  blood DC
DC were isolated from PBMC by using the MACS Blood DC isolation kit 
(CLB, Amsterdam, The Netherlands). Briefly, blood DC were pre-enriched 
from PBMC by immunomagnetic depletion of CD3+ T cells, CD11b+ 
monocytic cells and CD 16+ natural killer (NK) cells. During a second 
immunomagnetic separation CD4+ blood DC were positively selected. To 
obtain activated CD4+/CD11c+ blood DC, freshly isolated blood DC were 
cultured in RPMI-1640 (Life Technologies, Inc.) enriched with 10% FCS and 
50% (v/v) MCM for 3 days [15]. Stimulated CD4+/CD11c- blood DC were 
obtained by depletion of CD11c+ cells, using anti-CD11c mAbs and magnetic 
cell sorting (Dynal, Oslo, Norway), from the pre-enriched blood DC fraction 
followed by a positive selection for CD4. Isolated CD4+/CD11c- blood DC 
were activated in RPMI-1640 medium (Life Technologies, Inc.) enriched with 
10% FCS and 100 U/ml IL-3 for 4 days, one day before harvesting of cells, 1 
mg/m l of CD40L trimer was added [16].
87
Chapter 6
Isolation of Langerhans cells from the skin
Full-thickness hum an skin specimens were obtained from healthy donors 
undergoing plastic surgery of the breast or abdomen. These specimens were 
shaved into slices of 0.2 mm thickness by using a dermatome. To enable 
separation of the epidermis from the dermis the slices were incubated with 
0.2% dispase II (Boehringer Mannheim, Germany) in PBS at 37°C for 30 
minutes. Subsequently, epidermal sheets were rinsed in PBS and cultured 
dermal side down in IMDM (Life Technologies, Inc.) enriched with 10% FCS 
and 50 |ig/ml gentamycin (Sigma). After 42 hours, the cells that had 
migrated out of the epidermal sheets were collected [17]. LC were enriched 
using anti-HLA-DR mAbs and magnetic cell sorting (MACS, CLB) and were 
>98% pure as analyzed by FACS.
Taqmari™ primers and probes
TaqmanTM probes were synthesized by PE Biosystems (Branchburg, New 
Jersey). The chemokine-specific probes were labeled at the 5' end with a 
FAM fluorescent group and at the 3' end with a TAMRA quencher group. 
Probes specific for the housekeeping genes glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and porphobilinogen deaminase (PBGD) were 
labeled at the 5' end with a VIC fluorescent group and at the 3' end with 
TAMRA. Sequences of all primers and probes used in this study are given in 
Table 1.
Real-time semi quantitative PCR analysis
Total RNA was extracted using Trizol Reagent (Life Technologies, Inc.) and 
subsequently treated with RNAse free DNAse (Boehringer Mannheim). 
Reverse transcription was performed using 2.5 to 5 ^g total RNA, random 
hexamers and Mo-MLV reverse transcriptase (Life Technologies, Inc.). As a 
control, the reaction was also performed in the absence of reverse 
transcriptase. PCR reactions were performed in triplicate in accordance with 
the TaqmanTM assay instructions [18, 19], using an end concentration of 
175 nM probe and 600 nM primers. The amplifications were performed on 
an ABI/PRISM 7700 Sequence Detector System (PE-Applied Biosystems). 
This system produces a real-time amplification plot based upon the 
normalized fluorescence signal. The fractional cycle number at which the 
number of amplified target reaches a fixed threshold, called the threshold 
cycle (CT), is determined. The CT obtained is equivalent to the initial number 
of templates in the sample. Based on the exponential amplification of the 
target genes, as well as the GAPDH gene, the am ount of amplified molecules 
at the threshold cycle is given by the equation: T0 /R 0  = K • (1 + e)(ct>r -ct>t ). 
Here, Tö= initial number of target gene copies; Rö= initial number of GAPDH 
gene copies; E= efficiency of amplification; CT,R= threshold cycle of GAPDH 
gene; CT,T= threshold cycle of target gene; and K= constant (described in ref.
20). This relation is based on the premise that efficiency of targets and 
reference amplification are approximately equal. By comparing serial dilution 
of target and standard genes simultaneously, we demonstrated that the 
value of the slopes of log input am ount versus CT were indeed approximately
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equal (not shown). The am ount of chemokines expressed was normalized to 
GAPDH and per donor related to the expression level of the housekeeping 
gene PBGD.
Chemokine 5' primer 3' 5' probe 3'
D C -C K 1 CCTGGAGGCCACCTCTTCTAA AGTCCCATCTGCTATGCCCAGCCAC
(C C L 1 8 ) TGCAGCTCAACAATAGAAATCAATT
Fractalkine CGCAATCATCTTGGAGACGA TTCTGTGCCGACCCGAAGGAGC
(C X 3 C L 1 ) ACCTCGCCGATCTGCTTCT
ELC CAGAGGACCTCAGCCAAGATG CCTATGACCGTGCAGAGGGAGCCC
(C C L 1 9 ) TTCACAATGCTTGACTCGGACT
I L - 8 AGAAGTTTTTGAAGAGGGCTGAGA T C CAAGAAT CAGT GAAGAT G C CAGT G
(C X C L 8) CAGACCCACACAATACATGAAGTG AAACTT
Lymphotac- GGACAGGAAAT C CAACAC CAGA CAACAGGAAC C CAGCAAT CGAC CAA
t i n (X C L 1) GGACAGGGTGCCAGAGACTACT
MDC GTCCTGTTCCCATCAGCGAT CCATGACTCCCCACTGCCCTAAGCT
(C C L 2 2 ) CAGGCTGGAGACAGAGATGGA
M I P - l a TGTGTTTG TG A TTG TTTG CTCTG A CCTTCCCTCACACCGCGTCTGG
(C C L 3 ) TGGTGCCATGACTGCCTACA
M I P - 3 a GGACATAGC C CAAGAACAGAAAGA TCCATGATGTGCAAGTGAAACCTCCA
(C C L 2 0 ) CAAACTATGATGCAATATGAATCA
ACTTC
A
S D F - l a ACTAAAACCTTGTGAGAGATGA CCTTAACCATGAGGACCAGGT
(C X C L 1 2 ) GGGTCTAAATGCTGCAAACCT
S D F - l ß ACAAGAGGTTCAAGATGTGAGA TAGGAG CCCAGCTCT GAAAC CAG
(C X C L 1 2 ) AGTGTGCAAAACAAAGCCCTT
SLC GTCTCCCAGGGAGCATGAGA ACTGTCCCCTTGAAGGAGAATCATCA
(C C L 2 1 ) GGGAGCCGTATCAGGTCCA GGA
TARC GCAAAGCCTTGAGAGGTCTTGA CCTCCTCACCCCAGACTCCTGACTGT




PBGD GGCAATGCGGCTGCAA C TCA TCTTTG G G CTG TTTTCTTCCG C
GGGTACCCACGCGAATCAC C




The secretion of the chemokines DC-CK1, MDC and TARC in culture 
supernatants was analyzed using specific sandwich ELISAs. In the DC-CK1 
ELISA, mouse anti-hum an DC-CK1 mAb (AZN-CK18B, Lindhout et al, 
submitted) was used as the primary (catching) Ab, and goat anti-hum an 
PARC as secondary (detection) Ab (R&D-systems Europe LTD, Abingdon, 
UK). The primary and secondary antibodies for the MDC ELISA were mouse 
anti-hum an MDC (Clone 252Y, gift from Dr. R. Rodenburg) and rabbit anti­
hum an MDC (Preprotech Inc, Rocky Hill, NJ, USA), respectively. In the TARC 
ELISA rat anti-hum an TARC mAb (clone 25D8, DNAX) and goat anti-hum an 
TARC (R&D-systems) were used. Detection Abs were stained with horse 
radish peroxidase (HRP)-conjugated donkey anti-goat IgG (Jackson 
Immunoresearch Lab Inc, West Grove, PA, USA) or HRP-conjugated goat 
anti-rabbit IgG (Zymed, Laboratories Inc., San Francisco, CA). HRP was 
visualized by incubation with TMB-substrate. Absorption was measured at 
450 nm using a Titertek multiscan ELISA reader. Detection limits for all 
ELISA were 0.8 ng/ml.
IL-12p70 sandwich ELISA
The measurement of IL-12p70 (detection limit 0.2 ng/ml) was performed 
using a specific sandwich ELISA. Anti-human IL-12p70 mAb was used as 
the primary Ab, and anti-hum an IL-12p40/p70 biotin-labeled mAb (both 
Endogen, Woburn, MA) as detection Ab. Streptavidin-HRP conjugate (CLB) 
was used to specifically stain the biotin-labeled mAb and was visualized by 
incubation with TMB-substrate. Absorption was measured at 450 nm.
R esu lts
Monocyte-derived DC express high levels o f DC-CK1, ELC, TARC, and MDC 
The presence and activity of chemokines in a microenvironment is regulated 
on multiple levels. Here we examine in more detail the regulation of 
chemokines expressed by DC. Upon arrival in secondary lymphoid organs, 
DC have to attract B cells and T cells to initiate an immune response. 
Therefore, we have selected twelve chemokines that are involved in the 
recruitment of leukocytes into and inside secondairy lymphoid organs. The 
expression levels of these chemokines in DC were examined by real-time 
quantitative PCR analysis. The housekeeping gene GAPDH was used as an 
internal control for the am ount of cDNA. Moreover, for each donor, the 
expression levels of the chemokines were related to the expression level of 
PBGD, another housekeeping gene expressed at intermediate levels. Serial 
dilutions of target and standard genes demonstrated that all PCR reactions 
had approximately the same efficiency (data not shown).
We first analyzed chemokines expressed by monocyte-derived immature and 
mature DC. Immature DC expressing MHC class I, low levels of MHC class II 
and B7.2 (CD86) but neither B7.1 (CD80) nor CD83 were generated by 
culturing monocytes in the presence of GM-CSF and IL-4. Immature DC
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were stimulated with LPS or TNF-a resulting in mature DC that expressed 
high levels of MHC class I and II, and were positive for B7.1, B7.2 and CD83. 
Relative mRNA levels of chemokines produced by freshly isolated monocytes, 
immature DC, and mature DC are depicted in Figure 1. Monocytes expressed 
high levels of IL-8 and smaller am ounts of MIP-1a, MIP-3ß and lymphotactin 
(Fig. 1a). Expression of IL-8 in immature and mature DC was dramatically 
decreased (1000-fold) compared to that in monocytes (Fig. 1b). Interestingly, 
immature DC expressed high levels of MDC and TARC. TARC was up- 
regulated approximately 10 fold in mature DC compared to immature DC, 
while MDC levels remained constant. DC-CK1 and ELC were expressed at 
intermediate levels by immature DC, but expression increased 60- and 7­
fold, respectively, upon maturation. The other chemokines tested were 
expressed at lower levels, and no expression of SDF-1a and SDF-1ß was 
detected in cultured DC.
Since DC-CK1, MDC and TARC were the chemokines expressed at the 
highest levels in mature DC, their secretion by DC was tested using 
chemokine-specific sandwich ELISAs. As shown in Fig. 1c, the production of 
the DC-CK1 and TARC proteins was increased upon maturation, while MDC 
production remained constant. These results are in agreement with the 
quantitative PCR data.
Chemokine expression by cultured DC is independent o f FCS 
The above data demonstrate that DC cultured in medium containing FCS 
expressed high levels of chemokines. To exclude the involvement of FCS in 
the induction of chemokine expression, DC were cultured in autologous 
serum and subsequently analyzed for chemokine expression. Figure 2 shows 
that immature DC cultured in autologous serum (MHC class Ip°s/MHC class 
IIlow/B 7.2low/B 7.1neg/CD83neg) generally expressed comparable levels of 
chemokines as immature DC cultured in FCS. However, IL-8 was expressed 
to a higher level and TARC was expressed to a lower level than in DC 
cultured in FCS. In DC m aturated with TNF-a, PGE2  and MCM (MHC class 
Ihigh/MHC class IIhi§h/B7.2p°s/B7.1p°s/CD83p°s) the expression of chemokines 
was up-regulated, especially DC-CK-1, IL-8, MDC and TARC were highly 
expressed. These results are consistent with the chemokine levels measured 
in mature DC cultured in FCS and demonstrate that the chemokine 
expression by cultured DC is independent of FCS.
ELC but not DC-CK1 is up-regulated in CD40 ligand-activated DC 
CD40 ligation is known to be a strong stimulus, which further activates DC 
[4]. To address the question whether CD40 triggering specifically influences 
the expression of certain chemokines in DC, immature DC were activated 
with CD40L for 48 hours. Chemokines expressed by these activated DC 
(MHC class Ihigh/MHC class IIhigh/B7.2p°s/  B7. 1p°s/CD83p°s) were examined 
using real-time quantitative PCR analysis. The expression levels of two 
chemokines differed between CD40L-activated DC and DC stimulated with 
LPS or TNF-a (Fig. 3 and Fig. 1b). Activation with CD40L increased the 
expression of ELC to high levels (up to 25-fold higher than those of immature
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DC). Furthermore, we found that, compared with immature DC, CD40L- 
activated DC did not up-regulate or only slightly up-regulated DC-CK1. 








Figure 1. Expression of chem okines by immature and mature monocyte-derived DC. 
Chemokines expressed by freshly isolated m onocytes (a) immature monocyte-derived DC 
(day = 6) and DC stimulated with LPS or TNF-a (b) relative to PBGD. Each graph represents 
data from one representative donor out of 3. (c). Sandwich ELISA for DC-CK1, MDC and 
TARC produced by immature DC (for 48 hours) and DC stimulated with LPS or TNF-a (for 48 
hours).
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Q im m a tu re  DC

















Figure 2 . Relative mRNA expression of monocyte-derived DC cultured in autologous serum. 
Immature DC were generated by culturing m onocytes with IL-4 and GM-CSF in the presence 
of autologous serum for 6 days. Immature DC were matured using the combination of MCM, 
TNF-a and PGE2 . One representative experiment out of 4 is shown.
DC that produce large amounts o f IL-12 still express high levels o f MDC and 
TARC
Immature and mature monocyte-derived DC express high levels of MDC and 
TARC, two chemokines that preferentially support the attraction of T helper
2 cells via chemokine receptor CCR4 [21]. DC have been shown to induce 
either a T helper 1 or T helper 2 response, depending mostly on the 
production of IL-12, which skews the immune response towards a T helper 1 
response. DC m aturated via one stimulus, such as CD40L or LPS, do not 
produce IL-12. In contrast, DC stimulated with CD40L or LPS in the 
presence of IFN-y produce large am ounts of IL-12 [22, 23]. We investigated 
whether DC expressing high levels of the T helper 1-inducing cytokine IL-12 
down-regulate the expression of MDC and TARC. Therefore, immature DC 
were stimulated with CD40L and with a combination of CD40L and IFN-y. 
Both immature and CD40L-stimulated DC hardly expressed IL-12, however 
DC stimulated with a combination of IFN-y and CD40L produced large 
am ounts of IL-12 (Fig. 4a). Interestingly, we found that the addition of IFN-y 
to CD40L-stimulated DC had no effect on the expression of MDC and TARC 
(Fig. 4b) or on any chemokine in our panel. These data demonstrate that 
both DC types produce high levels of MDC and TARC, despite the difference 
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Figure 3. ELC but not DC-CK1 is up-regulated in CD 4 0L-activated DC. Relative mRNA 
levels of chemokines expressed by immature DC (day = 6) and DC activated with CD40L. 
One representative experiment out of 4 is shown.





























Figure 4. MDC and TARC are highly expressed in DC that produce high levels of IL-12. (a). 
IL-12p70 production of immature DC (day = 6), DC stimulated with CD40L and DC 
stimulated with CD40L in the presence of IFN-y, measured by ELISA. (b). Relative mRNA 
levels of DC-CK1, ELC, MDC and TARC expressed by these DC. One representative 
experiment out of 2 is shown.
Blood DC express lower levels of chemokines than monocyte-derived DC 
Knowing that cultured DC are capable of producing high levels of 
chemokines, we analyzed whether freshly isolated peripheral blood DC
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produced comparable levels of chemokines. Blood DC were isolated from 
PBMC by a negative depletion of B cells, T cells and monocytic cells, followed 
by a CD4 positive selection. The obtained blood DC were >95% pure and 
consisted of two defined DC subsets. According to literature, the lymphoid­
like CD 11c- DC subset had an oval or indented nucleus and expressed low 
levels of HLA-DR molecules (Fig. 5a), while the myeloid CD11c+ DC subset 
had a hyperlobulated nucleus and expressed higher levels of HLA-DR 
molecules and CD86 (Fig. 5a) [15, 24]. Semi-quantitative PCR analysis 
showed that freshly isolated blood DC expressed low levels of IL-8, 
lymphotactin, and MIP-1a, while the other tested chemokines were not 
expressed or at minor levels (Fig. 5b). To investigate whether chemokine 
expression is up-regulated in activated blood DC, CD 11c- DC were 
stimulated with IL-3 and CD40L [16]. CD11c+ DC were stimulated with 
MCM, which preferentially supports the maturation of CD11c+ blood DC [15]. 
Stimulated CD 11c- DC clearly up-regulated the expression of ELC (100-fold) 
and MDC (4500-fold), and induced relatively high expression of TARC (Fig. 
5c). In addition, these DC expressed low levels of IL-8, lymphotactin, and 
MIP-1 a. Interestingly, CD11c_ DC did not express DC-CK1. Mature CD11c+ 
DC expressed ELC, IL-8, MDC, MIP-1a, and TARC and, to a lower extent, 
DC-CK1, lymphotactin, and MIP-3a (Fig. 5b). ELISA confirmed the secretion 
of MDC and TARC by blood DC (Fig. 5d), while the production of DC-CK1 did 
not exceed background levels (data not shown). Altogether, these data 
indicate that the chemokine profiles of activated blood DC are surprisingly 
similar to the chemokine profile of monocyte-derived DC, though the 
expression levels are significantly lower.
a CD3, CD14 
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Figure 5. Relative mRNA levels of chemokines expressed by freshly isolated blood DC. (a). 
Freshly isolated blood DC were stained with PE-conjugated Abs to CD3, CD14, CD16, CD19 
and FITC-conjugated anti-HLA-DR Ab. Blood DC were defined as lineage-negative and HLA- 
DR positive cells (lower right quadrant). Nuclei of freshly isolated DC was stained with 
heamatoxylin and eosin, and surface markers were identified with PE-conjugated CD 11c, 
CD80, CD83 and CD86. (b) Relative mRNA levels of chemokines expressed by freshly 
isolated blood DC and CD11c+ DC stim ulated with MCM. (c). Freshly isolated blood DC and 
CD11c- DC stim ulated with IL-3 and CD40L. Each graph represents data from one 
representative donor out of 3. (d). Sandwich ELISA for MDC and TARC produced by 
activated CD11c- DC and CD11c+ d C (for 3 days).
96
Quantitative analysis of chemokines expressed by DC
LC express high levels o f IL-8, MDC and TARC
The DC in the skin are represented by LC [25]. We determined the 
chemokine profile of this in vivo DC subset. For this purpose, LC were 
allowed to migrate out of epidermal sheets during 2 days. LC expressed 
mainly IL-8, MDC and TARC and minor levels of ELC, fractalkine, 
lymphotactin and MIP-1a (Fig. 6). The chemokines DC-CK1, SDF-1a and 
SDF-1ß were not detected. Interestingly, LC expressed chemokines at levels 
similar to those of activated peripheral blood DC.
1000 n
Figure 6 . LC express high levels of IL-8, MDC and TARC. LC were allowed to migrate out of 
epidermal sheets for 2  days. Relative mRNA levels of chemokines expressed by LC were 
measured. One representative experiment out of 3 is shown.
D iscu ssion
Chemokines are important regulators for the recruitment of cells involved in 
the induction of an immune response. Since DC play a central role in the 
immune system, we analyzed the chemokine expression profiles of different 
hum an DC subsets in vitro and in vivo. Several studies have shown that DC 
express a variety of chemokines [5, 26]. We have analyzed in detail, using 
real-time quantitative RNA analysis, the expression of twelve chemokines 
that are involved in the recruitment of leukocytes into and inside secondary 
lymphoid organs DC. This technique allows the correlation of the expression 
levels of different chemokines with each other. In addition, chemokine 
profiles of distinct DC populations can be directly compared. Using this 
approach, we were able to demonstrate that monocyte-derived DC express a 
unique chemokine profile, different from that of monocytes. Additionally, 
hum an umbilical vein endothelial cells, a cell type known to produce various 
chemokines upon activation, expressed a completely different chemokine
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profile, including high levels of fractalkine, IL-8, MIP-3a, SDF-1a and SDF- 
1ß (data not shown).
Real-time quantitative PCR analysis revealed that monocyte-derived DC 
express high levels of the chemokines MDC and TARC. A recent study using 
serial analysis of gene expression also demonstrated a high abundance of 
messages for MDC and TARC in cultured DC [27]. Additionally, we 
demonstrated by ELISA that cultured DC secreted large am ounts of MDC 
and TARC proteins. Both chemokines attract T helper 2 cells, expressing the 
chemokine receptor CCR4 [21]. Recently, it has been shown that monocyte- 
derived DC mediating the induction of a T helper 1 response produce a 
cytokine profile different from that of those mediating the induction of a T 
helper 2 response [22, 23]. Interestingly, we showed that these two DC 
populations express similar chemokine levels, including MDC and TARC. 
This suggests that with regard to chemokine levels, monocyte-derived DC do 
not discriminate between the attraction of T helper 1 and T helper 2 cells. 
Rather, it seems that monocyte-derived DC are able to attract naïve T cells 
(DC-CK1 and ELC) as well as memory T cells (MDC and TARC), which have 
also been shown to express CCR4 [28]. Additionally, NK cells have been 
shown to express CCR4 and as a result respond to TARC and MDC [29, 30]. 
Thereby, DC may provide a link between the innate and acquired immune 
responses, since they can attract and activate NK cells [31].
Maturation of monocyte-derived DC by either LPS or TNF-a induced a 
significant up-regulation of DC-CK1 (60-fold), ELC (7-fold) and TARC (10­
fold), while the high-level MDC expression remained constant. Upon arrival 
of mature DC in secondary lymphoid tissue, DC can attract naïve T cells by 
secretion of the DC-specific chemokine DC-CK1 [32]. MDC and TARC will 
attract subpopulations of recently activated and memory T cells. In the case 
of an antigen-specific interaction the DC will activate the T cells, resulting in 
up-regulation of CD40L. CD40L in turn further activates the DC. 
Interestingly, we observed that ligation of the CD40 molecule on cultured DC 
induced a further up-regulation of ELC (25-fold). ELC can attract additional 
mature DC and subsets of T-lymphocytes, expressing CCR7 [33], and 
thereby help to sustain an inflammatory reaction. Accordingly, the 
expression of CCR7 gradually increases during DC maturation [26]. These 
findings support an important role for chemokines produced by mature DC 
in the organization of secondary lymphoid structures.
Compared to the housekeeping gene PBGD monocyte-derived DC produce 
large am ounts of chemokines. The analysis of immature DC cultured in 
autologous serum showed that these chemokine levels were independent on 
the presence of FCS. The most significant difference between DC cultured in 
medium containing autologous serum and those cultured in the presence of 
FCS was a higher expression of IL-8, which was up-regulated during 
maturation in the former. Monocytes produce high levels of IL-8 which 
decreases during the differentiation of these cells into DC (data not shown). 
Therefore, immature DC cultured in the presence of autologous serum seem 
less differentiated from monocytes than FCS cultured DC. This is supported 
by the finding that we were not able to mature DC cultured in autologous
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serum by the addition of a single stimulus. The combination of stimuli 
needed for the full m aturation of these DC could have contributed to the 
observed up-regulation of IL-8 expression.
We isolated peripheral blood DC and LC to study chemokine expression by 
DC subsets in vivo. Freshly isolated blood DC expressed only very low levels 
of IL-8, lymphotactin and MIP-1a, while activated blood DC expressed nearly 
all tested chemokines. ELC, MDC and TARC were up-regulated most 
strongly, while SDF1-a and SDF-1ß were not detected. Strikingly, the CD11c- 
lymphoid-like and CD11c+ myeloid blood DC subset had comparable 
chemokine profiles. The DC-specific chemokine DC-CK1 was detected only in 
activated CD11c+ blood DC. The absence of DC-CK1 expression in activated 
CD11c- DC could either represent a  lineage-dependent difference or result 
from the difference in stimulation of both subsets. The chemokine 
expression pattern of activated blood DC closely resembled that of monocyte- 
derived DC. Consequently, peripheral blood DC are capable to attract the 
same population of cells as monocyte-derived DC. The absolute chemokine 
levels expressed by peripheral blood DC were significantly lower than in 
monocyte-derived DC. However, in vivo, the chemokine concentration will not 
be dependent only on the am ount of protein produced but also on 
chemokine stability and the capture of chemokines by extracellular matrix 
proteins such as proteoglycans. This could allow chemokines expressed at 
lower concentrations to be functionally active in the appropriate 
microenvironment.
We (Fig. 5a) and others [15, 24] have demonstrated that the CD11c- blood 
DC subsets can clearly be distinguished phenotypically from the CD11cPos 
blood DC. However, at present, it is still uncertain which cells in vivo 
correspond to the in vitro stimulated blood DC subsets. The presence of 
lymphoid-like CD4+/CD11c- DC, also referred to as plasmacytoid cells, 
surrounding the high endothelial venules (HEV) in secondary lymphoid 
organs [34, 35], strongly suggests that lymphoid-like DC have directly 
migrated from blood through the HEV into the T cell area of the lymph node. 
This migration pattern is functionally distinct from the migration of DC 
which have migrated from peripheral tissues to secondary lymphoid tissues 
through afferent lymphatic system. CD 11+ blood DC are also capable of 
migrating across HEV, but seem to migrate into the B cell areas, likely 
represented by the phenotypically similar CD4+/CD11c+ germinal center DC 
[15, 34]. This is supported by specific expression of the B cell 
chem oattractant BLC (CXCL13) in both germinal center DC and activated 
CD11c+ blood DC (Chapter 7). The presence of high levels of co-stimulatory 
markers on the activated blood DC we have used for our analysis indicates 
that these cells most likely correspond to these lymphoid tissue DC.
LC are bone marrow-derived DC from the myeloid lineage that localize in the 
epidermis of the skin and are involved in antigen uptake [25]. The LC 
population used for our PCR analysis had migrated out of the epidermis over 
a two-day period, thereby inducing LC activation. These LC mainly express 
IL-8, MDC and TARC, which are also expressed at high levels by activated 
blood DC. LC do not express DC-CK1 and express only minor levels of ELC,
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although these chemokines are expressed by activated blood DC (DC-CK1 
only by CD11c+ blood DC) and in vitro cultured DC. Further studies in our 
laboratory indicate that at least DC-CK1 is a lineage-specific chemokine 
expressed by DC and is not expressed in LC, supporting the theory that LC 
form a separate myeloid DC lineage.
DC attract different cell types by adjusting their production of chemokines. 
Chemokine expression can be influenced by signals from inflammatory 
agents, contact with T cells and a changing microenvironment. Here, we 
demonstrated that despite differences in chemokine expression levels, all DC 
subsets in vitro and in vivo are able to attract the same leukocyte subsets. 
Therefore, regulation at the level of chemokine receptor expression on 
responder cells, including DC, is also important. In addition, high levels of 
chemokines will desensitize the receptor and render cells unresponsive to 
the appropriate chemokine(s), allowing responder cells to reside at particular 
sites despite the continued exposure to chemokines. Although various 
aspects of the chemokine system still have to be unraveled, chemokine 
regulation is now well appreciated to be essential for immune cells to find 
the proper partner at the right place and time during the immune response.
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BLC (CXCL13) is expressed by different dendritic cell 
subsets in vitro and in vivo
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Dendritic cells (DC) attract both T- and B-lymphocytes to induce an efficient 
antigen-specific immune response. Recently, it was shown that naïve T cells 
are attracted to DC by dendritic cell chemokine 1 (DC-CK1, CCL18). The 
potent B-lymphocyte chemoattractant BLC (CXCL13) was previously shown 
to be essential for homing of lymphocytes into secondary lymphoid organs 
and for the development of B-cell follicles. As the cells that produce BLC are 
largely unknown and BLC could be a candidate chemokine for the 
recruitment of B cells to DC, we analyzed different DC subsets for expression 
of BLC. Here we demonstrate that monocyte-derived DC as well as activated 
blood DC indeed express and secrete BLC. Interestingly, ligation of the CD40 
molecule down-regulated BLC expression in monocyte-derived DC. Staining 
of tonsilar sections indicated that BLC is expressed by follicular dendritic 
cells and germinal center dendritic cells (GCDC) in vivo. Real-time 
quantitative PCR confirmed the expression of BLC in isolated GCDC. Since 
both B cells and activated T cells express the receptor for BLC, our findings 
implicate an important role for BLC in establishing the interaction of DC 
with T cells and B cells. Furthermore, CD40/CD40L interactions could 
modulate this process by down-regulating the expression of BLC.




An antigen-specific immune response starts with capturing of antigens by 
immature dendritic cells (DC) in peripheral tissues. After antigen uptake, 
these DC migrate to the T-cell areas of the secondary lymphoid organs and 
become fully stimulatory DC. Clustering of DC with B cells and T cells is 
essential for the induction of an immune response [1]. Therefore, DC attract 
B cells and T cells by secreting chemokines. Chemokines induce directional 
migration of leukocytes during inflammation and are involved in the 
constitutive homing of lymphocytes into secondary lymphoid organs [2]. 
Homeostatic trafficking of DC, B cells and T cells into these organs is guided 
by specific chemokines, such as stromal cell-derived factor-1 (SDF-1, 
CXCL12), EBI1-ligand chemokine (ELC, CCL19), secondary lymphoid-tissue 
chemokine (SLC, CCL21) and B-lymphocyte chem oattractant (BLC, CXCL13) 
[2]. Recently, it has been demonstrated that DC produce DC-CK1 to attract 
naïve T cells [3].
A potential candidate for the attraction of B cells to DC is the potent B-cell 
chem oattractant BLC, which is constitutively expressed in lymphoid tissue 
[4, 5]. Its importance in homing of lymphocytes into secondary lymphoid 
organs came from studies on CXCR5-/- mice. Mice lacking CXCR5, the 
receptor for BLC, exhibited a defect in the development of B-cell follicles in 
the spleen and Peyer's patches and lacked inguinal lymph nodes [6]. The 
BLC receptor is expressed on mature B cells, a  subpopulation of memory T 
cells and is up-regulated on antigen-specific CD4+ T cells [7]. Here, we 
demonstrate that monocyte-derived DC, peripheral blood DC, follicular DC 
(FDC) and germinal center DC (GCDC) express BLC. These data suggest an 
important role for BLC in the chemoattraction of B cells, and also antigen- 
specific T helper cells, by DC in vivo.
M aterials and M ethods
Immunohistochemistry
Cytospins with cultured DC were stained with mouse anti-hum an BLC mAb, 
negative for crossreactivity to more than 50 mouse and hum an chemokines 
(R&D Systems Europe Ltd., GB), horse anti-mouse biotinylated IgG, 
avidin/biotin complexes (both Vector Laboratories Inc., Burlingame, CA) and 
peroxidase activity was revealed using AEC (Zymed Laboratories Inc., San 
Francisco, CA). Fixed cryosections of tonsils were permeabilized with 0.1% 
saponin (Sigma Chemical Co., St. Louis, MO). As primary Ab were used: 
mouse anti-hum an BLC mAb (single staining) and goat anti-hum an BLC 
(double stainings), both from R&D Systems Europe Ltd., Edu-2 (mouse anti­
hum an CD4, IgG2a, Novocastra Laboratories Ltd., UK), and DRC1 (mouse 
anti-hum an FDC, IgM, Dako, Denmark). BLC was stained with horse anti­
mouse biotinylated IgG or donkey anti-goat biotinylated Ab, enhanced with 
avidin/biotin complexes and stained with Fast-Blue substrate. Free avidin- 
and biotin-groups were blocked using an avidin/biotin blocking kit (all
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Vector Laboratories Inc.). Cell-specific antigens were stained with either goat 
anti-mouse biotinylated IgM or horse anti-mouse biotinylated IgG. Sections 
were incubated with 0.3% H2 O2 , enhanced with avidin/biotin complexes and 
peroxidase activity was revealed using AEC.
Generation of monocyte-derived DC
Immature DC were generated as described [3]. Immature DC (day 6) were 
stimulated by addition of either 10 ng/m l TNF-a, (Bender Wien, Vienna, 
Austria), 2 ^g/m l LPS (Sigma Chemical Co.) or 1 m g/ml CD40L trimer in 6 
well culture plates and harvested at day 8. DC cultured in autologous serum 
were prepared according to the same procedure, using X-VIVO 15 medium 
(BioWhittaker, Walkersville, MD) enriched with 1% autologous serum. 
Maturation was established by addition of the combination of 10 ng/m l TNF- 
a (Bender Wien), 10 ^g/m l PGE2  (Sigma Chemical Co.), and 50% (v/v) 
monocyte-conditioned medium (MCM), obtained from IgG-activated 
monocytes.
Isolation of fresh  blood DC and GCDC
Blood DC were isolated from PBMC using the MACS Blood DC isolation kit 
(CLB, Amsterdam, The Netherlands). To obtain activated CD4+/CD11c+ blood 
DC, freshly isolated blood DC were cultured in RPMI-1640 (Life 
Technologies, Inc.) enriched with 10% FCS and 50% (v/v) MCM for 3 days 
[12]. CD4+/CD11c- blood DC were obtained by an additional depletion of 
CD11c+ cells from the pre-enriched blood DC fraction using anti-CD11c mAb 
and magnetic sorting (Dynal, Oslo, Norway), followed by a positive selection 
for CD4. Isolated CD4+/CD11c+ blood DC were activated in RPMI-1640 
medium (Life Technologies, Inc.) enriched with 10% FCS and 100 U/ml IL-3 
for 4 days; one day before harvesting 1 mg/m l CD40L was added [11]. GCDC 
were purified as described by Grouard et al [14].
Real-time semi qua.ntitative PCR analysis
Reverse transcription was performed using 2.5 to 5 ^g DNAse treated total 
RNA, random hexamers and Mo-MLV reverse transcriptase (Life 
Technologies, Inc.). PCR amplifications were performed in triplicate using the 
TaqmanTM assay and the ABI/PRISM 7700 Sequence Detector System (PE- 
Applied Biosystems). Calculations were performed as described previously 
[8]. These calculations are based on the precondition that the efficiencies of 
BLC and reference amplification are approximately equal, which was 
confirmed by simultaneous comparison of serial dilutions of BLC and 
standard genes (not shown). The am ount of BLC expressed was normalized 
to GAPDH and per donor related to the expression level of the housekeeping 
gene PBGD. The BLC primers yield a specific product of 143 bp and 
surround an intron, resulting in a product of 437 bp on genomic DNA 
(sequence available upon request): forward primer, TCATAGTCTG- 
GAAGAAGAACAAGTCAA and reverse primer, TCAGCATCAGGGAATCTT- 
TCTCT and probe: CCATTCAGCTTGAGGGTCCACACACA (PE Biosystems, 
Branchburg, New Jersey). The sequences of the probes and primers of the
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housekeeping genes GAPDH and PBGD are as described [8].
BLC sandwich ELISA
The measurement of BLC (detection limit 25 pg/ml) was performed using a 
specific sandwich ELISA. Mouse anti-hum an BLC mAb was used as catching 
Ab and goat anti-hum an BLC polyclonal Ab as detection Ab (both R&D 
Systems Europe Ltd.), followed by donkey anti-goat biotinylated Ab (Vector 
Laboratories Inc.). Streptavidin-horseradish peroxidase conjugate (CLB) was 
used to specifically stain the biotin-labeled Ab and was visualized by 
incubation with TMB substrate. Absorption was measured at 450 nm.
R esu lts
Expression of BLC by cultured DC
We examined whether DC produce BLC in order to attract B lymphocytes. 
For this purpose we used real-time quantitative PCR, a new technique to 
precisely quantify mRNA levels. The housekeeping gene glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) was used as an internal control for the 
am ount of cDNA. Moreover, per donor the expression levels of the 
chemokines were related to the expression level of phorphobilinogen 
deaminase (PBGD), another housekeeping gene expressed at intermediate 
levels.
Real-time quantitative PCR analysis revealed that freshly isolated monocytes 
and monocytes cultured for 3 days with GM-CSF and IL-4 did not express 
BLC (Fig. 1). Interestingly, day 6 immature DC (MHC class I+, MHC class 
IIlow, B7.2low, B7.1-, CD83-) expressed BLC (Fig. 1). The expression level of 
BLC by monocyte-derived immature DC was lower than the expression of 
chemokines such as macrophage-derived chemokine (MDC, CCL22) and 
thymus and activation-regulated chemokine (TARC, CCL17), but was higher 
than that of lymphotactin (XCL1) and macrophage inflammatory protein-3a 
(MIP-3a, CCL20) [8]. Staining of cytospins of immature DC with an anti-BLC 
specific monoclonal antibody (mAb) demonstrated that BLC was also 















Figure 1. BLC is expressed by monocyte-derived immature DC. Expression of BLC in  
freshly isolated monocytes, immature monocyte-derived DC day = 3 and day = 6, relative to 
PBGD. Each graph represents data from one representative donor out of 3.
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Figure 2. Production of BLC by cultured DC and DC in B-cell follicles. Immature DC 
stained with isotype control Ab (a) and with anti-BLC mAb (red, b). Tonsil stained with 
isotype control Abs (c), and with anti-BLC mAb (blue, d). (e). Double-staining with anti-BLC 
(blue) and anti-DRC1 (orange). DRC1pos FDC expressing BLC are indicated by brown 
staining. (f). Double-staining with anti-BLC (blue) and anti-CD4 (orange). CD4pos GCDC 
expressing BLC are indicated by brown staining. Arrows indicate a single blue positive cell 
(^), a single orange positive cell (>) and a double positive cell (^), t = T cell area, and f = 
follicle. Magnification 10x (c and d) or 40x (e and f).
BLC is constitutively expressed by cultured DC and is down-regulated by 
CD40L
Immature DC were stimulated with either LPS or TNF-a, resulting in mature 
DC expressing (high) MHC class I and II, B7.1, B7.2, and CD83. Figure 3a 
shows tha t BLC expression is not affected by these stimuli, bu t is 
constitutively expressed by immature and mature DC. Analysis of immature 
DC and mature DC (stimulated with monocyte-conditioned medium (MCM), 
TNF-a and PGE2 ) generated in the presence of autologous serum excluded 
tha t the expression of BLC is dependent on FCS (Fig. 3b). CD40 ligation is a 
strong stim ulus which further activates DC [1]. Therefore, immature DC 
were activated with CD40L. Interestingly, CD40L-activated DC of all 4 tested 
donors down-regulated BLC expression approximately 5 times compared to
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immature DC (Fig. 3c). This down-regulation is specific for BLC, since other 
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Figure 3. Relative mRNA expression of BLC in several cultured DC populations. Immature 
monocyte-derived DC, DC stim ulated with LPS or TNF-a (a), immature and mature 
monocyte-derived DC cultured in autologous serum  (b) and immature DCs stim ulated with 
CD40L trimer (c). Each graph represents data from one representative donor out of 3.
1
BLC is expressed by peripheral blood DC
Having identified the production of BLC by in vitro cultured DC, the 
expression of BLC by freshly isolated peripheral blood DC was analyzed. The 
cell population was >95% pure, defined by the lack of lineage markers and 
high expression of MHC class II and the blood DC specific markers BDCA-2,
3 and 4. The isolated cell population contained two defined blood DC 
subsets: lymphoid like CD11c-/HLA-DRlow DC and monocytoid CD11c+/HLA- 
DRhigh DC [9, 10]. CD 11c- DC were specifically stimulated with IL-3 and 
CD40L [11] and CD11c+ DC with MCM [12]. Fig. 4 shows that freshly 
isolated blood DC expressed undetectable levels of BLC and activated 
CD11c- blood DC expressed low am ounts of BLC. However, activated CD11c+ 
blood DC expressed BLC at comparable levels as cultured monocyte-derived 
DC. A BLC specific sandwich ELISA demonstrated that activated CD11c+ 
blood DC secreted approximately 0.1 ng BLC protein per 1x106 DC in 3 
days, whereas BLC could not be detected in supernatant of activated CD11c- 
blood DC. BLC is secreted by activated CD11c+ blood DC at approximately 
250-fold lower levels than TARC, a chemokine that is highly expressed in 
both activated blood DC subsets [8].
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GCDC produce BLC in vivo
Since BLC was detected in B-cell follicles of secondary lymphoid organs, we 
studied whether DC in these follicles contribute to the production of BLC. 
Tissue sections of tonsils stained with anti-BLC mAb confirmed the 
expression of BLC in follicles (Fig. 2c, d). Double staining of BLC with a FDC- 
specific marker (DRC1) demonstrated that FDC expressed BLC (Fig. 2e), as 
was suggested by others [4, 13]. Not all FDC were positive for BLC, pointing 
towards a strict regulation of BLC expression by FDC. Since GCDC are 
positive for CD4, we performed a double staining for BLC and CD4 (Fig. 2f). 
Next to single CD4+ T cells in the T cell area, we found double positive cells 
in B-cell follicles, indicating that GCDC might produce BLC [14]. Since a 
subpopulation of CD4+ T cells can express CXCR5 and thereby bind 
exogenous BLC, these cells could also stain for both CD4 and BLC. To 
demonstrate that GCDC indeed express BLC, we purified these cells from 
tonsils. Purified GCDC clearly expressed BLC mRNA, at comparable levels as 
activated CD11c+ blood DC (Fig. 4c).
a 10 n Q b lo o d  DC
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Figure 4 . BLC is produced by activated blood DC and GCDC. (a). Expression of BLC by 
freshly isolated blood DC and CD 11c- blood DC activated with IL-3 and CD40L. (b.) 
Expression of BLC by blood DC stim ulated with MCM, which preferentially activates CD11c+ 
DC. One representative experiment out of 3 is shown. (c). Relative mRNA expression of BLC 
by GCDC compared to the expression of BLC by activated blood DC. The expression levels 
are relative to the expression of BLC in GCDC.
D iscu ssion
The B-lymphocyte chem oattractant BLC has been shown to be imperative for 
the formation of B-cell follicles [6, 15, 16]. In this study we demonstrate that
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the chemokine BLC is exclusively expressed and secreted by different DC 
subsets, both in vitro and in vivo, and not by both monocytes and (activated) 
hum an umbilical vein endothelial cells (data not shown). Monocyte-derived 
DC constitutively express BLC, since immature DC and DC stimulated with 
LPS or TNF-a express similar levels of BLC. Interestingly, DC down-regulate 
BLC expression upon CD40 triggering. This down-regulation mediated by 
CD40-CD40L interaction of DC with activated T cells might coincide with a 
decreased requirement for DC to attract B-lymphocytes in vivo.
In resting blood DC and activated lymphoid CD 11c- blood DC, BLC 
expression was not detectable or low, respectively. However, activated 
myeloid CD11c+ blood DC showed a clear expression of BLC on mRNA level. 
The lower expression level of BLC in activated CD 11c- DC could either 
represent a lineage-dependent difference or result from the activation by 
CD40L, which we have demonstrated to down-regulate BLC expression in 
monocyte-derived DC. Activated CD11c+ blood DC, as well as monocyte- 
derived DC (not shown), produce approximately 0.1 ng BLC per 1x106 DC in
3 days. In vivo, the concentration of a chemokine will not only be dependent 
on the am ount of protein produced, but also on the chemokine stability and 
the capture and presentation of the chemokine by extracellular matrix 
proteins such as proteoglycans.
We have demonstrated by double stainings of tonsil sections that FDC and B 
cells (not shown) express BLC, as has been suggested by others [4, 13]. 
Besides FDC, we now also identified GCDC as a DC subset that participates 
in the production of BLC in B cell follicles. At the mRNA level, GCDC express 
comparable levels of BLC as in vitro cultured DC, activated CD11cPos blood 
DC and tonsilar B cells. Since both GCDC and myeloid blood DC are also 
positive for CD4 and CD11c, the expression of BLC gives additional support 
for the idea that GCDC might correspond to myeloid blood DC that have 
migrated into follicles.
After recruitment of DC, B cells and T cells into secondary lymphoid organs, 
these cells have to interact with each other for the induction of an antigen- 
specific immune response [1]. During this process B cells can directly 
migrate into the follicles, guided by BLC. Our present data indicate that 
these B cells can migrate towards FDC and GCDC, which play an important 
role in the induction of a germinal center reaction. Interestingly, isolated 
GCDC were shown to induce differentiation of naïve B cells into plasma cells 
[17]. Alternatively, B cells might first interact with DC in the T-cell area, 
which is supported by a recent study showing that isolated T-cell area DC 
can induce isotype switching and IgM production in CD40-activated naïve B 
cells [18]. B cells could be attracted to these DC by DC-CK1, which was 
recently shown to attract naïve B cells [19]. Subsequently, these activated B 
cells migrate into the follicles towards FDC and GCDC under the influence of 
BLC. Naïve T cells do not directly migrate into follicles, but are attracted to 
DC in the T-cell area under the influence of DC-CK1 [3]. Upon activation, T 
cells up-regulate CXC5R and CX3CR1, and as a result become sensitive for 
BLC and fractalkine (CX3CL1), respectively, both produced by follicles [20,
21]. The characterization of a  subset of CXCR5+ T helper cells that efficiently
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enhance the production of immunoglobulins by tonsilar B cells supports a 
role for BLC in recruiting activated T cells into the follicle [22, 23]. Finally, 
FDC, GCDC, activated T helper cells and B cells are all present in the follicle 
to complete the germinal center reaction. Since FDC and GCDC express 
CD40, CD40L on the activated T cell could subsequently down-regulate BLC 
expression by FDC and GCDC to prevent the attraction of additional 
lymphocytes into the germinal center.
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Dendritic cells (DC) form a very heterogeneous population of cells that play a 
central role in the regulation of immune responses. DC combine efficient 
antigen uptake with migration to secondary lymphoid organs in order to 
activate antigen-specific naïve T cells. DC are flexible cells which can adjust 
their function upon changes in the microenvironment. Thereby, they can 
induce distinct immune responses, adapted to the microorganism that has 
invaded the host. The set of genes expressed by DC continuously changes as 
they migrate through the body and mature from cells that take up antigens 
to antigen presenting cells. Although some of these genes might be 
intrinsically regulated during the differentiation of a  DC, it is obvious that 
the gene expression pattern is strongly influenced by the signals delivered 
via cytokines, chemokines and contacts with other cells. These 
environmental signals might also be crucial for the development of a certain 
DC subset. Although recent data argue for the existence of a myeloid and 
lymphoid DC lineage, within these two subsets many different differentiation 
and maturation stages exist. In vivo, it is expected that these DC types 
develop in a continuous process, dependent on the microenvironment.
The unique features of DC could be explained by the high expression of MHC 
class I and II, co-stimulatory molecules and the differential expression of 
genes also expressed by other cell types. However, several DC-specific 
characteristics, such as the switch from antigen uptake to antigen 
presentation and their directed migratory behavior, point towards the 
expression of cell-specific genes that contribute to these characteristics. 
Indeed, several genes have now been described that appear specific for DC, 
at least in the haematopoietic lineage, such as DC-LAMP, Langerin, and DC- 
SIGN. The characterization of these molecules has helped to better 
understand DC’s unique functions, including antigen processing and T cell 
interaction. Likewise, the characterization of other novel DC-associated 
molecules will help to further explain the unique role of DC in the immune 
system. The biological characteristics of the newly identified molecules DC­
CK 1, DC-STAMP and DC203 are discussed in the first part of this chapter 
(I).
DC and the rare T and B cells that have a specific antigen receptor need to 
come into close contact in vivo in order to allow proper lymphocyte 
activation. Leukocyte trafficking is mediated by a group of chemotactic 
cytokines, called chemokines. DC produce a large variety of chemokines in 
order to attract the cells needed for the initiation of an immune response. 
Our quantitative PCR analysis of chemokines expressed by DC provide new 
insights into the role that these molecules play in the initiation phase of an 
immune response and are discussed in the second part of this chapter (II).
I. Id en tifica tion  and characterization  o f n ovel D C -associated m olecu les
We have applied differential display PCR (DD-PCR) as well as random 
sequencing of DC cDNA libraries in order to isolate novel DC-associated 
genes. Other DC-associated molecules, such as DC-LAMP, decysin and
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Langerin, have been isolated by others using different techniques, including 
a PCR-based subtraction hybridization technique and the generation of DC- 
specific antibodies. The more recently applied subtractive PCR technique has 
been very successful in the isolation of several DC-associated genes. This 
technique seems a good alternative for the DD-PCR technique we have used. 
The main advantages of this technique over DD-PCR are a lower am ount of 
false positive clones, targeting to regions of the cDNA that contain an open 
reading frame and a less labor-intensive procedure. However, DD-PCR has 
also been subject to improvements since its introduction in 1992. Examples 
are the use of longer primers, increasing the specificity of the PCR reaction 
[1], and primers that target to internal RNA regions [2]. In addition, more 
closely related cell populations can be used for comparison in the DD-PCR, 
decreasing the am ount of false positive clones. Clearly, our isolation of 
DC203 and the chemokine CXCL16, both displaying a DC-restricted 
expression pattern, proves the feasibility of the DD-PCR approach for the 
isolation of DC-associated differentially expressed genes. Random 
sequencing of clones from cDNA libraries prepared from DC does not select 
for differentially expressed genes, but appeared remarkably successful in the 
isolation of DC-associated molecules. Regardless, many cDNAs need to be 
sequenced in order to isolate low abundant genes and the screening for 
differentially expressed genes can be a troublesome task.
The techniques described above usually result in the isolation of partial 
cDNAs. The complete messengers were previously mainly obtained by 
screening of cDNA libraries and RACE PCR. The Human Genome Project 
proceeds at a rapid pace and has lead to the generation of an enormous 
am ount of available sequences. This information greatly facilitates the 
retrieval of complete cDNA sequences. Finally, the use of DNA chips, on 
which many different gene products can be exposed for hybridization, will 
prove another useful approach for the measurement of differential 
expression of known and recently isolated genes. For instance, the 
expression of DC-associated genes might be compared between the different 
DC subsets.
DC-CK1
The DC-specific chemokine DC-CK1 plays an important role in the attraction 
of naïve T lymphocytes towards the DC (Chapter 2) [3, 4]. More recent 
studies elucidated that DC-CK1 can also attract naïve B lymphocytes [5]. 
Staining of tonsil sections with a specific antibody confirmed expression of 
DC-CK1 in the T cell areas and in germinal centers. Real-time quantitative 
PCR demonstrated the expression of DC-CK1 in germinal center DC [5]. 
These data indicate that also in vivo DC-CK1 plays an active role in the 
establishment of clusters of DC, T and B cells. Real-time quantitative PCR 
clearly showed expression of DC-CK1 in myeloid blood DC that have been 
cultured in vitro, whereas lymphoid blood DC and Langerhans cells were 
negative for DC-CK1 expression (Chapter 6). These data suggest that DC-
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CK1 is only expressed by the myeloid DC subset, although it is still unclear 
whether the absence of DC-CK1 expression in lymphoid-like blood DC is due 
to down-regulation by the stimulus CD40L or represents a lineage- 
dependent difference. Expression of DC-CK1 by dendritic cells is induced by 
the cytokine IL-4 [6], but also IL-13 and IL-10 were shown to induce DC-CK1 
expression in macrophages [7]. Analysis of the promotor region of the DC­
CK 1 gene revealed several STAT6 binding sites for IL-4, supporting 
regulation of DC-CK1 by IL-4. Genomic screenings have indicated that the 
mouse DC-CK1 gene probably does not exist. This is supported by the 
observation that the hum an DC-CK1 gene has been generated by fusion of 
two MIP-like genes with deletion and selective usage of exons [8]. The 
absence of a mouse DC-CK1 gene suggests that this gene duplication and 
fusion has been a relative recent event.
The receptor for DC-CK1 is still unknown, although there is evidence that 
the response to this chemokine is a G protein-coupled receptor-mediated 
event [6]. Desentitization experiments have shown that DC-CK1 binds to a 
single receptor, that is not one of the known chemokine receptors, 
suggesting the existence of a novel chemokine receptor [3]. Radioactive 
binding studies [9] followed by immuno-precipitation could result in the 
isolation of the receptor of DC-CK1. Another approach involves the use of 
expression systems using RNA from naïve T or B cells. Alternatively, since 
the Human Genome Project rapidly discovers potential genes, orphan 
chemokine receptors could be screened for their expression and 
subsequently tested for their reactivity to DC-CK1. However, an appropriate 
read-out system should be available to confirm functionality of the putative 
receptor. These studies are hampered by the fact that DC-CK1 only attracts 
a  low percentage of purified T or B cells. In line with this, we were never able 
to detect calcium fluxes in T cells upon addition of DC-CK1. The presence of 
the DC-CK1 protein in solution in an inactive form, due to self-aggregation, 
is a  possible explanation for these problems. Scavenger molecules might 
bind DC-CK1 in vivo and retain DC-CK1 in its active confirmation. It has 
been shown for other chemokines that they bind to heparan sulphate 
proteoglycans (HSPG) in order to form a gradient in vivo and become 
activated [10]. HSPG are expressed by endothelial cells and are highly 
upregulated upon inflammation [11]. Indeed, DC-CK1 contains potential 
heparin binding residues.
Interestingly, high levels of DC-CK1 (up to 200 ng/ml) were measured in 
hum an serum by a DC-CK1 specific sandwich ELISA (Lindhout et al, 
submitted). HCC-1, another C-C chemokine, is also present in high 
concentrations in hum an plasma [12]. Possibly, these chemokines exert 
another, systemic, function in addition to the contribution to the immune 
response, and has additional effects on other cell types. A recent study 
demonstrated that high concentrations of DC-CK1 inhibited CCR3-mediated 
signaling induced by MCP4 or eotaxin with 50% [13]. The expression of 
CCR3 by eosinophils, Th2 lymphocytes and basophils, suggests that DC- 
CK1 limits the recruitment of Th2 lymphocytes by acting as an antagonist 
for CCR3. Recently, the Th1 chemokines I-TAC, Mig and IP-10, all ligands of
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the chemokine receptor CXCR3, have also been shown to act as antagonists 
for CCR3 [14]. Additionally, DC-CK1 is induced by IL-4, which is a typical 
Th2 cytokine. However, whether the high serum levels of DC-CK1 are indeed 
related to a role for DC-CK1 in the inhibition of Th2 responses is still 
unclear.
DC-STAMP
Random sequencing resulted in the isolation of the novel multimembrane- 
spanning receptor DC-STAMP (Chapters 3 and 4). DC-STAMP is expressed 
by cultured DC and activated myeloid blood DC, but not by LC or lymphoid­
like blood DC, suggesting that DC-STAMP, similar to DC-CK1, is a myeloid 
DC marker. DC-STAMP is also expressed by macrophages, but not by freshly 
isolated monocytes. Preliminary studies with mouse DC-STAMP cDNA have 
indicated that also in the mouse, DC-STAMP is rather specific for DC and 
macrophages. Interestingly, database searches identified several identical 
hum an ESTs cloned from osteoclastoma, a  tumor derived from osteoclasts. 
Recent studies have indicated that macrophages, DC and osteoclasts are 
myeloid cells and are closely related, as exemplified by the shared expression 
of several molecules, such as TRANCE [15, 16]. Osteoclasts are involved in 
the remodeling of bone by uptake of bone material, whereas both 
macrophages and DC are specialized in the uptake of antigens. Expression 
of DC-STAMP by these cell types might point toward a role for DC-STAMP in 
the process of antigen uptake, which is supported by down-regulation of DC- 
STAMP in mature DC. However, we were not able to detect DC-STAMP 
expression in mouse and hum an osteoclast cell lines. Alternatively, fresh 
tumor tissue could be analyzed or osteoclasts could be obtained by culturing 
monocytes with the cytokines M-CSF and IL-4 [17].
Additional important information that leads to more insight in the function 
of DC-STAMP in DC could come from the analysis of DC-STAMP expression 
in tissues. For these studies specific antibodies are needed that recognize 
the DC-STAMP protein. Several attem pts were undertaken to generate DC- 
STAMP specific antibodies by immunizing rabbits or mice with peptides, DC- 
STAMP transfectants or lysates. These strategies failed to generate an 
antibody that recognizes the DC-STAMP protein on Western blot or by FACS 
analysis. Since these immunizations did result in peptide-specific 
antibodies, these difficulties could result from a different conformation, due 
to the highly hydrophobic structure of the DC-STAMP protein. Cell lysates 
for Western analysis need a special extraction procedure to prevent 
aggregation of the DC-STAMP protein, which results in only partial 
denaturation. A second potential problem for the generation of antibodies is 
the high homology of the DC-STAMP gene in other species. Part of the DC- 
STAMP mouse homologue was isolated and showed approximately 80% 
identity in the amino acid sequence. Alternative approaches for the 
successful generation of DC-STAMP specific antibodies could therefore 
include immunizations with peptides or partial protein products, which have
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the lowest homology to the mouse DC-STAMP protein. Finally, DNA 
vaccination might provide endogenously expressed DC-STAMP protein that 
is presented in its correct conformation.
DC-STAMP might serve as an additional DC marker that can help to identify 
DC subsets in vivo. Expression of the DC-STAMP protein at the cell surface 
would facilitate its use as a DC marker. Expression of a fusion protein of 
DC-STAMP with GFP (green fluorescent protein) in a hum an embryonic 
kidney cell line, 293, resulted in partial membrane expression of the DC- 
STAMP protein. Many of the fusion proteins remained intracellular, probably 
in the ER/Golgi secretory pathway. In contrast, the DC-STAMP fusion 
protein was completely retained intracellular after transfection in several 
other hum an and mouse cell lines. The surface expression of DC-STAMP in 
293 cells could either be due to over-expression of the protein, or to a lack of 
additional proteins in the other cell lines that are somehow needed to 
transport DC-STAMP to the cell surface. These results strongly argue for 
studies on the natural cellular localization of DC-STAMP in DC. These 
studies might become more feasible, now several new methods have been 
developed for the transfection of non-differentiating cells as monocyte- 
derived DC. These methods include the combination of RNA and 
electroporation or liposomes [18, 19] and the use of adenoviral vectors [20]. 
Staining of DC-STAMP-GFP transfectants with an antibody directed against 
GFP indicated that the C-terminus of the DC-STAMP protein is located 
intracellular. The C-terminus contains several putative sites for 
phosphorylation, suggesting a role in signal transduction. Interestingly, two 
alternatively spliced cDNAs were isolated that either had a putative 
extracellular C-tail or completely lacked the C-terminus. Although we were 
not able to detect these cDNAs by Northern blot analysis, they might perform 
a regulatory role under different conditions or in other, yet undefined cell 
types expressing DC-STAMP. Strikingly, also an alternatively spliced DC- 
STAMP cDNA was isolated in the mouse. This cDNA resulted from alternative 
splicing at a different position than the hum an variants, but also had a 
putative extracellular C-terminus. This cDNA was expressed at similar levels 
in several DC populations tested, suggesting that it might encode for a 
protein that has a (different) function in mouse DC.
The lack of homology to other genes suggests that DC-STAMP represents a 
novel protein family. Fluorescent hybridization of the hum an chromosomes 
identified 8q22 as the location of the DC-STAMP gene. This locus does not 
harbor other genes encoding multimembrane-spanning proteins. However, 
this chromosome has not yet been fully sequenced and characterized. 
Hybridization of a  genomic library with a DC-STAMP specific probe identified 
several weakly hybridizing clones, possibly representing related genes that 
are members of the same protein family. Future experiments will have to 





Differential display PCR identified DC203, a putative transcription factor 
with an expression pattern highly specific for DC. DC203 is expressed by all 
tested DC subsets, including monocyte-derived DC, freshly isolated blood 
DC, activated blood DC of both myeloid and lymphoid origin, and isolated 
LC. Since DC203 seems to be expressed by all blood DC populations, it 
could be used as a marker for the amount of DC in blood, and possibly also 
in tissues. The ubiquitous expression of DC203 in DC suggests that DC203 
might play a role in the regulation of genes that have an important function 
in all DC subsets. However, no other molecules have been characterized so 
far, which are expressed by all DC subsets. Alternatively, DC203 might act 
as an early regulator of DC differentiation essential in activation of other DC- 
associated transcription factors. Recent studies have shown that 
plasmacytoid DC can be cultured in vitro from CD34pos uncomitted cells. 
This might allow for more detailed studies, that determine the expression 
levels of DC03 in lymphoid-like DC at different stages of differentiation [21,
22]. Furthermore, the transcriptional inhibitors Id2 and Id3 inhibit the 
differentiation of these cells into both plasmacytoid DC and T cells, whereas 
there is no effect on the in vitro generation of myeloid DC [22]. This provides 
additional proof for the existence of separate lymphoid and myeloid hum an 
DC populations that have developed along different haematopoietic lineages. 
It will be interesting to analyze whether there is a specific effect of DC203 on 
the expression of these transcriptional inhibitors.
Since DC203 is a putative transcription factor, an important question 
regarding its function is which set of genes is regulated by DC203. 
Candidate genes could include the DC-associated molecules DC-CK1, DC- 
STAMP and DC-SIGN. Several strategies can be followed to identify the genes 
that are under control of DC203. First, the generation of transfectants which 
over-express DC203. Phenotypical or gene expression analysis will identify 
cellular processes or genes that are influenced by DC203 expression. 
Second, the expression of DC203 in DC can be blocked by the expression of 
dominant negative m utants or by anti-sense technology. The use of 
dominant negative m utants requires the characterization of the active 
domains of DC203 that are involved in transcriptional regulation. DNA 
arrays might be useful, because they allow to simultaneously screen the up- 
or down-regulation of a large number of selected cDNAs. Alternatively, 
subtractive hybridization can reveal differentially expressed genes that are 
under the influence of DC203.
The DC203 gene is highly conserved in other species, implying an important 
function for DC203. The mouse cDNA of DC203 has a very high identity to 
the hum an DC203, especially in the putative DNA binding region. In 
addition, the mouse cDNA is also highly restricted to DC in the immune 
system. The generation of knockout mice and DC203-specific antibodies 




A more detailed functional characterization of the molecules DC-CK1, DC- 
STAMP and DC203 will provide more insight in the unique DC biology. 
Besides the obvious role of DC-CK1 in the attraction of both naïve T and B 
lymphocytes, it might also play a role in the regulation of Th2 responses. 
Furthermore, it will be interesting to determine whether lymphoid DC are 
indeed negative for DC-CK1 expression and to know which chemokines are 
used by this DC subset to attract naïve lymphocytes. The function of DC- 
STAMP might reveal more information on the differentiation requirements for 
myeloid DC, since its expression seems specific for myeloid but not lymphoid 
DC. Finally, analysis of genes regulated by DC203 might lead to the 
identification of additional DC-associated genes.
It is unlikely that the identification and characterization of all DC-associated 
genes will answer all remaining questions regarding DC function. The type of 
immune response initiated by a DC might not only be dependent on the 
array of proteins that are expressed by the DC, but is likely also influenced 
by the general immune status of the body at a certain moment. DC are 
thought to continuously migrate through secondary lymphoid tissue, but in 
the absence of a “danger signal”, they might be involved in peripheral 
tolerance rather than the initiation of immune responses [23]. These 
“tolerizing” DC might either lack expression of high enough levels of co­
stimulatory molecules that can activate naïve T cells, or express specific, yet 
unknown, molecules that play a role in tolerizing T cells. Interestingly, 
immature DC express empty MHC class II molecules as well as the peptide 
exchange factor HLA-DM at their cell surface [24, 25]. Thereby, these DC 
might bind exogenous peptides and, since this direct binding of peptides 
does not trigger the expression of co-stimulatory molecules, might play a role 
in the induction of tolerance. As DC become activated by inflammatory 
stimuli, they mature and more DC will migrate to the T cell areas. The 
presence of larger am ounts of DC will enhance the encounters with T cells, 
allowing longer functional contacts between a DC and T cell. This in turn will 
result in the activation of a higher percentage of T cells, leading to a more 
efficient induction of the immune response. As the immune response 
progresses, less DC might arrive in the secondary lymphoid organs, due to a 
decrease in the availability of antigen. In addition, T cells will die by 
activation-induced cell death, due to the expression of the apoptosis 
inducing receptor FasL. Together, this will result in a  down-modulation of 
the immune response. The type of immune response initiated at a certain 
time point is thus critically dependent on the am ount of cells present as well 
as their activation stage.
II. Role o f ch em ok in es expressed  by DC in  th e  in itia tio n  o f im m une  
resp onses.
In order to initiate specific immune responses in secondary lymphoid 
organs, DC, T cells and B cells all have to migrate into these organs. 
Chemokines and chemokine receptors play an important role in this
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directional migration of leukocytes. DC change their chemokine receptor 
expression after m aturation stimuli and become responsive to the 
chemokines ELC and SLC, which are constitutively expressed in lymphoid 
organs. Both naïve T and B cells express the receptors for SLC and SDF-1, 
whereas naïve B cells are also responsive to the B cell chem oattractant BLC. 
The leukocytes are most likely recruited into the lymphoid organs via 
migration across high endothelial venules (HEV), mediated by adhesion via 
selectins and integrins. Secondly, T cell area DC and germinal center DC 
(GCDC) in the lymphoid tissue have to attract T and B cells to enable close 
contact between these cells, needed for proper activation and stimulation of 
both the DC and T or B cell (Figure 1).
Quantitative PCR analysis of the expression of 12 chemokines involved in 
the recruitment of leukocytes by different DC subsets showed that mature 
monocyte-derived DC express high levels of many chemokines, including 
DC-CK1, ELC, MDC and TARC (Chapter 6). Upon arrival in the secondary 
lymphoid tissue, DC-CK1 and ELC both attract naïve B and T cells. In 
addition, ELC attracts a  subset of CCR7p°s memory T cells, central memory 
cells, as well as other mature DC, whereas MDC and TARC attract 
subpopulations of recently activated T cells, memory T cells and NK cells 
towards the DC. The organizing role of the DC-derived chemokines is 
underscored by the fact that relB-deficient mice, which lack mature DC, 
have profoundly disorganized T cell areas [26]. In addition, functional 
analysis of the immune system of several knockout mice lacking a specific 
chemokine receptor has confirmed an important function of these receptors 
in the organization of lymphoid tissues and the trafficking of immune cells.
The role o f chemokines in the induction of Th1 and Th2 responses
The chemokines MDC and TARC preferentially attract Th2 cells. 
Interestingly, mature DC which have been induced to produce high levels of 
the Th1 cytokine IL-12 express similar levels of these chemokines. 
Apparently, DC that induce either Th1 or Th2 responses both produce high 
levels of the Th2 chemokines TARC and MDC. However, several other 
possible regulatory mechanisms might be involved in the induction of either 
a Th1 or Th2 response. First, the responder cells may have distinct sets of 
chemokine receptors or alternatively, their receptors become desensitized at 
high local concentrations of chemokine. Secondly, DC have been described 
to produce the Th1 chemokines Mig and IP-10 [27]. It would be interesting to 
know whether the levels of these chemokines also remain constant upon 
maturation of DC into IL-12 producing APC. Thirdly, monocyte-derived DC 
have been generated in vitro by culture in GM-CSF and IL-4. Although DC 
isolated from peripheral blood that have been activated in vitro also produce 
high levels of TARC and MDC, the conditions of immune induction in vivo 
can not be completely mimicked. It is likely that the induction of Th1 or Th2 
responses is influenced in vivo by many factors, including the cytokine 
environment, the activation status of the T cell, the am ount of DC versus T 
cells and the time-point in the immune response. Finally, the stage of DC
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activation might be important. It was recently shown that monocyte-derived 
DC produce IL-12 only during a narrow time window and can become 
refractory for IL-12 production after a 12 hour stimulation with LPS, even 
when further stimulated with CD40L. As a consequence, these DC 
sequentially induce Th1 and Th2 responses [28]. Likewise, the expression of 
chemokines could alter during DC activation. Since we only measured the 
expression levels after 48 hours of stimulation, it would be interesting to 
determine the chemokine levels at more time points during DC activation. 
Besides the preferential attraction of Th1 or Th2 lymphocytes, chemokines 
might also have a direct influence on the differentiation of naive T cells to the 
Th1 or Th2 phenotype. Both MIP-1a and MCP-1 have been described as 
capable of inducing the differentiation of Th1 and Th2 cells [29]. 
Furthermore, also B cells have now been described that produce a Th1/Th2- 
like profile, effector B cells type 1 and 2 (Be1 and Be2) [30]. It would be 
interesting to check the responsiveness of these cells to the different 
chemokines. Future studies are needed to determine the effect of 
chemokines on the development of Th1/Th2 responses and the role of Be1 
and Be2 cells in this process.
The role o f BLC in the induction of immune responses
The chemokines DC-CK1, MDC and TARC mainly affect the trafficking of T 
lymphocytes in lymphoid tissues. The B cell chemo-attractant BLC is 
essential for the homing of B lymphocytes into secondary lymphoid organs 
and the formation of B cell follicles. Expression of BLC in pancreatic islets 
proved to be sufficient to induce lymphoid neogenesis, underlining the 
importance of BLC in the organization of lymphoid structures [31]. In vitro 
cultured DC, activated myeloid blood DC and isolated germinal center DC 
(GCDC) were identified as producers of BLC, in addition to B cells and 
follicular DC (FDC). Naive B cells enter the secondary lymphoid organs by 
responding to the chemokines SDF-1, SLC, ELC and BLC (Figure 1). Once 
inside the lymphoid tissue, B cells might directly migrate into the follicles 
under the influence of high levels of BLC produced in the follicles. However, 
for the induction of T cell-dependent antigen responses B cells m ust first 
come into contact with T cells. Antigen-stimulated B cells acquire 
responsiveness to ELC and SLC, most likely by upregulation of CCR7, 
directing them to the boundary of the follicle and T cell area [32]. Meanwhile, 
a  subset of T cells that are activated by 0X40L on (CD40L) activated T cell 
area DC upregulate the expression of CXCR5 while downregulating CCR7, 
allowing them to move towards the follicle under influence of BLC [33]. These 
T cells have been shown to enhance the production of immunoglobulins by 
tonsilar B cells in vitro, supporting a functional B-T cell encounter [34, 35]. 
Indeed, Th2 cells that been enforced to express CCR7 have reduced 
capability to help an efficient antibody response, due to redirection into the 
central T cell area [36]. In addition, antigen-stimulated B cells produce MIP- 
1ß, MIP-1a and MDC, chemokines that are effective in attracting activated T 
cells [37, 38]. B cells can follow an alternative route for trafficking in
122
General Discussion
secondary lymphoid organs. B cells might directly enter the T cell area, by 
attraction to T cell area DC expressing DC-CK1 [5]. BLC might also be 
involved in this process. However, we were not able to detect BLC-expressing 
cells outside the B-cell follicles. This could either mean that T-cell area DC 
do not produce BLC or that the expression of BLC by these DC is strictly 
regulated in vivo and is hard to detect in highly activated tonsils. A recent 
study showed that T cell area DC can induce isotype switching and IgM 
production in CD40-activated naïve B cells [39]. Subsequently, the activated 
B cells migrate into the follicles towards FDC and GCDC under the influence 
of BLC. GCDC also produce DC-CK1 and BLC, which might serve to attract 
more T and B cells for an antigen-specific encounter. Interestingly, isolated 
GCDC were shown to induce differentiation of naïve B cells into plasma cells 
[40]. Finally, some antigen-stimulated B cells that have been further 
activated by contact with T helper cells and GCDC will proliferate and give 
rise to the germinal center reaction.
Figure 1. Role of chemokines in the secondary lymphoid organ.
Leukocytes enter the secondary lymphoid organ via the high endothelial venules (HEV), 
mediated by several chemokines constitutively expressed in these organs (1). The B cells can 
either migrate directly into the follicle guided by the chemokine BLC (2), or first encounter T 
cell area DC th a t express DC-CK1 (3). DC-CK1 attrac ts  both naïve T and B lymphocytes. 
Both activated T cells and antigen-experienced B cells will subsequently migrate into the 
follicle under the influence of the chemokines DC-CK1 (expressed by GCDC) and BLC 
(expressed by GCDC and FDC). Inside the follicle, antigen-stim ulated B cells s ta rt the 
germinal center reaction.
Adapted from the Immunologist 7 /5  (1999.)
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P rospects for m olecular understanding o f DC im m unobiology
Although the number of genes, including DC-associated genes, that are 
being discovered is still increasing, the major challenge for the near future 
will be the biological characterization of these novel molecules. Their role in 
the induction of immune responses has to come from functional studies and 
the use of in vivo models. Likely, more information about their in vivo 
expression and about the factors that regulate their expression will help to 
understand the flexibility of the DC to induce distinct types of responses 
under different conditions. Furthermore, their differential expression might 
explain the contribution of the different DC subsets to the immune response. 
This information will be invaluable for the use of DC in the treatm ent of a 
variety of diseases, such as cancer, autoimmunity and transplant rejection. 
Although clinical trials have been started that make use of DC to vaccinate 
patients, their application certainly needs optimization. A more profound 
knowledge of the role of chemokine and chemokine receptors in the 
induction of immune responses will allow to specifically inhibit or promote 
the recruitment of subpopulations of immune cells to specific immunological 
sites. Thereby, immune modulators may be developed that support the effect 
of the DC vaccination protocols.
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N ederlandse S am en v a ttin g
Het immuunsysteem beschermt het lichaam tegen aanvallers van buitenaf, 
zoals virussen en bacteriën. De T en B cellen vormen een onderdeel van het 
immuunsysteem. Deze cellen hebben receptoren op hun oppervlak, waarmee 
ze specifiek stukjes eiwit herkennen. Elke cel bestaat uit vele eiwitten, die 
ieder een bepaalde funktie uitoefenen in de cel, bijvoorbeeld als een 
transporteiwit of als onderdeel van een ionkanaal. Ook bacteriën en virussen 
maken allerlei eiwitten, die verschillen van de humane eiwitten. Als de T of B 
cel een stukje herkent van een lichaamsvreemd eiwit, of een gemuteerd eigen 
eiwit, zoals dat voorkomt in tumoren, zal de T en /of B cel worden 
geaktiveerd. Deze stukjes lichaamsvreemde of veranderde eiwitten worden 
ook wel antigenen genoemd. De aktivatie van de T en /of B cellen is het 
signaal voor het van start gaan van de antigeen-specifieke immuunreaktie. 
De B cel gaat neutraliserende antilichamen produceren, die aan het 
herkende eiwit kunnen plakken. Hierdoor kunnen macrofagen, de opruimers 
van het immuunsysteem, cellen met dit eiwit op gaan ruimen. De T cellen 
gaan na herkenning van een antigeen oplosbare stoffen, cytokinen, 
produceren, of kunnen zelf de geïnfekteerde of gemuteerde cellen doden. 
Cytokinen helpen de T en B cellen bij het uitoefenen van hun funktie. 
D aarnaast zijn de B en T cellen in staat geheugen te ontwikkelen, zodat een 
zelfde afweerreaktie een volgende keer sneller en efficiënter op gang komt.
T en B cellen die nog niet eerder een bepaald lichaamsvreemd antigeen zijn 
tegengekomen, naïeve T en B cellen, zullen alleen worden geaktiveerd, indien 
het antigeen wordt gepresenteerd door cellen die hier gespecialiseerd in zijn. 
Dit zijn de zogenaamde dendritische cellen, verder DC genoemd. Deze DC 
bevinden zich in een onrijpe vorm in alle weefsels, om bij een infektie 
antigenen te herkennen en op te nemen. Na opname van de antigenen 
migreren de DC naar de lymfeklieren, waar de specifieke aktivatie plaats 
vindt van de B en T cellen. Hiervoor moeten veel contacten gelegd worden 
tussen DC, T en B cellen, om de kans te vergroten dat een T of B cel de 
receptor heeft die het gepresenteerde antigeen herkent. De migratie van de 
cellen van het immuunsysteem vanuit de perifere weefsels naar de 
lymfeklieren staat onder controle van een speciale groep eiwitten, de 
chemokines. Deze stoffen binden aan chemokine receptoren op het 
celoppervlak, waardoor de cellen in een bepaalde richting bewegen. Dit kan 
worden vergeleken met vissen die naar een bron van voedsel of licht 
toezwemmen. Doordat DC, T en B cellen andere combinaties van chemokine 
receptoren tot expressie brengen. volgen deze cellen verschillende routes in 
het lichaam en in de lymfeklieren.
DC spelen een kritieke rol in het aktiveren, en soms ook het afzwakken van 
de immuunrespons. Deze cellen zijn de afgelopen jaren dan ook steeds meer 
in de belangstelling komen te staan ten behoeve van de behandeling van 
ziekten, waaronder kanker en autoimmuunziekten, zoals reuma. Immers, bij 
deze ziekten is het van belang de immuunrespons te versterken of ju ist af te 
remmen. Hierbij wordt gebruik gemaakt van de mogelijkheid om DC in vitro, 
in het laboratorium, met behulp van specifieke cytokinen in een aantal
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dagen vanuit monocyten te kweken. Monocyten komen veelvuldig in het 
bloed voor, terwijl DC heel zeldzaam zijn (minder dan 0.5% van de witte 
bloedcellen). Deze gekweekte DC, die zijn beladen met antigenen, kunnen de 
immuunrepons aan- of afzetten. De eerste studies in patiënten hebben laten 
zien dat dit inderdaad mogelijk is. Er is echter nog veel onderzoek 
noodzakelijk voor de optimalisatie van deze vorm van immuuntherapie.
Het doel van het onderzoek beschreven in dit proefschrift is het vinden van 
nieuwe genen die specifiek tot expressie komen in de DC. Een verdere 
karakterisatie van deze genen zal meer inzicht geven in de specifieke funkties 
van DC. Ondanks dat elke cel al het genetische materiaal bevat (het 
genoom), komen slechts een beperkt aantal van de genen tot expressie. De 
set van verschillende genen die “aanstaan” bepalen het karakter van de cel. 
Een oog heeft een duidelijk andere struk tuur en funktie dan bijvoorbeeld een 
vinger. Elk gen (DNA) dat tot expressie komt, wordt overgeschreven in het 
boodschapper RNA. Het RNA bevat de genetische code voor de vertaling in 
eiwitten. Verschillende genen staan in bijna elke cel aan, terwijl andere 
genen alleen aktief zijn in bepaalde type cellen.
Voor de isolatie van DC-specifieke genen beschreven in dit proefschrift zijn 
twee verschillende DNA technieken gebruikt: “random sequencing” en 
“differential display PCR”. Voor random sequencing is er een kopie gemaakt 
van al het RNA in een DC (copy DNA) en van deze cDNA’s is vervolgens de 
sequentie, de DNA volgorde, bepaald (het sequencen). Deze methode kan 
worden vergeleken met het “vissen” in een grote oceaan vol met genen. De 
tweede strategie maakt gebruik van een gel matrix, dat de cDNA molekulen 
op grootte kan scheiden. Door de cDNA populaties van verschillende celtypen 
naast elkaar te zetten, kan het patroon van de DC-cDNA’s worden vergeleken 
met dat van andere cellen (zie Figuur 1, hoofdstuk 5). cDNAs die specifiek in 
de DC tot expressie leken te komen, zijn vervolgens uit de gel matrix 
geïsoleerd en gesequenced. Deze techniek maakt dus al een voorselektie voor 
genen die voornamelijk in DC aktief zijn. Er wordt nu dus op genen “gevist” 
in een geselekteerde vijver. De verkregen cDNA sequenties zijn vergeleken 
met de bekende cDNAs, die in publieke databases op het internet zijn te 
vinden. Op basis hiervan zijn enkele cDNAs geselekteerd die nog onbekend 
zijn en een specifieke expressie in DC vertonen.
Hoofdstuk 2 beschrijft het eiwit DC-CK1 (dendritische cel chemokine 1). DC- 
CK1 is een chemokine dat specifiek gemaakt wordt door de DC. Studies met 
allerlei soorten cellen toonden aan dat DC-CK1 betrokken is bij het 
aantrekken van naïeve T cellen. Samen met de expressie van DC-CK1 in de 
lymfeklieren, geeft dit sterke aanwijzingen dat dit chemokine belangrijk is 
voor het leggen van contacten tussen DC en naïeve T cellen. Dit contact is 
onmisbaar voor het starten van een specifieke immuunrespons in het 
lichaam.
Een ander DC-specifiek eiwit dat door random sequencing is geïsoleerd, is 
het eiwit DC-STAMP (hoofdstuk 3). DC-STAMP, DC-specifiek transm em braan 
protein, komt specifiek tot expressie in DC en macrofagen. Analyse van de 
eiwitsequentie toonde aan dat dit eiwit in de membraan voorkomt en zich 
meerdere malen door de membraan heen- en terugvouwt. Over de funktie
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van het DC-STAMP eiwit is nog niets bekend. Gezien de vroege expressie van 
DC-STAMP in de ontwikkeling van monocyt naar DC, is het mogelijk dat DC- 
STAMP belangrijk is voor de uitrijping tot een DC.
Behalve het cDNA is ook het gen geïsoleerd dat codeert voor het DC-STAMP 
RNA en eiwit. Het koppelen van een fluorescente, licht uitstralende stof aan 
het gen toonde aan dat het DC-STAMP lokaliseert op het 8e chromosoom, op 
positie q22. Deze regio op het chromosoom is geassocieerd met bepaalde 
vormen van bloedkanker, de zogenaamde myeloide leukemiëen. Onduidelijk 
is nog of een verstoorde funktie van het DC-STAMP eiwit iets te maken heeft 
met het ontstaan van deze leukemiëen. Bovendien is gekeken naar de 
genstruktuur van DC-STAMP. Elk gen bestaat uit stukken DNA die de code 
voor het eiwit bevatten, de coderende gedeelten, en de niet-coderende, 
gedeelten, respectievelijk exonen en intronen. Het DC-STAMP eiwit wordt 
gecodeerd door 3 exonen en 4 intronen. Tijdens het proces van kopiëren van 
het DNA in het RNA worden de intronen verwijderd. Door variaties in dit 
proces kunnen er nieuwe RNA varianten ontstaan, die voor een alternatief 
eiwit coderen. Hoofdstuk 4 beschrijft dat ook voor het DC-STAMP gen twee 
van zulke varianten bestaan. Echter, de gevonden expressie van deze 
varianten in de DC is zo laag, dat een funktionele relevantie van deze 
eiwitten in de DC twijfelachtig is.
De differential display techniek leverde een heel klein stukje cDNA op, dat 
zeer specifiek in de DC tot expressie komt, en waarvan de sequentie geheel 
onbekend is. Dit gen is DC203 genoemd en staat beschreven in hoofdstuk 5. 
Met veel moeite kon het volledige cDNA van DC203 worden geïsoleerd. Dit 
bleek een nieuwe sequentie te bevatten, met daarin een stukje DNA dat 
codeert voor een DNA-bindend domein. Dit geeft zeer sterke aanwijzingen dat 
DC203 voor een transcriptiefactor codeert. Transcriptiefactoren zijn eiwitten 
die betrokken zijn bij de regulatie van het aan- en afzetten van genen. 
Toekomstig onderzoek van DC203 zal zich daarom richten op de isolatie van 
genen die door DC203 worden gereguleerd. Ook voor DC203 is de 
genstruktuur bepaald. Het DC203 eiwit wordt gecodeerd door 5 exonen. 
Verder is het DC203 gen gedurende de evolutie hoog geconserveerd. Dit 
bleek ondermeer uit de isolatie van het DC203 gen bij muizen. De sequentie 
van het DC203 eiwit in de muis is meer dan 80% identiek aan het humane 
eiwit.
Chemokines zijn belangrijk voor het bij elkaar brengen van de DC, T en B 
cellen in de lymfeklieren om efficiënt een imm uunrespons tot stand te 
brengen. Van een twaalftal chemokines die betrokken zijn bij dit proces is 
nauwkeurig de expressie door een DC bepaald. Hiervoor is gebruik gemaakt 
van de kwantitatieve PCR, een techniek die specifiek cDNA vermenigvuldigd, 
zodat deze detekteerbaar worden. Deze nieuwe methode maakt gebruik van 
een fluorescent stukje specifiek DNA. Doordat deze fluorescente groep 
specifiek vrij komt als het cDNA zich vermenigvuldigt, kan in de tijd de 
reaktie worden gevolgd. Een gen dat heel aktief is, zal meer RNA molekulen 
in de cel opleveren, waardoor er meer fluoriscentie vrijkomt bij de 
vermenigvuldiging van het RNA. Doordat tegelijkertijd de expressie wordt 
gemeten van een zogenaamd “huishoudgen”, dat in alle cellen ongeveer even
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hoog tot expressie komt, is het mogelijk nauwkeurig de hoeveelheid 
chemokine RNA van verschillende celpopulaties met elkaar te vergelijken. 
Behalve door het kweken uit monocyten, kunnen DC ook uit vers bloed 
worden geïsoleerd. Deze bloed DC kunnen weer worden onderverdeeld in 
twee verschillende populaties, die vermoedelijk een verschillend 
differentiatieproces ondergingen. Ook kunnen de monocyt-DC en de bloed 
DC weer met verschillende combinaties cytokinen verder worden uitgerijpt 
en geaktiveerd. Hoofdstuk 6 beschrijft dat deze DC populaties over het 
algemeen hetzelfde expressiepatroon van de gemeten chemokines vertonen. 
Dit zou betekenen dat deze populaties allemaal dezelfde cellen kunnen 
aantrekken, ongeacht waar de DC zich in het lichaam bevindt. Aangezien dit 
niet erg waarschijnlijk is, duidt dit erop, dat er nog meer 
regulatiemechanismen aanwezig moeten zijn in het lichaam. Het aan- en 
uitschakelen van de chemokine receptoren op de cellen die worden 
aangetrokken is hiervan een voorbeeld.
Het chemokine BLC (B lymfocyt chemoattractant) speelt een belangrijke rol 
bij de migratie van B cellen naar de lymfeklieren. Echter, het is tot nog toe 
onduidelijk welke cellen dit chemokine produceren. Hoofdstuk 7 beschrijft 
dat de DC in de B cel gebieden van de lymfeklieren specifiek BLC tot 
expressie brengen en ook het BLC eiwit kunnen maken. Deze waarneming 
geeft aan dat ook hier de DC een belangrijke rol speelt bij het aantrekken 
van een deelpopulatie van lymfocyten.
Tenslotte geeft hoofdstuk 8 aan, wat deze resultaten betekenen voor het 
beter begrijpen van de funktie van de DC, en waar toekomstig onderzoek zich 
op kan richten. Een beter begrip van de funktie van de eiwitten DC-STAMP 
en DC203 geeft inzicht in de regulatieprocessen die leiden tot de uitrijping 
van een DC. In de toekomst kan hierdoor gerichter worden besloten welke 
soort DC en in welk aktivatiestadium deze het beste kan worden gebruikt 
voor de behandeling van kanker, autoimmuunziekten, en orgaan- 
transplantaties. De chemokines kunnen hierbij mogelijk worden gebruikt om 
specifieke populaties van lymfocyten, die belangrijk zijn voor de aktivatie of 




Nu het boekje af is, is het moment gekomen om iedereen te bedanken die op 
enige wijze heeft bijgedragen aan het tot standkomen van dit proefschrift. 
Zonder de hulp van velen was het me nooit gelukt om mijn promotie­
onderzoek tot een goed einde te brengen. Ik wil iedereen die een bijdrage 
heeft geleverd hartelijk bedanken, en een aantal mensen met name noemen.
Gosse, als co-promotor ben je zeer nauw betrokken geweest bij het 
onderzoek. Ik heb je enthousiasme voor het ontrafelen van de moleculaire 
biologie van de DC altijd erg gewaardeerd. Verder wil ik je bedanken voor je 
inzet om er samen iets van te maken. Carl, als promotor heb je de grote 
lijnen van het onderzoek altijd goed in de gaten gehouden. Bedankt voor je 
vertrouwen dat dit een goed boekje zou worden, en je bijdragen aan de 
discussies.
Alle medewerkers van het TIL wil ik bedanken voor alle gezelligheid en hulp, 
m aar vooral ook voor alle steun tijdens de perioden dat ik vanwege mijn knie 
niet naar het lab kon komen. Maaike en Joost, ik ben erg blij dat jullie mijn 
paranimfen zijn, omdat jullie mij zoveel gezelligheid en steun hebben 
gegeven. Maaike, behalve dat ik op het lab altijd vol vertrouwen van alles aan 
je over kon laten, heb je ook daarbuiten veel voor me gedaan. We zijn samen 
overal geweest, AH, EHBO, Intratuin, fitness, niets vond je te veel moeite. 
Joost, ons gezamenlijke chemokine-projekt is een groot succes geworden. We 
hebben heel wat afgepraat tijdens het uitvullen van de duizenden Prism 
epjes en avondvullende DC isolaties. Je  gaf nooit de moed op, ook al hadden 
we uiteindelijk geen DCs of RNA, en was het de hoogste tijd voor yoga!
De ex-TIL-lers Gill, Edwin, Bram, Jose, Riet en Danielle wil ik bedanken voor 
de gezelligheid in mijn eerste jaren op het TIL. Jolanda, bedankt voor je 
steun en optimisme tijdens alle leuke en iets minder leuke momenten en het 
vervoeren van van alles en nog wat naar mijn huis. Marco, je hebt me heel 
wat keren opgevrolijkt met je gekke uitspraken en gewaagde rolstoelritjes. 
Judith , Rik, Danielle, ik ben blij dat ik naar de AIO-kamer op de 2e 
verdieping ben verhuisd. Ik denk nog vaak terug aan alle momenten waarin 
we de hindernissen van het AIO-schap, m aar ook de belevenissen van het 
afgelopen weekend deelden.
Ruurd, bedankt voor al je moeite een specifiek antilichaam tegen DC-STAMP 
te maken. Ernst, je kennis van de chemokines was altijd zeer bruikbaar. 
Dagmar, bedankt voor al je hulp bij de antilichaamscreeningen, en ik weet 
zeker dat je de topologie van DC-STAMP nog gaat ophelderen!
Bas en Claudia, als student hebben jullie een belangrijke bijdrage geleverd 
aan dit proefschrift. Ik heb het erg leuk gevonden samen aan DC-STAMP en 
DC203 te werken, en jullie enthousiasme heeft me geholpen om tijdens de 
wat moeilijkere periodes de motivatie erin te houden.
Sandra, Danielle en Maaike, ik hoop dat er nog veel gezellige wandel, fiets 
en /of vaarweekendjes zullen volgen!
Ger, jij hebt als “ICS mentor” veel voor mij betekend, omdat ik altijd bij je 
terecht kon om even stoom af te kunnen blazen en een mening “van
131
Dankwoord
buitenaf” te horen. Ik vind het dan ook erg leuk dat je lid bent van de 
manuscriptcommissie.
De medewerkers van de afdelingen Haematologie en Celbiologie ben ik erg 
dankbaar voor de vele keren dat ze met een gesorteerde cellijn, antistof, 
vector of advies voor me klaar stonden. Gerard Merkx van de afdeling 
Anthropogenetica wil ik bedanken voor de mooie FISH plaatjes.
Ook veel mensen buiten het lab hebben ervoor gezorgd dat ik een leuke tijd 
heb gehad in Nijmegen, en uiteindelijk ook nog ga promoveren! Gienke, Gill, 
Bram, Jose en Suzan, bedankt voor alle gezellige avondjes en etentjes! Jose 
en Bram, ook bedankt voor al jullie hulp als “bijna buren”. Esther, Anja, 
Louise, bedankt voor al die keren dat jullie naar het “verre oosten” zijn 
afgereisd en we de omgeving hebben verkend, en gewoon omdat jullie er 
altijd voor me zijn.
Marcel Gerritse en Martijn Wijdeveld wil ik bedanken voor hun inzet mij weer 
aan het lopen respectievelijk rennen te krijgen.
Pieter, je hebt van heel dichtbij de laatste periode van mijn promotie­
onderzoek meegemaakt. Samen zijn we heel wat keren tot de conclusie 
gekomen dat de wetenschap een heel aparte wereld is. Bedankt dat je altijd 
altijd bereid was om naar me te luisteren, en, Leiden is zeker niet verder dan 
Zuid-Limburg!
Mijn ouders wil ik hier heel hartelijk bedanken voor hun onvoorwaardelijke 
steun, en het vertrouwen in een goede afloop. Als het nodig was, sprongen 
jullie altijd meteen in de trein naar Nijmegen. De komende tijd zal ik weer 
wat vaker in de gelegenheid zijn eens een avondje langs te komen.
132
Curriculum Vitae
C urricu lum  V itae
Franca Hartgers werd op 28 januari 1972 geboren te Haarlem. Na het 
eindexamen VWO aan het Ichtus College te Driehuis-Velsen, begon zij in 
1990 aan de studie Medische Biologie aan de Vrije Universiteit van 
Amsterdam. Tijdens de doctoraalfase werden twee immunologische stages 
gelopen bij de afdeling KNO (VU ziekenhuis Amsterdam) onder leiding van 
Dr. Ruud Brakenhoff en de afdeling Immunohaematologie en Bloedbank, 
sectie Tumorimmunologie (Academisch Ziekenhuis Leiden) onder begeleiding 
van Dr. Stephen Schoenberger en Dr. Martin Kast. Als afsluiting van haar 
studie deed zij onderzoek aan apoptose bij het Institut de Recherches 
Cliniques de Montréal (Canada) in het Laboratoire d’ Immunologie van Dr. 
Rafick-Pierre Sékaly. In januari 1996 behaalde zij haar doctoraalexamen 
medische biologie.
In februari 1996 begon ze als assistent in opleiding (AIO) bij de afdeling 
Tumorimmunologie van het Academisch Ziekenhuis St. Radboud te 
Nijmegen, onder begeleiding van Dr. Gosse Adema en Prof. Dr. Carl Figdor. 
Op deze afdeling werd onderzoek verricht aan de moleculaire karakterisatie 
van dendritische cellen, zoals beschreven in dit proefschrift. In 1998 ontving 
zij het Dr. Frye stipendium, een stimuleringsprijs voor vrouwelijke 
promovendi, waardoor zij het 5th International Symposium on Dendritic 
Cells in Fundamental and Clinical Immunology, Port Douglas, Australië, kon 
bijwonen.





List o f P ub lica tions
Alam, A., Braun, M.Y., Hartgers, F., Lesage, S., Cohen, L., Denis, F. and 
Sékaly, R.-P. (1997) Specific activation of the cystein protease CPP32 during 
negative selection of T cells in the thymus. J. Exp. Med.., 186: 1503-1512.
Marland, G., Hartgers, F., Veltkamp, R., Königswieser, M.F.C., Gorman, 
D.M., McClanahan, T., Figdor, C.G. and Adema, G.J. (1997) Analysis of 
dendritic cells at the genetic level. In: Dendritic Cells in Fundamental and 
Clinical Immunology, Vol 3; ED: P. Ricciardi-Castognoli, Plenum Publ. 
Corporation.
Adema, G.J., Hartgers, F., Verstraten, R., De Vries, E., Marland, G., Menon,
S., Foster, J.S., Xu, Y., Nooyen, P., McClanahan, T., Bacon, K.B. and Figdor, 
C.G. (1997) A dendritic-cell-derived C-C chemokine that preferentially 
attracts naive T cells. Nature 387: 713-717.
Schoenberger, S.P., Jonges, L.E., Mooijaart, R .J.D., Hartgers, F., Toes, 
R.E.M., Kast, W.M., Melief, C. J.M. and Offringa, R. (1997) Efficient direct 
priming of tumor-specific cytotoxic T lymphocytes in vivo by an engineered 
APC. Cancer Research 58: 3094-3100.
Hartgers, F.C., Vissers, J.L.M., Looman, M.W.G., van Zoelen, C., Huffine, C., 
Figdor, C.G. and Adema, G.J. (2000) DC-STAMP, a novel multimembrane- 
spanning molecule preferentially expressed by dendritic cells. Eur. J. 
Immunol. 30: 3585-3590.
Hartgers, F.C., Figdor, C.G. and Adema, G.J. (2000) Towards a molecular 
understanding of dendritic cell immunobiology. Immunol. Today 21: 542-545.
Lindhout, E., Vissers, J.L.M., Hartgers, F.C., Huijbens, R.J.F., Scharenborg, 
N.M., Figdor, C.G., and Adema, G.J. (2001) The dendritic cell specific CC- 
chemokine DC-CK1 (CCL18) is expressed by germinal center dendritic cells 
and attracts CD38-negative mantle zone B lymphocytes. J. Immunol. 166: 
3284-3289.
Hartgers, F.C., Looman, M.W.G., van der Woning, B., Gerard Merkx, G., 
Figdor, C.G. and Adema, G.J. (2001) Genomic organization, 5' regulatory 
region and chromosomal localization of the hum an DC-STAMP 
gene.Immunogenetics, In Press.
Vissers, J.L.M., Hartgers, F.C., Lindhout, E., Teunissen, M.B.M., Figdor,
C.G. and Adema, G.J. (2001) Quantitative analysis of chemokine expression 
by dendritic cell subsets in vitro and in vivo. J. Leuk. Biol., In Press.
Hartgers, F.C., Vissers, J.L.M., Lindhout, E., Figdor, C.G. and Adema, G.J.
135
Publications
(2001) BLC is expressed by different dendritic cell subsets in vitro and in 
vivo. Eur. J. Immunol., In Press.
136
